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Abstract 
The yeast Saccharomvces cerevisiae utilises many transport pathways for the 
efficient and accurate segregation of proteins to the compartments of the cell in 
which they function. Of these, the secretory pathway is responsible for the 
localisation of proteins to the endoplasmic reticulum (ER), Golgi apparatus, 
endocytic and vacuolar compartments and the cell surface. The first step along this 
pathway is the targeting of nascent polypeptides to the ER membrane. For many 
proteins, the signal recognition particle (SRP), a cytosolic ribonucleoprotein, and its 
cognate receptor (SR) on the ER membrane are responsible for this step. SRP and 
the SR direct proteins to the translocon, which forms an aqueous channel through 
which the nascent proteins are translocated or from which they are then integrated 
into the ER membrane. The aim of this study was to dissect incompletely understood 
interactions that occur at the ER membrane between SRP, SR and the translocon and 
to reconstitute the SRP-dependent translocation reaction with purified proteins. In 
particular, through 2-hybrid analysis and pull-down assays a novel interaction was 
identified between SR and the major translocon component Sec6lp. To facilitate the 
study of this and other interactions, attempts were made to reconstitute the SRP-
dependent targeting pathway with SR and translocon purified from yeast. It was 
demonstrated that SRP-dependent translocation could be reconstituted with 
solubilised yeast ER membrane proteins. SR was purified and shown to be 
functional, and the translocation reaction was shown to be stimulated by the presence 
of the ER-lumenal chaperone Kar2p. Preliminary experiments were also carried out 
that suggested that the purified translocon was active; indicating that the goal of 
reconstituting SRP-dependent translocation with purified components is attainable. 
xi 
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The yeast Saccharornvces cerevisiae utilises many transport pathways in order to 
efficiently and accurately target proteins to the area of the cell where they carry out 
their specific functions. One of these is the secretory pathway, responsible for 
targeting proteins destined for secretion from the cell, integration into membranes 
and a subset of other subcellular organelles. The first step in the secretory pathway 
involves translocation of proteins into the lumen of the endoplasmic reticulum (ER) 
or insertion into the ER membrane. The lumen of the ER contains many chaperone 
proteins that ensure that all proteins sent further along the secretory pathway are 
correctly folded, and many modifying enzymes, which add disulphide bonds to, 
glycosylate and add co-factors to proteins. In order for these proteins to be correctly 
modified they must first be targeted accurately from the cytosol, where they are 
synthesised, to the ER membrane. A population of proteins exist, some of which are 
conserved from bacteria to man, that ensure that this targeting event occurs. S. 
cerevisiae utilises two methods of targeting proteins to the ER. The first involves a 
soluble cytosolic ribonucleoprotein known as the signal recognition particle (SRP), 
its cognate receptor, the signal recognition particle receptor (SR), Sec63p and the 
lumenal chaperone Kar2p. The second involves the proteins Sec62, 63, 71 and 72p 
and Kar2p. Both of these targeting pathways converge on a group of proteins known 
collectively as the translocon, consisting in yeast of Sec6lp, Sbhlp and Ssslp. The 
translocon components form a protein channel through which nascent polypeptide 
chains are translocated into the lumen of the ER. The pathway involving SRP and 
SR is known as the SRP-dependent targeting pathway and targets proteins with a 
hydrophobic signal sequence at their N-terminus to the translocon. The 
Sec62/63/71/72p pathway is known as the post-translational targeting pathway and 
proteins targeted through this pathway do so independently of SRP and SR. The aim 
of this study was to dissect incompletely understood interactions at the ER 
membrane between SRP, SR and the translocon. To achieve this, SRP-dependent 
protein targeting was reconstituted in an in vitro system using components of the 
pathway purified from yeast. The assay itself is described alongside details of 
experiments that show that the purified material is active for promoting translocation 
of both SRP-dependent and —independent substrates. The purification of one of the 
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components necessary for SRP-dependent translocation, SR, brought to light a 
previously unidentified interaction between the 13 subunit of SR and Sec6lp, the 
major component of the translocon. The defining experiment is described, along 
with experiments carried out to further characterise this novel and unexpected 
interaction. 
1.2 Translocation 
There are numerous modes of protein translocation in eukaryotic and prokaryotic 
cells. Many similarities exist between the different transport mechanisms, however 
varied the substrates or environments may be (Agarraberes and Dice, 2001). In this 
section 1 describe translocation pathways that exist in bacteria and two eukaryotic 
organelles: mitochondria and chioroplasts. 
In addition to the conventional Sec-dependent and SRP-dependent pathways in 
bacteria (sections 1.5.3 and 1.6.2) there exists the twin-arginine translocation (TAT) 
system. Proteins exported by the TAT pathway have unusually long signal 
sequences of up to 48 amino acids. The signal sequence has an invariant twin 
arginine motif in its amino terminal region followed by a short hydrophobic 
sequence and one or more basic amino acids. A consensus twin arginine targeting 
motif is senne-arginine-arginine-X-phenylalanine-leucine-lysine (SRRXFLK) in 
which X can be any amino acid (Stanley et al., 2000). This motif constitutes a Sec 
avoidance signal (Bogsch et al., 1998). Any disruption of the motif renders the 
protein incapable of translocation by the TAT system and transforms it into a 
substrate for the Sec pathway (Cristobal et al., 1999). Proteins can be translocated 
across the membrane via the TAT system while folded (Berks, 1996). Many of the 
substrates for this pathway in bacteria are metalloenzymes that reside in the 
periplasmic space or are associated with the periplasmic face of the inner membrane 
(Berks, 1996). It is not completely understood how fully folded proteins are 
competent iranslocation substrates, however transport is dependent on the proton-
motive force across the membrane (Berks et al., 2000). 
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Mitochondrial import in eukaryotic cells has been the focus of much investigation. 
Although mitochondria contain their own genome, most mitochondrial proteins are 
encoded by nuclear genes and are synthesised in the cytosol as precursors. 
Mitochondrial biogenesis requires protein targeting to four compartments: the outer 
membrane, the intermembrane space, the inner membrane and the matrix. 
Translocation of mitochondrial precursors is an energy-dependent process that is 
assisted by heteromeric transiocation complexes in both membranes. Four 
transiocation complexes have been identified, two translocons in the outer 
mitochondnal membrane (Tom) and two in the inner mitochondrial membrane (Tim) 
(Dekker et al., 1996; Dekker et al., 1997; Dekker et al., 1998). Some proteins can be 
imported into mitochondria independently of Tom and Tim complexes, perhaps due 
to their abilities to associate spontaneously with lipid bilayers (Rassow and Pfanner, 
2000). Precursor proteins destined for the mitochondrial matrix are usually 
hydrophilic polypeptides with amino-terminal signal peptides that form amphipathic 
helices in solution (von Heijne, 1986 Roise and Schatz, 1988). Inner membrane 
proteins, such as the ATP/ADP carrier (AAC) and the phosphate carrier, are 
hydrophobic and contain internal targeting signals not yet characterised (Truscott and 
Pfanner, 1999). Translocation across the inner membrane is dependent on the 
proton-motive force (Schleyer et al., 1982; Martin et al., 1991). The driving force 
for translocation across the outer membrane has not yet been determined, although 
ATP is required for the transfer of substrate from a receptor-bound to membrane-
inserted state (Pfanner et al., 1987; Pfanner and Neupert, 1987). 
Chloropiasts have six distinct compartments: outer membrane, intermembrane space, 
inner membrane, stroma, thylakoid membrane, and thylakoid lumen (Agarraberes 
and Dice, 2001). Each compartment contains specific proteins. Like mitochondria, 
chioroplasts contain their own genome, but most chioroplast proteins are synthesised 
in the cytosol and imported post-transiationally. Chioroplast targeting sequences are 
variable in length (from 20 to more than 120 amino acids) and contain basic amino 
acids with a high content of serine and threonine (Schnell, 1995; Chen and Schnell, 
1999). Translocation across the outer and inner membrane occurs simultaneously for 
most proteins, probably at regions where the outer and inner membranes are in close 
contact (May and Soil, 1999; Chen and Schnell, 1999). The translocon at the outer 
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membrane of chloroplasts (Toc) binds to a substrate protein and transfers the protein 
to the translocon at the inner chioroplast membrane (Tic). This process is stimulated 
by ATP and in the absence of ATP only weak binding of substrate proteins to Toc 
subunits occurs. In addition, precursor insertion into the Tic complex requires ATP 
hydrolysis within the stroma (Chen and Schnell, 1999). Protein translocation into 
thylakoid membranes is varied similarly to the translocation pathways in bacteria. 
Many proteins utilise the components homologous to the Sec apparatus while others 
require a stromal homologue of SRP for import (Robinson el al., 1998; Thompson et 
al., 1999). Other proteins are transported into the thylakoid lumen by a route similar 
to the TAT system. The proteins are transported while folded and contain a twin 
arginine motif in their targeting sequences (Thompson et al., 1999). 
Many common features exist between the different translocation pathways. Most 
involve ATP or the proton-motive force, almost all require cytosolic or membrane 
associated chaperones and in all cases insertion is through a gated, aqueous channel. 
In this study, the focus is on how proteins are translocated into the lumen of the ER, 
as the first step in entering the secretory pathway. 
1.3 The secretory pathway 
Eukaryotic cells are characterised by the presence of organelles that carry out a 
variety of highly specialised functions. The structure and function of each organelle 
is defined by its unique complement of proteins. Since most proteins begin their 
synthesis in the cytosol, targeting mechanisms and transport pathways exist to 
efficiently direct proteins to their correct destinations. One of these is the secretory 
pathway. The endoplasmic reticulum (ER) plays a very important part in 
intracellular protein trafficking and targeting to the ER is the first step in the 
secretory pathway. Proteins translocated into the ER can either remain resident 
there, or may be transported to the Golgi apparatus, the lysosomal network, or the 
cell surface (Figure 1.1). Protein targeting to the ER is mediated by a variety of 
proteins, both cytosolic and ER membrane bound, and can occur either co- or post-
translational I y. Co-translational targeting of polypepti des requires a cytosolic 









ribonucleoprotein the signal recognition particle (SRP) and its ER bound receptor 
(SR). This pathway is known as SRP-dependent targeting, and is described below. 
1.4 SRP-dependent targeting 
In order to explain how proteins in the cell were integrated into or translocated across 
cellular membranes the signal hypothesis was proposed (Blobel and Sabatini, 1971; 
Blobel and Dobberstein, 1975; Blobel, 1980). The signal hypothesis proposed that 
each protein translocated across or integrated into a cellular membrane must contain 
a signal sequence that is membrane specific. A signal sequence-specific recognition 
factor and a cognate receptor on target membranes must mediate recognition of the 
signal sequence and the subsequent protein targeting. Finally, translocation across 
the membrane would occur via a proteinaceous channel. Subsequent experiments 
confirmed that this hypothesis was essentially correct and defined what is now a 
well-established protein-targeting pathway to the ER. Thus, the signal recognition 
particle targets ribosomes synthesising nascent secretory and membrane proteins to 
the ER. The nascent proteins are, at this point, integrated into or translocated across 
the membrane into the lumen of the ER (Figure 1.2). During translocation, signal 
sequence removal and protein glycosylation occur by proteolysis by the signal 
peptidase complex and through the action of oligosaccharyltransferase (OSTase) 
respectively (Görlich etal., 1992). Signal peptidase typically cleaves at the sequence 
AXA where A is any small, aliphatic amino acid (Perlman and Halvorson, 1983). 
OSTases transfer an oligosaccharyl moiety to asparagine residues in the polypeptide 
when the glycosylation site (NXS/T) has reached a distance of at least 12 amino 
acids from the lumenal side of the ER membrane (Nilsson and von Heijne, 1993). 
Both signal peptidase and oligosaccharyltransferase are multi-subunit, membrane-
spanning complexes of which there appears to be one for every translocation site in 
the ER membrane (Rapoport et al., 1996). 
The SRP-dependent co-translational targeting pathway requires interactions between 
SRP, its receptor and a group of proteins in the ER membrane, known collectively as 
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Figure 1.2 SRP-dependent protein targeting pathway 
SRP binds to emerging signal sequence of nascent chain and the ribosome 
causing elongation arrest of the nascent polypeptide 
SRP docks with the SRP receptor (SR) in the ER membrane 
Ribosome is targeted to the translocon and dissociates from SRP, releasing 
elongation arrest. Nascent protein is translocated through the translocon to the 
lumen of the ER 
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the translocon (Wilkinson et al., 1997). in vitro experiments with mammalian 
components have shown that SR and the translocon are the minimum apparatus 
required for translocation. These experiments have also shown a requirement of 
some nascent proteins for the translocating chain-associated membrane (TRAM) 
protein whose function will be discussed later (Görlich and Rapoport, 1993). 
1.5 The signal recognition particle 
1.5.1 Components of SRP 
Mammalian SRP was first isolated from canine pancreas and was found to be an uS 
ribonucleoprotein (Walter and Blobel, 1980). SRP consists of six polypeptides 
named SRP9, 14, 19, 54, 68 and 72 according to their apparent molecular weight in 
kilodaltons and the 7SL RNA (Walter and Blobel, 1982). 7SL RNA provides a 
"backbone" to SRP with the protein subunits binding to it as either heterodimers 
(SRP9/14 and SRP68172) or monomers (SRP54 and SRP19) (Walter and Blobel, 
1983). 
SRP has been identified in all organisms studied to date. It comprises a highly 
conserved group of proteins and RNA, homologues of which are found from bacteria 
to mammals. In this study, I have been concerned with SRP-dependent targeting of 
proteins in the yeast Saccharornyces cerevisiae. SRP in yeast, as in mammalian 
cells, consists of six polypeptides Srpl4, 21,54,68 and 72p and Sec65p, and one 
RNA, scRl (Hann and Walter, 1991; Hann and Walter, 1992; Stirling and Hewitt, 
1992; Brown et al., 1994). Srp14, 54, 68 and 72p and Sec65p are homologous to 
mammalian SRP14, SRP54, SRP68, SRP72 and SRPI9 respectively. There are no 
known homologues of Srp2lp, except in other yeast species (J. Brown and R. van 
Neus, personal communication) and the yeast particle does not contain an SRP9 
homologue (Brown et al., 1994). Sec65p is required for the stable association of 
Srp54p with scRi, however neither Sec65p nor Srp54p are required for the stability 
of SRP, a core SRP remaining with all other SRP proteins stably associated with 
scRi in their absence. A temperature-sensitive sec65-1 mutant has no Sec65p or 
SRP54 associated with scR 1 at the restrictive temperature. Over-expression of 
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SRP54 in a sec65-1 mutant will suppress this phenotype (Hann et al., 1992). 
Deletion of all but the central domain of Sec65p, which shares the most homology to 
SRP19, showed that this portion is required for activity of Sec65p in vivo (Regnacq 
et al., 1998). Only in deletions of the four core components of SRP do 
destabilisation of scRi and the particle itself occur (Hann and Walter, 1991). 
1.5.2 Functions of SRP 
Initial experimental evidence showed that nascent chain translocation across the ER 
membrane was a protein-mediated event. It was shown that protein-protein 
interactions (signal sequence + ribosome + SRP), at the ER membrane, provided the 
specificity for translocation and not protein-lipid interactions (signal sequence with 
lipid bilayer) (Walter et al., 1981). SRP was also shown to induce a site-specific 
arrest in nascent chain elongation on binding the amino-terminal signal peptide of a 
nascent chain. This arrest was released upon interactions between the SRP-nascent 
chain-ribosome complex (SRP-RNC) and the SRP receptor (SR) at the ER 
membrane, resulting in chain completion and translocation into the microsomal 
vesicle (Walter and Blobel, 1981). 
The functions of each component of SRP were established in experiments in which 
purified mammalian SRP was dissociated into its four protein subunits (SRP54, 19, 
9/14 and 68/72) and RNA and the particle reconstituted in the absence of 
components or with individual components chemically modified (Siegel and Walter, 
1988b). Three activities of SRP were measured: signal sequence recognition, 
elongation arrest and translocation promotion. Elongation arrest activity is thought 
to increase the efficiency of protein translocation by lengthening the amount of time 
available for the nascent chain to be targeted to the ER membrane (Thomas et al., 
1997). SRP9/14 are required for elongation arrest and SRP68/72 are required for 
translocation promotion. SRP54 is required for signal sequence recognition and was 
later shown to bind signal sequences directly by chemical cross-linking (Bernstein et 
al., 1989; Mothes et al., 1998). Cloning of SRP54 revealed that it has a GTPase 
domain. This is essential for its function and the structure of this conserved domain 
has been elucidated (Freymann et al., 1997). Neither elongation arrest nor 
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translocation promotion occurs without SRP54 binding to the nascent chain. 
Therefore, binding of SRP54 to the signal sequence is the first step in SRP-
dependent targeting of nascent polypeptides (Walter and Blobel, 1983; Siegel and 
Walter, 1988). 
Functions have been assigned to components of yeast SRP based on their homology 
to mammalian proteins (Figure 1.3). Srp54p has a GTPase domain and is thought to 
be responsible for signal sequence binding. Srp68/72p proteins exist as a stable 
heterodimer and may be important for translocation promotion of the nascent chain, 
while Srp2lp has no known function. It is known that intact Srpl4p function is 
required for elongation arrest (Strub et al., 1999; Mason et al., 2000). A recent, 
unexpected, discovery indicated that while mammalian SRPI4 exists as a dimer with 
SRP9, in yeast Srp14p exists as a homodimer, occupying an area on scRi in close 
proximity to Srp2lp (Figure 1.3)(Strub etal., 1999; Mason et al., 2000; J. Brown 
and L. Ciufo, unpublished observation). 
(i) Signal sequence binding 
Signal sequences of nascent polypeptides specify which route a protein will travel in 
targeting to the ER membrane. While they lack primary sequence homology a 
common feature among ER-targeting signal sequences is a stretch of 10-15 
hydrophobic amino acids (von Heijne, 1994). In yeast, the more hydrophobic the 
signal sequence the more likelihood the protein has of being targeted in an SRP-
dependent fashion, while less hydrophobic signal sequences result in targeting 
through the posttranslational translocation route (Ng et al., 1996). It has been shown 
with mammalian proteins that the length of the nascent chain is critical for SRP 
binding. In the case of the secretory protein preprolactin, once the chain length 
exposed from the ribosome is greater than 70 amino acids SRP is no longer able to 
sample and bind the polypeptide (Siegel and Walter, 1988a). SRP54 recognises 
signal sequences regardless of their lack of primary sequence homology. A model 
has been proposed in which a domain of SRP54 at the C-terminus rich in methionine 
(M domain) constitutes the critical region for the signal sequence-binding pocket. 
Binding of signal sequences of variable length and composition to SRP54 would be 
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Figure 1.3 Components and functions of yeast SRP 
On the basis of structural and biochemical studies of mammalian SRP, and 
through homology to those proteins, possible functions and potential binding 
sites on scRi have been assigned to yeast SRP proteins. 
Srp14p is a homodimer and has been shown to be necessary for elongation 
arrest, potentially with Srp2lp, which can be cross-linked to Srpl4p and thus is 
localised close to it in the particle Q. Brown, unpublished observation). 
Srp68/72p are thought to be involved in the targeting of SRP to the ER 
membrane. 
Srp54p is predicted to bind signal sequences as they emerge from the ribosome, 
and is necessary for targeting the ribosome-nascent chain complex to the ER 
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possible through the flexibility of the methionine side chains (Bernstein et al., 1989). 
An atomic view of the interaction between SRP54 bacterial homologue Ffh and 49 
nucleotides of 4.5S RNA (homologous to 7SL RNA, (section 1.5.3)) was achieved 
through x-ray crystallography. The structure resolved an unusual interaction 
between the two components. Ffh recognises a distorted RNA minor groove (Batey 
et al., 2000). Based on this structure and that of the M domain within Ffh (Keenan et 
al., 1998), it was proposed that the signal sequence recognition surface is composed 
of both protein and RNA. This surface would interact with signal sequences through 
a combination of hydrophobic and electrostatic interactions (Bernstein, 2000a). 
Changes in as little as one or two amino acids in a signal sequence can greatly reduce 
the efficiency of protein targeting and translocation (Belin et al., 1996) despite signal 
sequence recognition being independent of primary sequence. It was illustrated that 
signal sequence structure determined SRP binding affinity and the stability of 
translocation competent complexes (Belin et al., 1996). Collectively, the data on 
signal sequence binding suggest that SRP samples signal sequences as they emerge 
from the ribosome. This sampling appears to occur by sequential binding and release 
from the ribosome in a cyclic fashion (Walter and Johnson, 1994; Ogg and Walter, 
1995). When SRP binds to the signal sequence elongation of the nascent chain 
arrests. However, if a signal sequence is not present at this point SRP releases and 
elongation resumes. 
(ii) Elongation arrest 
Elongation arrest has long been thought an important function of SRP from in vitro 
experiments (Walter and Blobel, 1981; Ibrahimi, 1987; Rapoport etal., 1987; Wolin 
and Walter, 1989). Recently, the importance of elongation arrest for translocation in 
vivo was shown in yeast (Mason et al., 2000) confirming this as a crucial function of 
the particle. Elongation arrest activity requires the Alu domain of SRP RNA and the 
proteins that bind to it (Siegel and Walter, 1985,1986; Strub and Walter, 1990; Bui et 
al., 1997; Thomas etal., 1997; Chang et al., 1997). Alu-like elements comprise the 
most abundant family of interspersed repetitive sequences in primates and rodents 
(Schmid and Jelinek, 1982). The most highly conserved feature in the Alu-domain is 
a mostly single-stranded motif within the context of two hairpin structures at the 5' 
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end of 7SL RNA (CCUGUAAYCY; Strub etal., 1991). SRP particles that lack the 
SRP9/14 heterodimer and subparticles that lack the Alu domain both lack their 
elongation arrest activity (Siegel and Walter, 1985, 1986). These same particles have 
been found to be defective in binding directly, independently of signal sequences, to 
ribosomes (Hauser etal., 1995; Powers and Walter, 1996). This suggests that these 
particles have a more general defect in the way they interact with the ribosome as 
opposed to a specific defect in elongation arrest. A truncation of SRPI4 (AC20) was 
found to form, with SRP9, a stable complex with SRP RNA. However, SRP 
containing this truncated SRPI4 completely lacked elongation arrest activity. The 
particle had intact signal recognition, targeting and ribosome binding activities. 
Therefore, the truncated SRP14 only impaired interactions with the ribosome 
required to effect elongation arrest (Thomas et al., 1997). This provided evidence 
that direct interactions between the Alu-domain components of SRP and the 
ribosome are required for elongation arrest. A recent study identified the Alu-
domain present in yeast scRi. This is bound specifically by a homodimer of Srpl4p. 
Mammalian SRP9/14 does not bind scRi indicating substantial evolutionary changes 
in RNA-protein recognition between yeast and mammalian SRP Alu domains (Strub 
et al., 1999). A similar truncation to the mammalian SRP14 (AC20) was made in 
yeast Srpl4p (AC29). Expression of this truncated protein as the only Srp14p in 
yeast led to a complete lack of elongation arrest function of yeast SRP, both in vitro 
and in vivo. This demonstrated not only similar structural features of mammalian 
and yeast SRP14 but also provided evidence that elongation arrest is important in 
vivo (Mason et al., 2000). Homologues of SRP9 and 14 have not been identified in 
organisms other than eukaryotes and the eubacterial SRP RNAs identified so far lack 
the entire Alu-domain found in eukaryotes. The two exceptions are the SRP RNAs 
of Bacillus and Clostridium species with HBsu protein identified in Bacillus as 
interacting with the Alu domain of the SRP RNA (Nakamura et al., 1999). Recent 
evidence suggests that elongation arrest may have a function in bacterial cells despite 
the lack of SRP9/14 homologues (Avdeeva et al., 2002). The M domain of Ffh, the 
bacterial SRP54 homologue, was over-expressed in E. coli with a cleavable affinity 
tag and ribosome-SRP complexes recovered. The M-domain affinity tag fusion 
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retained its ability to bind signal sequences. However, in the absence of the N or G 
domains of Fth, responsible for membrane binding and GTP hydrolysis, SRP could 
not dissociate from ribosomes. The recovery of stable complexes of SRP and 
ribosomes suggests that translation was halted by binding of the Fth M domain to 
ribosome-nascent chains. In the absence of membrane targeting or GTP hydrolysis 
translation was unable to proceed. Perhaps in bacterial cells homologues of SRP9 
and 14 are not necessary, with Fth responsible for other functions in protein targeting 
than signal sequence binding, just as the SRO subunit appears unnecessary in the 
bacterial SR homologue (section 1.5.3). 
Yeast mutants with reduced levels of expression of functional SRP have reduced 
growth rate and accumulate untranslocated polypeptides in the cytosol. This 
phenotype is alleviated by the addition of cycloheximide or sordarin antibiotics to the 
growth media (Ogg and Walter, 1995; J. Brown, unpublished observation). 
Cycloheximide inhibits the transfer of peptidyl-tRNA from the aminoacyl (A) site to 
the peptidyl (F) site during the synthesis of nascent polypeptides (McKeehan and 
Hardesty, 1969). Sordarin antibiotics specifically stall the ribosome-eEF-2 complex 
(Justice et al., 1998; Dominguez et al., 1999). Thus, both these antibiotics inhibit the 
translocation step in the translation elongation cycle. If SRP binds the ribosome, to 
cause elongation arrest, at the same position in the elongation cycle the drugs will 
provide an increased window of opportunity for low levels of SRP to bind to and 
target nascent chains to the ER. Alternatively, the drugs could provide more time for 
the nascent chain to be targeted to the ER independently of SRP. Importantly, blocks 
at other stages of translation (initiation and peptidyl-transferase) do not alleviate 
these types of mutants indicating that the effect is specific to a particular step in the 
elongation cycle (Ogg and Walter, 1995). The similar effect of sordarin, as 
cycloheximide, on SRP-deficient cells suggests the possibility that SRP interacts 
with the ribosome while eEF-2 is still bound to the ribosome (Justice et al., 1998; 
Shastry etal., 2001). 
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(iii) Translocation promotion 
Alkylation of SRP68/72 subunits results in a decreased affinity of SRP for SR 
(Siegel and Walter, 1988b). This observation suggests a function for SRP68/72 
either targeting of SRP-RNCs to the ER membrane or in the promotion of 
translocation at the membrane. Further evidence, from manipulation of Srp72p in 
yeast, suggests that Srp72p may interact with the SRP receptor (J. McDonald and J. 
Brown, unpublished observations). Mutants of Srp72p have been generated that 
display translocation defects for SRP-dependent substrates in vivo, but which do not 
compromise overall SRP stability. SRP containing such mutants are unable to 
associate stably with immobilised SR in vitro. This suggests that Srp72p may have a 
function required for the association of SRP-RNCs with the ER membrane via SR. 
1.5.3 SRP is evolutionarily conserved 
Since homologues of SRP components have been found across all three kingdoms, it 
has been suggested that SRP-dependent protein targeting is a process of ancient 
evolutionary origin (Althoff et al., 1994). While the study of related SRP proteins 
has been concerned mostly with homologues in E. coli and budding yeast a number 
of other species are studied, if to a lesser extent. Homologues of SRP54 have been 
identified in chloroplasts (Franklin and Hoffman, 1993; Schuenemann et at., 1999). 
1 I and lOS SRP has been identified in Schizosaccliaro ,nvces pombe and Yarrowia 
lipolvrica respectively (Poritz et al., 1988). A homologue of SRP has been found in 
Bacillus subtilis that, unlike other bacterial homologues, contains an Alu domain in 
its RNA component. The protein HBsu binds specifically to this domain of the RNA 
(Kohler and Marahiel, 1998; Nakamura et al., 1999; Yamazaki et al., 1999). 
The E. coli SRP homologue consists of 4.5S RNA, homologous to 7SL RNA SRP54 
binding domain (domain IV), and FTh a homologue of SRP54 (fifty-four homologue) 
(Bernstein et al., 1989; Romisch et al., 1989). The Ffh/4.5S RNA complex is 
essential in bacteria and, like the eukaryotic SRP interacts specifically with the signal 
sequence of nascent secretory proteins and is important for protein translocation 
(Brown, 1987; Luirink etal., 1992; Phillips and Silhavy, 1992). The Ffh/4.5S RNA 
complex binds to a bacterial homologue of SRct, FtsY. This interaction is entirely 
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GTP-dependent and results in the stimulation of GTP hydrolysis, in the same way as 
eukaryotic SRP and SR (section 1.6.3) (Miller etal., 1994). This GTP hydrolysis is 
essential for Ffh function in vivo (Samuelsson et al., 1995). Homologues of the E. 
co/i Ffh exist in other bacteria. The many bacterial Fth proteins exhibit marked 
homology throughout the entire sequence both amongst themselves and with the 
mammalian SRP54 (Zwieb and Samuelsson, 2000). Ffh-4.5S RNP and FtsY can 
replace mammalian SRP and SRa in targeting nascent secretory proteins to 
microsomal membranes in vitro. This requires a hydrophobic signal sequence, GTP 
hydrolysis and occurs co-translationally. However, bacterial SRP was unable to 
cause elongation arrest, presumably due to the considerably shorter RNA molecule 
and the lack of homologues of SRP9/14 (Powers and Walter, 1997). Fth protein has 
since been found to function in co-translational signal sequence recognition in vivo 
(Valent et al., 1998). That bacterial proteins can replace their eukaryotic 
homologues is remarkable and supports the belief that SRP-dependent targeting must 
have a role in bacterial protein transport (Herskovits et al., 2000). Bacterial SRP and 
SR have been found necessary for the targeting of a-helical membrane proteins to 
the inner membrane (MacFarlane and Muller, 1995; de Gier et al., 1996; Ulbrandt et 
al., 1997; Koch etal., 1999). As in yeast, the specificity of bacterial SRP for nascent 
chains increases with hydrophobicity of the signal sequence (Ulbrandt et al., 1997; 
Lee and Bernstein, 2001). 
Soluble periplasmic and f3-pleated outer membrane proteins of E. co/i are targeted to 
the inner membrane via SecB and translocated across the inner membrane via the 
motor protein SecA, in a process that is completely independent of SRP and SR 
(Behrmann et al., 1998; Koch c/ al., 1999). Despite the existence of two separate 
targeting pathways, both of these appear to converge, as in eukaryotic cells (section 
1.7.1), on the same translocation apparatus in the inner membrane. This translocon is 
composed of SecY, SecG and SecE (Valent et al., 1998). This is consistent with the 
finding that SecA is necessary for the translocation of SRP-dependent substrates in 
E. coli (Qi and Bernstein, 1999). 
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1.5.4 Biogenesis of SRP 
Whilst the activities of SRP have been examined extensively, both in vivo and in 
vitro, until recently very little work had been carried out to determine how and where 
the proteins in the particle are assembled with SRP RNA. SRP is a relatively simple 
ribonucleoprotein (RNP) and is thus a good model for the study of RNP assembly. 
Recently, SRP RNA was found to localise to the nucleolus of mammalian cells, 
suggesting that perhaps the processing of SRP RNA or its assembly into SRP 
involved a nucleolar phase (Jacobson and Pederson, 1998). Ciufo and Brown (2000) 
defined the assembly of SRP. They found that most of the assembly of the particle 
takes place in the nucleus. Four of the SRP proteins (Srpl4, 21, 68 and 72p) had 
nucleolar pools and these same proteins are all required to form stable "core" SRP 
complexes with scRi RNA. The core SRP is also a competent nuclear export 
substrate. Of the remaining SRP components, Sec65p also enters the nucleus and 
assembles onto the core particle there, whereas Srp54p is solely cytoplasmic. The 
export of SRP from the nucleus required the transport receptor Xpolp/Crmlp and 
Yrb2p, both components of the pathway that exports leucine-rich nuclear export 
signal (NES)-containing proteins from the nucleus (Figure 1.4). 
Further work determined that the import of the core SRP components into the 
nucleolus requires the ribosomal protein import receptors Pseip and Kapl23p/Yrb4p 
(Grosshans et al., 2001). These receptors have been speculated to constitute a 
nucleolar import pathway. It has also been shown that ribosomal subunit export may 
be linked to the same pathway as that used by SRP. Export of 60S subunits of the 
ribosome requires the nuclear export sequence-containing non-ribosomal protein 
Nmd3p. This protein binds directly to the large ribosomal subunit protein RpllOp. 
Nmd3p shuttles between the nucleus and the cytoplasm and this shuttling requires 
the nuclear export factor Xpolp. Therefore, the export of 60S ribosomal subunits, 
like the export of SRP, is Xpolp dependent (Gadal etal., 2001). Nmd3p is not, 
however, required for SRP export (Ciufo and Brown, 2000) and it is currently 
unclear if Xpolp binds to a nuclear export signal in SRP or whether an adapter 
protein is required. 
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Figure 1.4 Model for yeast SRP assembly 
All SRP proteins except Srp54p are imported into the nucleus. Core 
subunits are directed to the nucleolus, whereas Sec65p is not (a). Core 
SRP proteins are assembled with nascent scRi RNA. This step may take 
place in the nucleolus (b). The assembled core SRP is released from the 
nucleolus to the nucleoplasm (c) where Sec65p binds to it (d). The 
particle is exported to the cytoplasm bound to the importin homologue 
Xpolp/Crmlp (e), where Srp54p binds, completing the particle (f. 
Circle, the nucleus; grey crescent, the nucleolus; grey rectangles, 
nuclear-pore complexes (from Ciufo and Brown, 2000). 
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Reproduced from Ciufo and Brown, 2000 
1.5.5 Cellular response and structural consequences to loss of 
SRP and mutations in SR 
As previously discussed, both the components and the mechanism of SRP-dependent 
targeting are conserved in every organism studied to date from bacteria to eukaryotic 
cells. SRP-dependent targeting is essential in all organisms that have been examined 
except S. cerevisiae. Deletion of the genes encoding any of the components 
necessary for SRP-dependent targeting in yeast result in the disruption of the entire 
pathway. Yeast strains lacking SRP are petite (they lack mitochondrial function), 
grow three to six-fold slower than isogenic wild type strains and accumulate SRP-
dependent substrates in the cytosol (Hann and Walter, 1991; Ogg etal., 1992; Hann 
etal., 1992: Stirling et al., 1992; Brown et al., 1994; Ogg et al., 1998). Therefore, 
while SRP may not be essential in S. cerevisiae the loss of SRP-dependent targeting 
of proteins has severe consequences for the cell (Mutka and Walter, 2001). By 
depleting SRP or SR subunits from a population of yeast cells, the adaptation of 
yeast to the loss of SRP can be examined in more detail. Two to four hours after 
depletion of SRP the accumulation of SRP-dependent precursor proteins can be seen 
that disappear by six hours after depletion (Mutka and Walter, 2001). Previous 
studies indicate that the adaptation to the loss of SRP-dependent targeting is not due 
to the accumulation of a suppressor mutation. It is a physiological adaptation to a 
situation requiring an immediate stress response from the cell (Ogg et al., 1992). It 
would be logical to assume that the adaptation to the accumulation of precursor 
proteins in the cytosol is simply due to the up-regulation of expression of translocon 
components. However, this is not the case. While an increase in available 
translocation sites in the ER membrane would alleviate the precursor accumulation 
problem this is not the adaptive route taken by the cell. Instead, the cell responds 
immediately by repressing the synthesis of ribosomal proteins, inducing the 
expression of a large number of heat shock factors and chaperone proteins and 
repressing the synthesis of mRNAs encoding mitochondrial and energy generating 
proteins. In all, 11% of the total yeast genome is affected by this adaptation with 
one-third of these genes being induced while the other two-thirds are repressed. The 
major response of the cell appears to be the repression of synthesis of ribosomal 
proteins. This results in not only a reduced growth rate of the cell but also a decrease 
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in the level of untranslocated protein in the cytosol. Less ribosomal protein results in 
less protein synthesis therefore the cell trades speed of growth for fidelity in protein 
synthesis, and survives the stress of losing the SRP-dependent protein targeting 
pathway (Mutka and Walter, 2001). The loss of SRP has many effects on the yeast 
cell, from carbon utilisation and growth rate to protein synthesis rates. However, 
these drastic adaptive measures allow the cell to survive a defect that is lethal to all 
other organisms studied. 
The peripheral ER membrane in yeast forms a dynamic network of interconnecting 
membrane tubules, similar to the ER in higher eukaryotes (Prinz et al., 2000b). 
Maintenance of this network does not require microtubule or actin filaments, but its 
dynamic behaviour is largely dependent on the actin cytoskeleton. Mutants in SR 
have been isolated that disrupt peripheral ER structure (Prinz ci al., 2000b). In both 
wild type and mutant cells, the ER and mitochondria have been found to partially co-
align. Mutations that cause defects in peripheral ER structure also cause defects in 
mitochondrial structure. It has been suggested that both trafficking between the ER 
and Golgi complex and ribosome targeting are important for the maintenance of ER 
structure (Prinz et at., 2000b). Perhaps the maintenance of proper ER structure may 
be required to maintain mitochondrial structure. The defect in ER, Golgi and 
mitochondrial structure was a result of mutations in SR which decreased its affinity 
for ribosomes. The decrease in ribosome binding to the ER membrane, due to the 
mutations in SR, led to the abnormal ER structure. In cells lacking SR abnormal ER 
structure is not observed. Also, in mutant cells grown in the presence of sublethal 
doses of the translational inhibitor cycloheximide, the defect in ER structure is 
suppressed. This, presumably, is due to cycloheximide slowing the rate of 
translation, giving the SRP-bound ribosomes more time to reach the ER in SR 
defective strains. As cells lacking the SRP-dependent targeting pathway have 
reduced global synthesis of protein, perhaps the general slowing of protein targeting 
allows ribosome binding to the ER not possible in a SR deletion mutant during rapid 
growth. This, albeit reduced, ribosome binding to the ER membrane would result in 
normal ER structure (Prinz et al., 2000b). It can only be speculated why reduction in 
ribosomal binding to the ER membrane should cause such a drastic structural 
phenotype in otherwise healthy cells. Recently, a Sec63p-GFP fusion was used to 
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investigate ER cortical and nuclear structure and inheritance. Cortical ER 
morphology was found to be sensitive to mutations in the actin-encoding gene 
(ACT]) and to the actin-destabilising drug latrunculin-A (Fehrenbacher et al., 2002). 
Cortical ER inheritance appears to be cytoskeleton dependent, relying on anchorage 
as opposed to directed movement (Fehrenbacher et al., 2002). Perhaps ribosome 
binding to the ER affects its anchorage to the plasma membrane leading to a 
disruption of ER structure in the absence of ribosome binding. 
1.6 The signal recognition particle receptor 
1.6.1 Components of SR 
The SRP receptor (SR) was first thought to be a single protein whose function was 
mediating both the binding of SRP-RNCs to the ER membrane and release of SRP 
from the ribosome (Gilmore and Blobel, 1983). However, it was quickly established 
that SR was a complex consisting of two distinct polypeptide chains that tightly 
associate with one another on the ER membrane. 
Mammalian SR is composed of two subunits, a and P. The cx subunit is a 69 kDa 
protein bound to the ER membrane through stable association with the 30 kDa 
transmemhrane anchored 13 subunit. Both SRa and 13 are GTP binding proteins and 
the GTPase activity of both subunits of SR are essential for targeting of SRP-
dependent substrates to the ER membrane. SR was first purified through the affinity 
of SRa for SRP54 using SRP immobilised on a chromatography column. This 
allowed identification of two polypeptides that associated on the column with SRcc, 
mp30 and SRI3. mp30 binds to SRP-sepharose directly and is present in the ER 
membrane in several-fold molar excess of SRa and SR13. The affinity of mp30 for 
SRP suggests that it may serve a yet unknown function in protein translocation. 
mp30 was found in mammalian cells, however no homologue of this protein has 
been identified or investigated in yeast (Lauffer etal., 1985; Tajimaetal., 1986). 
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Homologues of mammalian SR components were identified in S. cerevisiae. The 
yeast SR is also composed of two GTPases, a and P. As with mammalian SR, the a 
subunit is a peripheral membrane protein associated with the transmembrane 
anchored 3 subunit (Ogg et al., 1992; Ogg et al., 1998). Depletion of SR from yeast 
leads to impaired translocation of soluble and membrane proteins across the ER 
membrane. This is substrate dependent with Kar2p and dipeptidyl aminopeptidase-B 
(DPAP-B), a soluble ER lumenal protein and a vacuolar integral membrane protein, 
showing the worst defects. Less affected are invertase and pre-pro-a-factor, and no 
defect at all is seen for carboxypeptidase Y (CPY) (Ogg et al., 1992). These defects 
are similar to those found in SRP deficient cells. Deletion of the genes encoding 
SRa or P leads to a six-fold reduction in growth rate, deletion of both scRl and SRa 
results in indistinguishable phenotypes confirming that SRP and SR function in the 
same pathway (Ogg et al., 1992; Ogg et al., 1998). 
During its synthesis a 140 residue N-terminal domain of SRa targets and anchors the 
polypeptide to the ER membrane through its interaction with SRO by a mechanism 
independent of the pathway involving SRP. It has been shown in vitro that the 
mammalian SRa assembles co-translationally on the ER membrane during an 
mRNA-encoded translation pause. The interaction between SRa and SRO is 
sufficient for this to occur. This has not been shown using yeast components, 
however, it has obvious implications for how or if the subunits of SR may be 
expressed independently (Young and Andrews, 1996). 
1.6.2 Functional domains within SR 
Both subunits of yeast SR are GTPases and the GTPase domain of SRO has been 
shown to be essential for its function (Ogg et al., 1998). During a round of targeting 
SRP interacts with SR at the ER membrane. This interaction leads to the GTP-
dependent transfer of the nascent chain from SRP to the translocation apparatus in 
the ER membrane. Displacement of SRP from the signal sequence of a nascent 
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polypeptide is GTP dependent and mediated by SRa. The GTPase domain of SRO, 
although essential for SRP-dependent translocation, has no assigned function in the 
pathway. The GTPase domains of SRP54 and SRa are related, defining their own 
GTPase subfamily. The GTPase domain of SRO, however, is structurally distinct, 
falling into its own subfamily of GTPases with its closest relative being Sarip, an 
ARF-like GTPase involved in ER to Golgi trafficking (Nakano and Muramatsu, 
1989; Miller et al., 1995). The discovery of a GTP/GDP binding domain makes it 
unlikely that SRO is simply a membrane anchor for SRa. It suggests that a network 
of three directly interacting GTPases function during protein targeting to the ER 
membrane. The role of GTP hydrolysis in SR function was examined using the non-
hydrolysable analogue 3-y-imidoguanosine 5' -tn phosphate (Gpp(NH)p) during the 
targeting and insertion steps of a protein translocation reaction. It was found that in 
the presence of Gpp(NH)p SRP co-sedimented with ER membranes, presumably 
unable to dissociate from SR (Rapiejko and Gilmore, 1997). Previous work had 
established that SRP54 and SRa are reciprocally activating GTPase activating 
proteins (GAPs). The interaction between SRP54 and SRa on the ER membrane 
activates their GTPase function, both proteins hydrolyse the GTP bound to them, this 
allowing the dissociation of SRP from SR for another round of targeting (Connolly et 
al., 1991; Bacher et al., 1996). Mutants in the GTPase domain of SRO were 
generated (Ogg et al., 1998). Many of these were predicted to have phenotypes such 
as reduced nucleotide affinity and reduced GTP hydrolysis. However, though many 
of the mutants are temperature and/or cold sensitive most have not been 
characterised further. It has also been established that the transmembrane domain of 
SRO is not required for its function (Ogg et at., 1998). It should be noted however, 
that a proportion of this SR-ATM remains associated with the ER membrane 
(approximately 25% of the total protein), suggesting that an ER membrane protein 
interacts with SRO and that this interaction is sufficient to allow the partial 
localisation of SRO-ATM to the ER. 
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16.3 GTPase involvement in SRP-dependent targeting 
All GTPases bind and hydrolyse GTP and thus can exist in any one of three states: 
GTP-bound, GDP-bound, and empty. Typically the active state of a GTPase is in the 
GTP-bound form. Hydrolysis of GTP to GDP turns the protein "off" while the 
empty state of the GTPase is considered a transient intermediate in the exchange of 
GDP for GTP. Both the rate of hydrolysis of GTP and the release of GDP are 
usually slow. Regulation of these steps is by GTPase activating proteins (GAPs) and 
guanine nucleotide release proteins (GNRPs) (Bourne eta!, 1991). Because the 
hydrolysis of GTP is effectively irreversible, the cycle is unidirectional. Targeting of 
proteins to the ER has been modelled as two intersecting conventional GTPase 
cycles. Cycle-1 begins with SRP54 binding to the ribosome nascent chain complex 
(RNC) promoting the exchange of bound GDP for GTP. In cycle-2 the GTP-bound 
form of SRa binds SRP-RNCs at the ER membrane. The two cycles intersect as the 
GTP-bound SRP and SR not only bind directly to one another but also function as 
reciprocal GAPs (Powers and Walter, 1995; Millman and Andrews, 1997). 
Hydrolysis of GTP results in the release of the nascent secretory protein to the 
translocon. The GDP-bound forms of SRcx and SRP54 dissociate and are recycled. 
The observation that binding of SRP54 to the ribosome increased the affinity of 
SRP54 for GTP 10-fold, suggested that the ribosome acts as a GNRP in the targeting 
reaction (Bacher et al., 1996). In recent years, evidence has been provided that this 
conventional model of GTPase action is not appropriate to describe the interactions 
involved in the targeting of SRP-bound RNCs to the ER membrane. 
Rapiejko and Gilmore (1997) examined the GTPase activity of SR in the following 
way. They utilised a mutant of SRc with altered nucleotide binding specificity such 
that XTP replaces GTP as the preferred substrate. SRu mutants were incorporated 
functionally into microsomes using an established assay (Andrews et al., 1989). 
Using different combinations of XTP, GTP and nonhydrolysable analogues of the 
two, they were able to analyse the nucleotide bound states of each protein during a 
functional targeting reaction. GTP binding to both proteins was shown to be 
reversible, and the nucleotide-binding status of SRP54 and SRa remained unfixed 
until the SRP-RNC interacted with SR. Furthermore, GTP hydrolysis was not 
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required for either the stable docking of the RNC or the signal sequence transfer to 
the translocon, but was necessary for dissociation of SRP54 and SRa. 
Further study of the GTPase cycle in SRP-dependent protein targeting by Bacher et 
al., 1999 led to the proposal that the third GTPase involved, SRO, regulates the 
interaction of SR with ribosomes, allowing SRa to "scan" ribosomes for the 
presence of SRP. The interaction between SRP and SRa would lead to signal 
sequence release from SRP and insertion into the translocon and GTP hydrolysis 
would dissociate SR from the ribosome and SRP from SR. To test GTP binding to 
SR subunits they used UV light-mediated cross-linking of a[ 32P]GTP to purified SR 
reconstituted into liposomes with RNCs and/or translocon components. They found 
that GTP binding to SROwas drastically reduced in the presence of RNCs and that 
an increase in GTP hydrolysis was observed (Bacher et al., 1999). Legate et al., 
2000 showed that GTP binding by SRO was necessary for dimerisation of SRa and 
SRO. They also proposed that dissociation of SRa and SRO could play an important 
role in SRP-dependent targeting. GTP hydrolysis by SRO would release the RNC-
SRP-nascent chain complex for transfer to the translocon, with SRa still bound to 
SRP54. Transfer of the nascent chain to the translocon would trigger hydrolysis of 
GTP by SRP54 and SR(, allowing SRP to return to the cytoplasm and SRct to rebind 
to SRO. Fulga et al., 2001 extended this model by showing that a 21 kDa ribosomal 
protein could be cross-linked to SRO only in the absence of bound nucleotide or in 
the presence of GDP. Binding of SRO to this 21 kDa ribosomal protein was lost 
upon transfer of the RNC to the translocon and appeared to stabilise the nucleotide-
free form of SRO. The use of the DI8IN mutant of SRO (Legate etal., 2000), which 
has a higher affinity for XTP than GTP, demonstrated that GTP binding by SRO is 
essential for translocation (Fulga et al., 2001). GTP bound SRO is essential for the 
release of the nascent chain from SRP and binding of SRO to the 21 Wa ribosomal 
protein stabilises its nucleotide-free state. These two observations are compatible as 
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binding of SRO to the 21 kDa ribosomal protein is lost when the translocon is 
present. Therefore, GTP binding to SRO ensures that SRP releases the nascent chain 
only in the presence of an available translocon. A model, integrating all of these 
observations, and data described in this study (chapter 5), is described in Figure 1.5. 
SRP binding to the signal sequence of a target nascent chain and the ribosome 
promotes GTP binding by SRP (1). Strong interaction between SRP54 and SRct 
targets the SRP-RNC complex to the ER membrane, stimulating GTP binding by 
SRa (2). GDP-bound SRO interacts with the ribosome (GNRP) and loses the bound 
GDP, causing SRcx and SRO to dissociate (3). Tight binding between SRa and 
Srp54p is sufficient to maintain the RNC-SRP-SR complex on the ER membrane. 
Ribosome binding to the translocon, and possibly SRO binding to the translocon, 
stimulates GTP binding and hydrolysis by SRO and release of the RNC from SRP 
(4). Translocation of the nascent chain proceeds, causing structural changes in the 
ribosome that mediate GTP hydrolysis by SRa and 5RP54. This leads to recycling 
of SRP and binding of SRct to GDP bound SRO in the ER membrane (5). In this 
way, the ribosome acts as a GNRP for SR, while the translocon, or the translocon 
and the ribosome together, act as a GAP for SR. 
1.6.4 SRa is evolutionarily conserved 
Homologues of SRa have been found in eukaryotic, bacterial, and archaeal species. 
The existence of SRP and SR in all organisms examined indicates a universal 
conservation of SRP-dependent targeting. While homologues of SRa have been 
found, homologues of SRO appear only to exist in eukaryotic cells. The existence of 
this third GTPase reveals an apparent need for another layer of regulation in SRP-
dependent targeting in eukaryotes not required in bacterial cells. 
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Figure 1.5 Model of GTPase action in SRP-dependent 
targeting 
SRP binding to the signal sequence of a target nascent chain and the ribosome 
promotes GTP binding by SRP (1). Strong interaction between Srp54p and 
SRc targets the SRP-RNC complex to the ER membrane, stimulating GTP 
binding by SRa (2). GDP-bound SRO interacts with the ribosome (GNRP) 
and loses the bound GDP, causing SRa and SRO to dissociate (3). Tight 
binding of SRa to Srp54p is sufficient to maintain the SRP-RNC-SR complex 
on the membrane. Ribosome binding to the translocon, and possibly SRO 
binding to the translocon, stimulates GTP binding and hydrolysis by SRO and 
release of the RNC from SRP (4). Translocation of the nascent chain proceeds 
causing structural rearrangements in the ribosome that mediate GTP hydrolysis 
by SRa and Srp54p, leading to recycling of SRP and re-binding of SRa to 
GDP-bound SRO in the ER membrane (5). 
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The bacterial SRa homologue is FtsY. FtsY is essential in E. coli for the biogenesis 
of integral membrane proteins, indicating that FtsY and eukaryotic SRa have similar 
functions (Seluanov and Bibi, 1997). The binding of Fth to FtsY requires 4.5S RNA, 
and FtsY alone does not interact with 4.5S RNA. The interaction between Fth and 
FtsY is strongly influenced by the structure of a region of 4.5S RNA known as the 
tetraloop region. There is strong evidence that both 4.5S RNA and Ffh undergo 
structural changes to form a functional interaction with FtsY and that 4.5S RNA may 
regulate the GTPase cycle of the Ffh-FtsY complex (Peluso et al., 2000; Jagath et al., 
2001; Peluso et al., 2001). Ribosome binding to the inner membrane in E. coli 
requires FtsY but is not dependent on the SRP54 homologue Fth, suggesting that 
perhaps Fth operates downstream of FtsY (Herskovits and Bibi, 2000). 
Sequence alignments of all SRP-type GTPases, except SR, identified a domain 
conserved throughout called the NG domain (Romisch et al., 1989; Bernstein el al., 
1989). In FtsY and SRa, the NG domain is linked to a highly charged domain at the 
N-terminus, which, in SRa is involved in membrane attachment through its 
interaction with SRO (Young et al., 1995). This N-terminal, 198-residue long, 
segment of FtsY constitutes an independent domain, required only for the targeting 
of the C-terminal NG domain of FtsY to the membrane (Zelazny et al., 1997). 
Herskovits et a! ., 2001 showed in vivo evidence that the catalytic NG domain of 
FtsY could be separated from the N-terminal targeting domain by proteolytic 
cleavage with no loss of FtsY function. When these domains were separated by a 
polypeptide spacer function was lost suggesting that FtsY is targeted to the inner 
membrane and assembled co-translationally. Targeting of FtsY to the inner 
membrane was described previously. It was shown that FtsY binds to the inner 
membrane through interactions with phosphatidylethanolamine (PE) and an 
unknown membrane protein (Millman et al., 2001). In the absence of PE, FtsY is 
still targeted to the membrane and assembled through an interaction sensitive to the 
addition of trypsin. The crystal structure of the NG domain of FtsY (Montoya et al., 
1997) revealed 3 regions: the N region, a GTPase region and an --a insertion 
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called the "1 box". The I box was suggested to be a built-in factor that stabilises the 
nucleotide-free form of FtsY. To bind GTP, a conformational change is needed 
which might be induced by the interaction of the I box with a regulatory factor, such 
as FfhI4.5S RNA (Montoya et al., 1997). Lu et al., 2001 provided evidence that Fth 
and FtsY do not bind GTP unless previously "primed" by binding to an external 
"substrate". In the case of Fth this would be a hydrophobic signal sequence and for 
FtsY the translocation apparatus. The existence of a priming step in SRP-dependent 
targeting in bacteria suggests that targeting is not dependent on the completion of one 
cycle of GTP binding and hydrolysis but on two intersecting cycles which cannot 
interact productively unless both are bound by appropriate substrate molecules. 
These findings correlate with those of Legate ci' al., 2000 (section 1.6.3) and 
strengthen the evidence for a possible role in targeting and/or translocation for 
dissociation or significant rearrangement of the interactions between eukaryotic SRa 
and SRO. Re-association of these proteins could constitute one "priming" step in 
eukaryotic SRP-dependent targeting with signal sequence binding providing the 
other. The requirement for priming steps in targeting of proteins might be a way of 
ensuring the faithful delivery of nascent chains to available translocons and prevents 
non-productive association of SRP54 and SRot at the membrane that would 
effectively short-circuit the targeting pathway. 
1.7 Co-translational translocation 
Protein insertion through the ER membrane is not by diffusion through the lipid-
bilayer. Polypeptide insertion is an active process requiring energy and proteins. 
Protein transport across the membrane of the ER can occur either co- or post-
translationally. Events at the membrane during translocation can be dissected into 
individual steps. The first involves the interaction of signal sequences with 
membrane proteins. The second involves the formation of the ribosome-membrane 
junction (in co-translational translocation only) and the third is translocation. 
Translocation can be detected experimentally by modification of the translocated 
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protein by enzymes within the lumen of the ER (OSTase and the signal peptidase 
complex) and by its protection from exogenously added proteases. 
Nascent chains translated in the presence of rough microsomes (RMs) are relatively 
resistant to protease treatment. This suggests that an interaction with an integral or 
peripheral membrane protein is responsible for the protection of the nascent protein 
(Sabatini and Blobel, 1970; Connolly et al., 1989). Early evidence for an aqueous 
translocation channel (translocon) in the ER membrane was demonstrated by 
electrophysiological techniques, Simon and Blobel (1991) finding that attached 
ribosomes kept the translocon in an open conformation and that they closed when 
ribosomes detached. Fluorescence collisional quenching has also been used to detect 
the open or closed conformation of the translocon and what proteins or complexes 
are necessary for closing or blocking the pore (Liao et al., 1997; Hamman et al., 
1998). The functions of the translocon complex will be discussed in relation to each 
step of translocation as it occurs at the ER membrane. 
1.7.1 The Translocon 
Genetic studies in S. cerevisiae led to the isolation of a variety of mutants defective 
in the secretory pathway, the sec mutants (Schekman et al., 1983). One such mutant 
identified Sec6lp, a multi-spanning integral membrane protein of the ER required for 
the translocation of both secretory and membrane proteins. This protein can be 
isolated from yeast ER membranes in a tight complex with two other proteins, Sbhlp 
and Sssip and these heterotrimers form the translocon. The analogous complex in 
mammalian ER consists of Sec6 Ia, 3 and y these being homologous to Sec6lp, 
Sbhlp and Ssslp respectively (Deshaies etal., 1991; Gorlich etal., 1992; Stirling et 
al., 1992; Sanders et al., 1992; High etal., 1993). The evolutionary conservation of 
the translocon extends to the bacterial translocon SecYEG, in which two 
components, SecY and SecE are homologous to Sec6la and  (Meyer et al., 1999). 
Genetic screens and biochemical reconstitution experiments have indicated that the 
Sec6lp complex is essential for translocation and forms the core of the translocon 
(Deshaies and Schekman, 1987; Rothblatt etal., 1989; Görlich and Rapoport, 1993; 
Panzner etal., 1995). Cross-linking experiments have demonstrated that Sec6lp, 
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with ten putative membrane-spanning domains, is in close proximity to polypeptide 
chains as they pass through the membrane. Indeed, a translocating nascent chain can 
be cross-linked to Sec6l(x at every amino acid within the plane of the lipid bilayer, 
implying that Sec6la surrounds the nascent chain in a ring (Görlich etal., 1992; 
MQsch ci al., 1992; High et al., 1993a+b; Mothes et al., 1994). The characterisation 
of cold sensitive mutants in sec6] helped to define two early stages in translocation 
for which the function of Sec6lp is necessary. The first class of mutants is defective 
in the docking of nascent chains onto the cytosolic face of the Sec complex, with 
Sec6lp required for this interaction. The second class of mutants allow the 
interaction of precursor proteins with the docking site but are defective in the ATP-
mediated release from this site, which in wild type membranes leads to translocation. 
Sec6 I  may have to undergo a conformational change for release of the polypeptide 
to occur (Pilon ci al., 1998). While factors such as the ribosome and Kar2p are 
known to regulate the state of the translocon, these sec6l mutants indicate that 
Sec6 1 p  itself has a role in the regulation of the transition from the closed to the open 
conformation of the pore, and therefore a regulatory role in translocation itself. 
Ssslp is an 8.9 kDa, C-terminally anchored essential component of the Sec6l 
complex. Purified Ssslp, in SDS micelles, is very stable and adopts a helical 
secondary structure (Beswick ci al., 1998). In order to gain some insight into the 
architecture of the Sec6l complex, complementary N- and C-terminal fragments of 
Sec6lp were expressed in yeast (Figure 1.6; Wilkinson etal., 1997). Chemical 
cross-linking using membranes derived from these strains revealed that Ssslp 
interacts with transmembrane domains 6, 7 and 8 (Wilkinson et al., 1997). 
Suppression of normally lethal sec6l mutants by over-expression of Ssslp provided 
supporting evidence of this interaction (Wilkinson ci al., 1997). It has been 
speculated that Ssslp acts as a surrogate signal sequence in the empty translocon and 
is a blocking protein for the pore, moving out of the translocon during translocation. 
The small, helical structure of Ssslp would fit inside the translocon until a suitable 
substrate was available, blocking any non-specific translocation of small cytosolic 
proteins. 
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Figure 1.6 Membrane topology of Sec6lp 
The lOtransmemhrane domains of Sec6lp are depicted (rectangles I-
10) with the relative lengths of each cytoplasmic and lumenal loop 
(1-9). The orientation of the N-terminal domain of Sec6 Ip along the 



















Reproduced from Wilkinson etal., 2000. 
It is apparent that the Sec6l complex is not only involved in translocation into the 
ER but also dislocation from it. When protein folding or processing within the 
lumen of the ER is prevented the protein is handled in one of three ways. First, the 
protein may aggregate and elicit the unfolded protein response (UPR) (McMillan et 
al., 1994). The UPR is mediated through an ER transmembrane protein, Ire ip, 
which along with tRNA ligase removes a non-canonical intron from the mRNA 
encoding a transcription factor (Haclp) responsible for induction of expression of 
many chaperones and translocon components (Shamu and Walter, 1996; Shamu, 
1998). Second, the protein may be transported to the vacuole for degradation (Hong 
et al., 1996). Third, the ER quality control machinery may recognise the misfolded 
protein and target it for immediate degradation and removal from the secretory 
pathway by a process known as the ER-associated degradation process (ERAD) 
(McCracken and Brodsky, 1996). ERAD is carried out by the 26S proteasome, the 
multicatalytic protease complex that mediates the majority of protein degradation in 
the cytosol and nucleus (Plemper and Wolf, 1999). It has been demonstrated that 
ERAD substrates (with possible exceptions; Walter etal., 2001) gain access to the 
proteasome by being extracted from the ER via the Sec6lp translocon in a process 
referred to as dislocation (Wiertz el al., 1996b; Pilon et al., 1997; Plemper etal., 
1997; Zhou and Schekman, 1999). Major substrates for ERAD include proteins that 
are conformationally abnormal as a result of mutation, lack of assembly partners, or 
imperfect folding. 
1.7.2 Ribosome binding to the Sec6lp complex 
In co-translational translocation, the Sec6lp complex associates with the translating 
ribosome at the ER membrane (Görlich and Rapoport, 1993; Kalies et at., 1994; 
Hanein et al., 1996; Beckmann et al., 1997). Electron micrograph images of purified 
Sec6l complex from yeast confirmed that it forms an oligomeric ring structure 
comprising 3-4 Sec6l trimers (consisting of Sec6lp, Sbhlp and Ssslp). The overall 
diameter of the ring is 85-95A with the internal pore having a mean diameter of 20-
35A. This diameter is greater or lesser depending on the open or closed state of the 
pore and if ribosomes are bound (Hanein et al., 1996; Beckmann et al., 1997). 
Recently it has been established that the tunnel in the large ribosomal subunit 
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through which the nascent polypeptide exits (Lake, 1985; Yonath et al., 1987) is 
aligned with the protein-conducting channel of the translocon (Beckmann et al., 
1997; Beckmann et al., 2001). Fluorescence collisional quenching data showed that 
the ribosome, while bound to the translocon, regulates the gating of the pore during 
membrane protein integration (Do et al., 1996; Liao et al., 1997). Regulation of the 
pore by the ribosome includes recognition of membrane proteins requiring insertion 
into the lipid bilayer, leading to structural changes in both the ribosome and the 
translocon required to effect insertion. One striking observation is that the lumenal 
and cytosolic sides of the translocon are never open simultaneously. Significant 
structural rearrangement would be required to close a pore with a mean diameter of 
40-60A which suggests that a lumenal protein acts as a "gate". Further fluorescence 
collisional quenching experiments identified this "gate" protein as the ER lumenal 
chaperone BiP (Kar2p in yeast) (Hamman et al., 1998). BiP, only in the nucleotide-
bound state, not only acts as a lumenal seal during translocation but also seals the 
pore when no ribosomes are present (Hamman etal., 1998; Section 1.9). 
Cryo EM reconstruction of the yeast ribosome-nascent chain translocon complex has 
recently been extended to 15.4 A. The reconstruction revealed four connection 
points between the ribosome and the Sec6lp complex across a gap of approximately 
10-20 A and this "gap" was also seen with mammalian ribosome-translocon 
complexes (Ménétret etal., 2000; Beckmann etal., 2001) (Figure 1.7a). The 
compact appearance of the channel indicated that gating of the translocon by a signal 
sequence could lead to an opening just large enough to be completely occupied by an 
inserted nascent polypeptide chain, without allowing ion conductance (Beckmann et 
al., 2001). These findings led to the proposal of a model of ribosome-protein-
conducting channel function in co-translational translocation and membrane protein 
insertion (Figure 1.7b). In this model the exit tunnel of the large ribosomal subunit 
constitutes a functional domain of the ribosome allowing folding of secondary helical 
structure. Any hydrophobic signal sequence would be probed by the channel and 
lead to insertion and capture with the C-terminal side of the signal sequence either 
exposed to the cytosol or the lumen depending on its orientation (Figure 1.7b). The 
channel would open wide enough to only allow insertion of the signal sequence, as a 
result, the nascent chain following the signal sequence will either accumulate on the 
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Figure 1.7 Alignment of translocon and ribosome during 
translocation 
A 
Reconstruction of the translating and translocating ribosome-nascent chain complex (RNC)
Sec6l complex in 0.2% (w/v) deoxyBigCHAP at 15.4 A resolution. Note the presence of tRNA 
density in the P site and the Sec6lp channel with the shape of a compact disc in the active 
channel. Colour coding: yellow, small ribosomal subunit (40S); blue, large ribosomal subunit 
(60S); red, Sec6lp complex; green, P site tRNA. 
Same as (a) but rotated upward by 90 0 . 
Reconstruction of the empty complex in 0.2% (w/v) deoxyBigCHAP at 18.9 A resolution. 
Note the absence of tRNA density and the elongated shape of the channel. Colour coding as 
described for (a). 
Same as (c) but rotated upward by 90°. Bar: 100 A (Beckmann et al., 2001). 
B. 
Binary Model of Cotranslational Protein Translocation 
The model is based on the finding that a gap exists between the RNC and the protein conducting 
channel (PCC), and that the translating PCC has a compact conformation. The PCC can provide 
a seal to maintain the ion permeability barrier of the ER membrane: (1) The tunnel in the large 
ribosomal subunit facilitates folding of a-helical segments. (2) The emerging segment is probed 
by the PCC before insertion. Hydrophobicity, helicity, and the nature of the flanking regions 
(i.e., positive charges) determine if and in what orientation the segment is inserted. (3) Insertion 
can occur in two different orientations with the channel opening just wide enough to 
accommodate the inserted nascent polypeptide. (4) In case of loop insertion, the following 
nascent chain is guided through the membrane, and translocation is possible. In case of non-loop 
insertion, the following nascent chain cannot translocate, accumulating on the cytosolic side of 
the membrane. Because of the sealed channel and the existence of the gap between ribosome and 
PCC, such cytosolic domains can easily exit into the cytosol at any time without compromising 
the ion permeability barrier. 
Nascent chain translocation after loop insertion and cytosolic accumulation after non-loop 
insertion are the only two principally different functional states of the RNC-PCC complex. A 
simple secretory protein would experience only one loop insertion of the signal sequence after 
targeting by SRP and translocate. For a polytopic membrane protein, the states would alternate 
with every new hydrophobic transmembrane domain. This model may be expanded by including 
additional regulation (i.e., pause transfer sequences (Chuck and Lingappa, 1992)) and exceptions 
(Beckmann etal., 2001). 
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cytosolic side or, if it has been co-inserted in a loop, translocated across the 
membrane (Beckmann et al., 2001). This provides a model of insertion and 
translocation of secretory proteins, signal anchor proteins and polytopic membrane 
proteins. 
Assays in which the binding of radiolabelled ribosomal components to purified ER 
membranes were analysed revealing that the ribosome-Sec6lp interaction is 
mediated by the 28S rRNA of the eukaryotic large ribosomal subunit. Bacterial 
ribosomes bound via their 23S rRNA to the bacterial homologue of the Sec6lp 
complex, SecYEG. Interestingly, eukaryotic ribosomes bind SecYEG while 
bacterial ribosomes bind the Sec6lp complex. This indicates that rRNA-mediated 
ribosome binding to the translocation channel is evolutionarily conserved (Prinz et 
al., 2000a). 
As mentioned earlier, Sec6lp is an integral membrane protein with 10 
transmembrane domains. The topology of the protein was elucidated through the use 
of C-terminal reporter-domain fusions and in situ digestion of specifically inserted 
factor Xa cleavage sites (Wilkinson et al., 1996). A representation of the topology of 
Sec6lp is shown in Figure 1.6. As Sec6lp has been highly conserved throughout 
evolution this data can be applied to homologues of Sec6lp in other organisms. 
Cytoplasmic loops of Sec6l(x have been found to be important in ribosome binding 
and translocation promotion by the Sec61 complex. Mild protease treatment of 
microsomal membranes results in the removal of SRa and, depending on the 
conditions and protease used, cytoplasmic loops of Sec61ct. It was found that 
membrane binding of non-translating ribosomes decreased upon removal of 
cytoplasmic loop 8 and the carboxy-terminal cytoplasmic tail of Sec6la. In contrast, 
removal of cytoplasmic loop 6 (but not loop 8 or the carboxy-terminal tail) severely 
inhibited translocation (Raden et al., 2000) (Figure 1.6). Thus, it appears there is 
differential regulation of ribosome binding and translocation within Sec6lct itself. 
This may allow for more flexibility within the protein targeting and translocation 
pathways and separate regulation of SRP-dependent and —independent translocation. 
Wilkinson et al., 2000 extended these findings by describing a role for 
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transmembrane domain 2 of Sec6lp in yeast in post-translational translocation. They 
also found this domain to be dispensable for co-translational translocation and 
protein dislocation. 
Sec6la is not the only protein within the translocon implicated in ribosome binding. 
Levy (200 1) identified an interaction between non-translating ribosomes and Sec6 113. 
It was shown that the cytoplasmic domain of Sec6 113  could inhibit the binding of 
ribosomes to ribosome-stripped ER membranes and that this interaction was 
sensitive to high salt concentrations. The conclusion that this represents an important 
Sec6113-ribosome interaction is strengthened by the observation that the absence of 
Sec6 113 results in impaired translocation (Kalies et al., 1998). It has also been 
suggested that one function of Secô 113 may be to stabilise the ribosome-Sec6lcx 
interaction (Raden eral., 2000). It has not been investigated whether Sec6 113 binding 
to the ribosome is protein- or rRNA-mediated. 
Puromycin is an aminoacyl-tRNA analogue that it is covalently incorporated into a 
nascent chain, and terminates protein synthesis. The reaction is catalysed by the 
peptidyl transferase activity of the ribosome, and the resulting peptidyl-puromycin is 
released (Blobel and Sabatini, 1971). Membranes stripped of ribosomes by 
puromycin and high salt treatment, as well as proteoliposomes reconstituted from 
microsomal proteins after detergent solubilisation, still contain large numbers of 
Sec6lp oligomers (Kalies et al., 1994). The survival of these complexes after 
puromycin and high salt treatment suggests that translocons are stable Sec6l 
complex oligomers. These results are supported by recent work that showed that 
non-translating ribosomes remain ER-bound following translocation until engaged 
by mRNA encoding a cytosolic protein (Potter and Nicchitta, 2002). Ribosomes 
bound to the ER membrane could support the translation and translocation of 
secretory protein independent of the SRP receptor. However, for a translationally 
active membrane-bound ribosome to maintain its association with the membrane, the 
emergence of a signal sequence must occur. The potential physiological importance 
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of this data is that it suggests a mechanism of regulating the equilibrium of 
membrane-bound and free ribosomal pools. Should the demand for the synthesis of 
cytoplasmic proteins exceed the capacity of free ribosomes, membrane-bound 
ribosomes could initiate protein synthesis and detach from the membrane. 
Conversely, should the demand for secretory proteins rapidly increase, an efficient 
mechanism may exist whereby membrane-bound ribosomes can undergo repetitive 
cycles of translation while remaining on the membrane, bypassing the need for 
detachment and re-targeting to the ER (Potter and Nicchitta, 2000; Potter and 
Nicchitta, 2002). 
1.7.3 Mechanisms of co-translational translocation 
In co-translational translocation nascent chain-ribosome complexes first interact with 
SRP in the cytosol. Upon interaction of the ribosome-nascent chain with the ER-
localised SR, the nascent-chain ribosome complex dissociates from SRP and is 
targeted to the Sec6lp complex. This targeting is determined by the affinity of the 
ribosome for the Sec6lp complex and by signal sequence-Sec6lp complex 
interactions (Walter and Johnson, 1994; Jungnickel and Rapoport, 1995). During co-
translational translocation the ribosome forms a tight seal with the Sec6lp complex 
(Liao et al., 1997). The driving force for translocation of a co-translational precursor 
is thought to be provided by the elongation of the nascent chain on the translating 
ribosome. Kar2p, a lumenal Hsp70, is thought to assist in folding of emerging 
polypeptides and to provide additional gating of the pore (Hamman et al., 1998). It 
has been shown by chemical cross-linking that Sec6 1 13  (the mammalian homologue 
of Sbhlp in yeast) interacts with Sec6lct and the 25 kDa subunit of the signal 
peptidase complex (SPC25) (Kalies et at., 1998). Cross-linking of Sec6113 to SPC25 
demonstrated for the first time a tight interaction between the Sec6l complex and the 
SPC. The cross-linking was dependent on the presence of membrane bound 
ribosomes, suggesting that these interactions only occur during translocation or upon 
translocation initiation (Kalies et al., 1998). 
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During co-translational integration of a type I membrane protein into the ER 
membrane, the opening or closing of each end of the aqueous translocon pore is 
tightly controlled. Type I membrane proteins have an N-terminal transmembrane 
domain and a large C-terminal cytosolic domain. Each event in the insertion of these 
proteins occurs in a fashion that does not compromise the integrity of the 
membrane's permeability barrier. The ribosome first recognises the transmembrane 
segment and triggers long-range structural changes that may be involved with 
shifting the function of the translocon from translocation to integration (Liao et al.. 
1997). Closing of the translocon pore on the lumenal side to maintain the 
permeability barrier precedes exposure of the pore to the cytosol during integration. 
This result is remarkable in that the ribosome, not the translocon, triggers the 
structural changes. It can be supposed that the translocon would be insufficient for 
the recognition of the transmembrane domain as there would be too little time to 
effect the structural changes needed for integration. 
Further investigation has revealed how the transmembrane domain of a membrane 
protein is co-translationally integrated into the ER membrane. It was demonstrated 
that the Sec6lp channel allows the transmembrane domain of the protein to bypass 
the barrier posed by the polar head groups of the lipid bilayer and come into contact 
with the hydrophobic interior of the membrane. Together with the TRAM protein, 
Sec6lp provides a site in the membrane, at the interlace of translocon and lipid, 
through which a transmembrane domain can partition into the lipid bilayer (Mothes 
et al., 1997; Heinrich et al., 2000). 
1.8 Post-translational translocation 
Post-translational translocation, identified in yeast, occurs after the polypeptide has 
been fully synthesised in the cytosol and released from the ribosome and involves 
interactions between substrate and cytosolic chaperones, the translocon and the 
Sec62/63p complex (Figure 1.8). Post-translational translocation occurs in distinct 
phases. In an initial binding reaction, a translocation substrate interacts with the 
cytosolic face of the Sec complex. This interaction is ATP- and Kar2p-independent. 
Subsequently, Kar2p interacts with the J domain of Sec63p to move the substrate 
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through the translocation channel. This interaction and translocation is ATP-
dependent (Matlack et al., 1997). Post-translational targeting in yeast can be 
reconstituted using proteoliposomes containing a heptameric membrane protein 
complex consisting of trimeric Sec6lp and the tetrameric Sec62/63p complex 
(Panzner et al., 1995). Neither of the sub-complexes can support post-translational 
translocation alone but wild type translocation levels can be restored if both 
complexes are reconstituted together. In yeast, cytosolic Hsp70 proteins, the 
products of the SSA gene family, and Ydj ip, a cytosolic DnaJ homologue, are 
required for translocation of a few post-translational substrates. Among these are 
pre-pro-a factor and proteinase A (Chirico et al., 1988; Deshaies el al., 1988; Caplan 
et al., 1992; Brodsky et al., 1995; Becker etal., 1996). KAR2, the gene encoding 
Kar2p in yeast, shows synthetic lethality with sec63-1 mutants confirming its 
essential role in translocation (Deshaies et al., 1991). 
1.8.1 The Sec complex 
Sec62, 63, 71 and 72p form the Sec62/63 or Sec complex in yeast (Panzner et al., 
1995). Selection of yeast cells defective in translocation of a signal peptide-cytosolic 
enzyme hybrid protein led to the identification of the SEC62, SEC63 genes. The 
observation that haploid yeast with mutations in any pair of the genes were inviable 
at 24°C and showed a marked increase in translocation defects led to the assumption 
that the products of these genes interacted with Sec6lp and each other (Rothblatt et 
al., 1989). Sec62p is a 30 kDa protein with two membrane spanning domains. The 
protein is believed to be oriented such that the amino and carboxy termini are 
exposed to the cytosol, with the N-terminal domain of Sec62p binding the C-terminal 
14 amino acid residues of Sec63p (Deshaies and Schekman, 1990; Wittke et al., 
2000). 
Sec63p is a 73 Wa protein that spans the bilayer three times and has an ER lumenal 
domain which is 42% identical to the E. co/i DnaJ protein (Feldheim et al., 1992; 
Sadler et al., 1989). The ER lumenal chaperone Kar2p interacts with the Sec 
complex via the lumenal J domain of Sec63p. The J domain is a 70 amino acid 
segment that defines the Hsp-70 interacting J protein family (Sanders et al., 1992; 
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Brodsky and Schekman, 1993; Scidmore et at., 1993; Lyman and Schekman, 1995; 
Corsi and Schekman, 1997; Matlack et at., 1997). Peptide binding of Kar2p is 
activated by the J domain of Sec63p and is ATP-dependent (Corsi and Schekman, 
1997; Misselwitz et at., 1998). 
When membrane targeting of proteins was reconstituted in vitro in the absence of 
Sec62p, two of the substrates affected were what are now thought of as classic post-
translational translocation substrates, carboxypeptidase Y (CPY) and pre-pro-cc 
factor (ppaF) (Deshaies and Schekman, 1989). While in mammalian cells co- 
translational translocation is favoured, the Sec6l complex has been found to 
associate with mammalian homologues of Sec62 and 63p, despite the lack of 
observed post-translational translocation (Meyer et al., 2000). 
SEC72 encodes the 23 kDa subunit of the Sec complex. The DNA sequence of 
SEC72 predicts a 21.6 kDa protein with neither a signal peptide nor any 
transmembrane domains. Antibodies directed against a carboxyl-terminal peptide of 
Sec72p confirmed the membrane location of the protein. SEC72 is not essential for 
yeast cell growth, although a sec72 null mutant accumulates a subset of post-
translationally translocated secretory precursors in vivo (Green et al., 1992; Fang and 
Green, 1994). SEC71 encodes a 31.5 kDa transmembrane protein of the Sec 
complex that is also non-essential in yeast and a null mutant of which accumulates 
the same subset of secretory precursors in vivo (Green et at., 1992; Fang and Green, 
1994). 
The heptameric Sec complex, consisting of Sec6lp, Sbhlp, Ssslp, Sec62/63/71 and 
72p may constitute a stable closed pore; it can be purified as a complete unit. The 
suggestion that the Sec62/63p complex may induce oligomerisation of Sec6lp 
predicts that this heptameric Sec complex would open only in the presence of a 
suitable signal sequence or substrate. These assembly and gating processes are 
thought to occur independently and consecutively (Simon and Blobel, 1991; Hanein 
et at., 1996). 
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Mutants of sec63, 71 and 72 have defects in karyogamy. From this observation it has 
been proposed that Sec63, 71 and 72p have auxiliary roles in the nuclear envelope 
fusion complex, with the ER lumenal chaperone Kar2p required for the process 
(Brizzio et al., 1999; Ng et al., 1996). 
1.8.2 Signal sequence detection by the 5ec62163p complex 
A post-translationally translocatcd substrate, used often in the analysis of this 
pathway, is pre-pro-alpha factor (pp(xF). Cross-linking studies have examined how 
the signal sequence of ppaF is recognised in the first step of translocation, signal 
sequence recognition. The signal sequence interacts in a Kar2p- and ATP-
independent reaction with Sec6lp and is specifically cross-linked to transmembrane 
domains 2 and 7 (Figure 16). While bound to Sec6lp, the signal sequence (in a 
helical structure formed inside the ribosome) is contacted on one side by Sec62p and 
Sec7lp. This binding site is located at the interface of the protein channel and the 
lipid bilayer (Plath et al., 1998). Signal sequence recognition in co-translational 
translocation in mammals appears to occur in a similar fashion (Mothes et al., 1998). 
This suggests a general mechanism by which the signal sequence opens the 
translocation channel for polypeptide transport (Plath et al., 1998). Previous cross-
linking experiments suggested that the initial contact of the signal sequence occurs 
with Sec62p, Sec7lp and Sec72p, and that contact with Sec6lp requires a subsequent 
ATP- and Kar2p-dependent step (Müsch et al., 1992; Sanders et al., 1992; Lyman 
and Schekman, 1997). However, these experiments used wild type ppaF, in which 
all the cross-linkable lysine residues were in the C-terminus of the protein. 
Therefore, the data from these experiments can be explained by the movement of the 
C-terminal portion of ppctF into the translocon during translocation, and not by ATP - 
and Kar2p-dependent signal sequence recognition by Sec6lp (Plath et al., 1998). 
Experiments using chimeras of signal sequences of one protein and the mature 
polypeptide of another demonstrated that a translocation defect seen in mutants of 
sec72 is associated with the signal peptide rather than with the mature region of the 
secretory precursor. These mutants failed to translocate an arginine permease- 
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invertase-HIS4C fusion protein and a Sec63-invertase chimera, both of which use 
internal hydrophobic segments as signal peptides. The phenotype of the sec72 
mutants is consistent with at least two potentially overlapping roles in translocation. 
Sec72p may be involved in recognition of "difficult" or charged signal peptides or 
Sec72p may increase the efficiency of transfer of these "difficult" secretory 
precursors to the translocation pore (Feidheim and Schekman, 1994). 
1.9 Kar2p 
Kar2p is essential for the post-translational translocation pathway in yeast where it is 
required at two stages. The first is in the initiation of translocation prior to the stable 
interaction of the precursor protein with the translocon. The second is in the 
promotion of vectorial transport of the polypeptide chain through the translocon to 
the ER lumen (Sanders et al., 1992; Lyman and Schekman, 1995, 1997). It has been 
shown in vitro that Kar2p stimulates the level of post-translational translocation 
three-fold (Brodsky and Schekman, 1993). Kar2p binds to nascent chains during 
translocation. ATP is required for the repeated binding and release of the nascent 
chain from Kar2p (Matlack et al., 1997). However, there is much speculation over 
whether Kar2p acts as a ratchet during translocation, binding to nascent chains to 
prevent them slipping back through to the cytosol, or whether it actively pulls the 
chain through. Recent evidence supports the ratchet model but this is unconvincing 
as only one substrate was analysed and a pared-down minimal reconstituted system 
was used (Matlack et at., 1999). Perhaps a combination of both effects is required to 
explain the translocation of all substrates into the ER lumen. 
It has been shown in co-translational translocation that BiP, the mammalian 
homologue of Kar2p in yeast, maintains the lumenal seal of the translocon, and is 
displaced when the translocating chain reaches greater than 70 amino acids in length 
(Hamman et al., 1998). In this way, BiP maintains the integrity of the ER lumen by 
effectively closing the translocon channel until the ribosome interacts with Sec6lp 
and seals the pore from the surrounding cytosol (Crowley et al., 1994). More 
recently, it has been shown that in the absence of Kar2p or Sec63p (but not Sec62p) 
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co-translational translocation was compromised in vivo. This suggests a role for 
Kar2p in translocation itself as well as providing a lumenal seal (Young et al., 2001). 
This is supported by previous data gathered through an in vitro assay involving co-
translational translocation into microsomes defective in Kar2p and/or Sec63p 
activity. Data from these experiments showed an absolute requirement for Sec63p 
and Kar2p in co-translational targeting in vitro (Brodsky et al., 1995). 
1.10 Lhslp 
A second ER-resident Hsp70-related protein, encoded by the LHSJ gene, has been 
characterised in yeast (Baxter et al., 1996; Craven et al., 1996; Hamilton and Flynn, 
1996). The Lhsl protein (Lhslp) represents a novel branch of the Hsp70 
superfamily (Saris et al., 1997) and appears ubiquitous amongst eukaryotes. Unlike 
Kar2p, Lhslp is not essential for cell viability, but i/is] null mutant cells display a 
partial defect in post-translational translocation (Baxter et al., 1996; Craven et al., 
1996; Hamilton and Flynn, 1996) and are also defective in the repair of misfolded 
proteins in the ER (Saris et al., 1997). However, interpretation of the z.%lhsl 
phenotype is complicated by the fact that these cells exhibit induction of the unfolded 
protein response (UPR). The LHSJ gene itself is UPR regulated, suggesting that 
Lhslp plays a role in the normal cellular response to folding stress (Baxter etal., 
1996; Craven et al., 1996). A functional UPR is required for the near normal growth 
rate observed in /i/?s] cells when compared with the parental strain. SILl is an 
UPR-regulated gene that is essential for the survival of Allis] cells. Silip interacts 
with the ATPase domain of Kar2p. Over-expression of Silip is sufficient to suppress 
the phenotypes associated with an lhsl deletion. However, a L!/zslz1sill double 
mutation results in a lethal phenotype with a complete defect in protein translocation 
into the ER (Tyson and Stirling, 2000). 
Whatever the actual functions and interactions of Lhslp and Silip, the translocation 
defect seen in zXlhs1z%siil double mutant cells demonstrate that Kar2p is not 
sufficient to drive co- or post-translational translocation into the ER in vivo. 
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1.11 TRAM 
Photocross-linking has been used extensively to analyse interactions of nascent 
chains during their insertion into the ER membrane (Wiedmann et al., 1987; Krieg et 
al., 1989; High etal.. 1991). One glycoprotein that is cross-linked to nascent chains 
is the 36 Wa translocating chain-associated membrane protein (TRAMp) (Görlich et 
al., 1992a). TRAM protein contacts the amino-terminal region of the signal 
sequence of translocating proteins in mammalian cells (High et al., 1993) and has 
been found to have a stimulatory role in the translocation of SRP-dependent 
substrates in vitro (Görlich and Rapoport, 1993). 
TRAM protein also regulates which domains of polytopic membrane proteins are 
exposed to the cytosol during translocation pauses. This process appears to be highly 
specific with the result of regulating the conformational state of the translocation 
apparatus, the rate of translocation and the environment of the nascent chain (Hegde 
et al., 1998). S. cerevisiae has no identified homologue of TRAM protein; therefore 
it is still unclear how this process is accomplished in yeast. 
1.12 The Sshl p complex 
The Sec6lp translocon accepts proteins through both the co-translational and post-
translational translocation pathways and allows dislocation from the ER. The yeast 
gene SSHJ (secsixty-one homologue), encodes a protein 30% identical to Sec6lp 
that is ER localized and associated with a homologue of Sbhlp, termed Sbh2p, and 
Ssslp (Finke et al., 1996). 
In contrast to SEC61, SSHJ is not essential, and initial analysis of the Sshlp complex 
by Finke et al. (1996) showed that though in its absence cells grew slower than wild-
type, they had no detectable translocation defects. However, the Sshlp complex 
binds ribosomes with similar affinity to Sec6lp (Prinz et al., 2000c), but does not 
bind Sec62p (Finke et al., 1996), suggesting that it may form translocons active only 
in co-translational translocation. Recent evidence supports the existence of two 
functionally nonequivalent translocons in the yeast ER, containing Sec6lp and 
Sshlp, respectively, both of which mediate translocation and dislocation (Figure 
1.8). First, it was shown that deletion of SSH] was strongly synthetic negative with a 
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Figure 1.8 Two translocons in the ER membrane 
The two pathways are depicted. In (A), the SRP-dependent co-translational 
pathway (orange), a ribosome translating a protein with a hydrophobic signal 
sequence, is bound by SRP and becomes localized to the ER membrane through 
interaction with the SRP receptor (SR). The ribosome may be docked to either 
the Sec6lp or Sshlp translocon. In (B), the post-translational pathway (blue), 
accepting proteins with less hydrophobic signal sequences (Ng et al., 1996), 
functions solely through Sec6lp as only this translocon interacts with Sec62p. 
Recent evidence (Young et al., 2001) indicates that both pathways additionally 
require Sec63p and the ER lumenal chaperone Kar2p (not depicted). The data of 
Wilkinson et al. (2001) suggest that the Sec6lp translocon does not provide 
sufficient capacity to accommodate all proteins under maximum growth rates. 
Thus in the absence of Sshlp, all SRP-targeted proteins are forced through 
Sec6lp, leading to translocation defects for proteins that use either pathway. 
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mutation in SRP (sec65-1). This synthetic negative interaction was not seen with a 
sec62 mutation. Also, it was found that sshlA cells had similar slow growth and 
respiration deficient phenotypes to SRP deficient cells. Cells deficient in Sshlp or 
SRP quickly lose mitochondrial function, they become p. These cells can be forced 
to retain their mitochondria if grown on non-fermentable carbon sources, such as 
ethanol and glycerol. These p sshIA cells have a severe defect in the translocation 
of dipeptidylaminopeptidase-B (DPAP-B), an entirely SRP-dependent protein. 
These cells also show defects in the translocation of CPY. CPY is targeted 
independently of SRP and since Sshlp does not interact with Sec62p this suggests 
that lack of Sshlp may place a general stress on the translocation apparatus 
(Wilkinson etal., 2001). The identification of a synthetic lethal interaction of Sshlp 
with Sec65p, the revelation that Sshlp, in a complex with Sbh2p and Ssslp binds 
ribosomes with the same affinity as the Sec6lp complex and the identification of 
translocation defects in cells lacking Sshlp provides evidence that Sshlp does indeed 
form a complex in the ER membrane, sufficient to promote translocation of SRP-
dependent substrates. Since sshlzi cells are slow growing the Sec6lp complex is 
insufficient for translocation on its own during rapid growth, where the burden on the 
secretory pathway is highest. However, Sshlp cannot transport a sufficiently broad 
spectrum of proteins to compensate for a lack of Sec6lp, as sec6lA cells are 
inviable. Therefore, it is a possibility that Sshlp exists as a "back-up" translocon 
providing extra translocation capacity and physiological flexibility to the cell under 
rapid growth conditions (Figure 1.8) (Robb and Brown, 2001). 
1.13 Reconstitution of protein targeting in vitro 
Reconstitution of the SRP-dependent targeting pathway determined the minimum 
complement of membrane proteins necessary for translocation. Görlich and 
Rapoport (1993) reconstituted the co-translational translocation apparatus of the 
mammalian ER membrane into proteoliposomes from pure phospholipids and 
purified membrane proteins. The results from this indicated that the minimum 
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translocation apparatus was very simple, comprising only the Sec6l complex and 
SR. These proteins were all that were required for translocation of preprolactin 
(Hegde et al., 1998; Voigt et al. 1996). However, translocation of pre-pro-a-factor 
required the addition of TRAM protein. Post-translational translocation in yeast was 
reconstituted by Panzner et al. (1995) using reconstituted proteoliposomes containing 
purified Sec complex. The Sec complex included the heterotrimenc Sec6lp complex 
and the Sec62/63p complex. Efficient post-translational translocation required the 
addition of Kar2p and ATP. The trimeric Sec6l complex was found to exist as a 
separate entity that, in contrast with the larger Sec complex, was associated with 
membrane-bound ribosomes. From this it was hypothesised that distinct membrane 
protein complexes function in co- and post-translational translocation pathways 
(Panzner et al., 1995). Reconstitution of protein targeting is an established method 
of elucidating the components and interactions necessary for different modes of 
translocation. These previously established assays provided a starting point in the 
reconstitution of SRP-dependent targeting from entirely yeast components described 
in this study. 
1.14 Yeast as a model organism 
The study of SRP-dependent targeting in yeast is simpler than corresponding study in 
mammalian cells due to the amenability of yeast to genetic and biochemical 
manipulation. The growth rate of yeast cells coupled with their ability to be 
transformed with heterologous DNA make the organism an excellent tool for the 
investigation of such a conserved pathway. The publication of the complete yeast 
genome also makes this organism an excellent model for the study of the first step of 
the secretory pathway. An obvious advantage to studying SRP and SR components 
in yeast is the fact that SRP and SR encoding genes are non-essential. The ability to 
delete SRP components from the yeast genome without inducing apoptosis allows 
the study of SRP-dependent targeting by a variety of other methods not open to the 
study of essential genes. 
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1.15 Aims 
1.15.1 Purification of SR from yeast 
While the functions of many of the proteins involved in SRP-dependent targeting 
have been elucidated, as described in the introduction, the function of SRO has 
remained elusive. While an active GTPase domain is required for SRO function and 
its transmembrane domain is not essential (Ogg et al., 1998), little else is known 
about this protein and no function has been assigned to it. In order to identify the 
role of SRO in SRP-dependent targeting in yeast, other than as a membrane anchor 
for SRa, in vitro reconstitution of the targeting pathway was to be attempted. In 
order to carry out this reconstitution SR had to be purified from yeast along with 
other membrane proteins required for translocation (Sec6lp and the Sec62/63p 
complex) and the lumenal chaperone Kar2p (required for co- and post-translational 
translocation). Purification of these components, for the eventual reconstitution of 
protein targeting, is described. 
1.15.2 Reconstitution of SRP-dependent targeting in vitro 
In order to investigate the sequence of interactions that occur in the delivery of a 
ribosome-nascent chain complex to the translocon in the ER membrane, 
reconstitution of the targeting pathway was attempted. Optimisation of 
reconstitution was carried out at every stage. Reconstitution of SRP-dependent 
targeting was successfully carried out with solubilised membrane proteins recovered 
from appropriate yeast strains and additional purified components. 
1.15.3 Identification of interactions of SR 
To aid in elucidation of the sequence of events that occur at the ER membrane and in 
determining a function for SRO experiments to identify proteins that interact with 
SRO were carried out. Pull-down assays, two-hybrid analysis, chemical cross-linking 
and immunoprecipitation were attempted to this end. Pull-down assays successfully 
identified a salt-concentration sensitive interaction between SRO and Sec6lp. Two- 
hybrid analysis localised this interaction to the N-terminus of Sec6lp. 
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Chapter 2 
Materials and Methods 
Materials 
2.1 Chemicals and Biochemicals 
General chemicals were obtained from Sigma Chemical Co., BDH Chemicals, Fisher 
Ltd, Cal biochem or Boehringer Mannheim. Media components were from Difco 
Laboratories. IgG, Q, SP, CM and DEAE Sepharoses (fast flow) and "S-methionine 
were from Amersham Pharmacia. Ni-NTA agarose and kits for plasmid DNA 
preparation were from Qiagen Ltd. 0.02 tm filters used to filter sterilise liquids and 
centricon centrifugal filter devices were obtained from Millipore. SpectralPor 
molecularporous regenerated cellulose dialysis membrane and clips were from 
Spectrum Laboratories Inc. Prosieve 50 modified acrylamide gel solution was 
obtained from Flowgen. 
2.2 Enzymes, proteins and antibodies 
Lysozyme, trypsin and micrococcal nuclease were all obtained from Sigma Chemical 
Co.. All DNA restriction and modification enzymes were from Promega or NEB and 
used as recommended by the manufacturer. Taq polymerase was from Prornega. 
Standard PCR reactions contained 0.2 p.M each dNTP, 100 pmol each 
oligonucleotide in 10 mM Tris.HCI (pH 8.3), 50 mM KC1, 2 mM MgCl,, 0.01% 
(w/v) gelatin. Antibodies not raised in this study were from Sigma Chemical Co., 
Diagnostics Scotland or BABCO (California) and are listed in table 3. In vitro 
mRNA transcription kit and the m 7G(5')ppp(5')G Cap analogue were obtained from 
Ambion. 
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2.3 Bacterial strains and plasmids 
The strains of E. co/i used in this study are listed in table 1. Transformants are 
denoted by listing the strain, followed by the plasmid with which it has been 
transformed. All plasmids used in this study are described in table 2. 
2.4 Yeast strains and plasm ids 
The strains of S. cerevisiae used in this study are listed in table 1. Transformants are 
denoted by listing the strain, followed by the plasmid with which it has been 
transformed. 
2.5 Media 
Yeast cultures were grown in complete medium (YPD) (1% (w/v) Bacto yeast 
extract, 2% (w/v) Bacto peptone and 2% (w/v) glucose (dextrose)). Bacto agar was 
added to the above to 2% (w/v) when solid medium was required. Maintenance of 
transformed plasmids and/or verification of auxotrophic markers inserted into the 
genome was achieved by growth in media comprising 0.67% yeast nitrogen base 
(minus amino acids), 2% glucose and 10% (v/v) lOx Drop-out media. Drop-out 
media was made from powder from Bio 101 Inc. dissolved in dHO producing a 
complete synthetic defined drop-out medium lacking the desired component(s). 
Bacto agar was added to 2% (w/v) when solid medium was required. 
Bacterial cultures were grown in Luria broth (LB) (1% (w/v) Bacto tryptone, 0.5% 
(w/v) Bacto yeast extract and 0.5% (w/v) NaCI). Bacto agar was added to the above 
to 1.5% (w/v) when solid medium was required. Liquid and solid media were 
supplemented where necessary with 100 tg/ml ampicillin and/or 50 [tg/ml 
kanamycin. 
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Methods 
2.6 DNA manipulations 
Standard DNA manipulation techniques including PCR amplification, ligation, 
extraction with phenol, precipitation with ethanol and restriction endonuclease 
cleavage were performed as described in Sambrook and Russell (2001), or according 
to the enzyme manufacturers instructions. 
Plasmid DNA was isolated from bacterial cells using QAiprep spin miniprep 
purification kits supplied by Qiagen using the manufacturers instructions. A 
miniprep routinely yielded approximately 20 lig of plasmid DNA that was stored at 
—20°C. 
Initial cloning of PCR products to be included in pARl43 (section 3.2. 1) was by 
"TA-cloning" using the commercial vector pCRTM  (Invitrogen). Gel electrophoresis, 
for the separation and visualisation of DNA fragments, was routinely carried out 
using 1% (wlv) agarose gels in TAE containing 1 tg/ml ethidium bromide. The size 
of the fragments of DNA was estimated by comparing their mobility with that of 
fragments of known size (1kB ladder markers, NEB). 
2.7 Transformation of bacterial cells 
Bacterial cells were made chemically competent by treatment with CaCl 2 and were 
transformed with plasmid DNA as described (Sambrook and Russell, 2001). 
2.8 Transformation of yeast cells 
Yeast cells were transformed with circular plasmid or linear integrative DNA by a 
lithium acetate method adapted from Gietz etal., (1992). 100 ml of yeast cells were 
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grown to logarithmic phase and harvested when the OD reached 0.5. The cells 
were pelleted by centrifugation at 1500 g for s min in a benchtop centrifuge 
(HERAEUS Labofuge 410). The cells were washed with 20 ml of sterile lithium 
acetate mix (LiOAc mix - 0.1M LiOAc, 1xTE), by resuspension and centrifugation 
and were resuspended finally in 1 ml of LiOAc mix. 100 jil of cells were added to 
0.1-0.5 pg of transforming DNA and 10 pd of 10 mg/ml freshly denatured and chilled 
carrier DNA (sonicated salmon sperm). After mixing these thoroughly, 700 j.tl of 
PEG mix (40% (w/v) PEG 2000, 0.1M LiOAc, lxTE) was added and the cells 
incubated at 30°C for 30 mm (or 24°C if transforming a temperature-sensitive strain). 
The cells were then transferred to 42°C for 15-20 mm, pelleted by centrifugation at 
3000 rpm for 1 min in a microcentrifuge and the supernate removed. The cells were 
washed once with sterile water by resuspension and centrifugation and resuspended 
in 200 tl of residual liquid from the wash step. Cells were spread onto solid YPDA 
medium for overnight incubation at 30°C before replica plating onto selective media 
(integrative transformation) or were spread directly onto solid selective medium 
(plasmid transformation) and incubated at 30°C. 
2.9 Yeast and bacterial stock preservation 
Glycerol was added to freshly grown saturated yeast culture to a final concentration 
of 20% (v/v), which was then stored at —80°C. Glycerol was added to freshly grown 
saturated bacterial culture to a final concentration of 30% (v/v), which was then 
stored at —80°C. 
2.10 DNA sequence analysis 
Plasmid DNA was isolated as described in section 2.6. 1 ltg of plasmid DNA was 
precipitated with 1110th  volume of 3M sodium acetate (pH5.3) and an equal volume 
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of 95% (v/v) ethanol and pelleted by centrifugation at 13000 rpm for 15 min in a 
microcentrifuge. The DNA pellet was washed once with 95% (v/v) ice cold ethanol 
and resuspended in 20 jtl of dHO. 5 tl (250 ng) of the resuspended DNA were 
added to 4 p.1 of the Perkin Elmer BigDye sequencing kit sequencing mix along with 
1.6 pmol of oligonucleotide to a final volume of 10 p.1 with dH,0. The PCR 
sequencing reaction and preparation of DNA for running on the sequencing gel was 
carried out according to the manufacturers instructions. Sequencing reactions were 
run by the ICMB sequencing facility. 
2.11 Purification of GST-fusion proteins from E. coli for 
antibody production 
2.11a Induction of expression from the lac promoter 
A 100 ml culture of DH5ct cells, harbouring either pSOY88 or pSOY90, was grown 
overnight at 37°C to saturation in LB medium containing ampicillin. The cells were 
diluted back to an OD of 0.1 in 6 1 of LB medium and allowed to grow to an OD 
of 0.5. At that time expression was induced by addition of IPTG to 0.1 mM and was 
allowed to proceed for 5-6 hr at 37°C. After this time the cells were harvested by 
centrifugation at 8000 rpm for 10 min in a Beckman JLAIO.500 rotor, washed in 
dH2O and stored at -80°C. 
2.11b Cell lysis and recovery of fusion protein 
Cells were thawed on ice and resuspended in 40 ml buffer A (50 mM Tris.HCI pH 
8.0, 200 mM NaCl, 3 mM EDTA, 2 mM 3-mercaptoethanol, 1 mM PMSF, 1 p.M 
pepstatin and leupeptin) containing 1 mg/ml lysozyme and incubated at 24°C for 30 
min. TritonX-100 was then added to a final concentration of 1% (v/v) and 
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incubation continued at 24°C for a further 15 mm. The cells were sonicated on ice 
(four bursts of 15 s with 1 min cooling intervals) and insoluble material pelleted by 
centrifugation at 15000 rpm for 30 min in a Beckman JA25.5 rotor. 
2.11c Solubilisation and purification of fusion protein 
As both the SRa-GST and SRI3ATM-GST fusion proteins were insoluble they were 
recovered in the pellet of the initial lysate clarification step. The pellet was washed 
by resuspending in 20 ml of PBS and resedimenting. The pellet was then 
resuspended in 3 ml of PBS and 30 ml of urea solution (8 M urea, 500 mM Tris.HCI 
pH 8.0, 500 mM NaCl, 1 mM EDTA, 30 mM 3-mercaptoethanol) added. Any 
insoluble material remaining was then pelleted by centrifugation at 15000 rpm for 30 
min in a Beckman JA25.5 rotor. The supernate of this centrifugation step was 
dialysed against 11 of dialysis buffer (50 mM I-IIEPES.KOH pH 7.6, 100 mM KCI, 
30% (v/v) glycerol) for 8 hr with the buffer replaced after 3 and 6 hr. Insoluble 
material present in the dialysate was pelleted by centrifugation for 30 min at 15000 
rpm in a Beckman JA25.5 rotor. The supernate of this step was incubated with 
approximately 200 mg (dry weight) of pre-swelled glutathione agarose beads on a 
rotating platform for 4 hr. The mixture was then poured into a 20 ml Poly Prep 
(BIORAD) chromatography column and the flow through collected. The beads were 
washed with 50 ml of PBS containing 1% (v/v) tritonX-100, 50 ml of PBS 
containing 1% (v/v) tritonX-100 and 0.5 M NaCl and 50 ml of PBS. Finally, the 
fusion protein was eluted from the agarose beads by competition with free 
glutathione using 10 x 2 ml washes of 50 mM Tris.HCI (pH 8.0) containing 5 mM 
reduced glutathione. The eluted protein was dialysed against 11 of dialysis buffer for 
8 hr with the buffer replaced after 3 hr. 
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2.12 Over-expression and preparation of lyticase 
This lyticase preparation is based on an osmotic shock method of lysing the outer 
cell wall of bacterial cells to release periplasmic components. The major constituent 
of the recovered periplasm is lyticase due to its over-expression in the cells. Strain 
DH5cz(pUV5-G1S) (tables 1 and 2) was grown, induced and harvested as in section 
2.1Ia. The culture was diluted 100-fold into 1 I of pre-warmed (37°C ) LB medium 
containing ampicillin. The cells were then grown at 37°C with vigorous shaking 
until they reached an OD 6.  of 0.5. Over-expression of lyticase was induced by 
addition of IPTG to 1 mM and allowed to proceed for 5 hr. The cells were harvested 
by centrifugation at 8000 rpm for 10 min in a Beckman JLA1O.500 rotor. The cells 
were washed in 200 ml of 25 mM Tris (pH 7.4) by resuspension and centrifugation 
as before. The cells were then resuspended in 11501h  of the original culture volume of 
25 mM Tris (pH 7.4) with EDTA added to a final concentration of 2 mM. An equal 
volume of 40% (wfv) sucrose and 25 mM Tris (pH 7.4) was added and the cells 
mixed with gentle swirling for 20 mm. The cells were pelleted by centrifugation at 
8000 rpm for 10 min in a Beckman JLA 10500 rotor and the supernate removed. The 
cell pellet was then resuspended in 1/5011  of the original culture volume of ice cold 
0.5 MM  MgSO4 and the cells mixed gently on ice. The cells were pelleted as before 
and the lyticase-containing supernate reserved. The supemate was immediately 
frozen in liquid nitrogen in 10 ml aliquots and stored at —80°C. 
2.13 Purification of Kar2p 
The method of purification of hexahistidine-tagged Kar2p was adapted from 
McClellan et al. (1998). pMR2623 was a kind gift of Dr J Brodsky (University of 
Pittsburgh). Strain DH5a(pMR2623) was grown, induced and harvested as in 
section 2.l la except induction was at 24°C for  hr. The cells were washed once in 
water by resuspension and centrifugation as before. The cell pellet was resuspended 
in 20 ml of sonication buffer (50 mM HEPES.KOH (pH 7.4), 300 mM NaCl, 10 mM 
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imidazole, 5 mM 3-mercaptoethanol, 1 mM PMSF, 1 .tM pepstatin) and sonicated 
for 3 x 60 s with 2 min cooling on ice between bursts. Insoluble material was 
pelleted by centrifugation at 10,000 rpm for 10 min in a Beckman JA25.5 rotor. The 
supernate was loaded onto a 5 ml column of Ni-NTA agarose beads equilibrated with 
sonication buffer. The column was washed sequentially with 20 ml of sonication 
buffer, 30 ml of wash buffer 2 (50 mM HEPES.KOH (pH 7.4), 300 mM NaCl, 1% 
(v/v) tritonX-100, 10 mM imidazole, 5% (v/v) glycerol, 5 mM -mercaptoethanol, 1 
mM PMSF, 1 jAM pepstatin) and 30 ml of wash buffer 3 (50 mM HEPES.KOH (pH 
7.4), 1 M NaCl, 10 mM imidazole, 5% (v/v) glycerol, 5 mM 13-mercaptoethanol, 1 
mM PMSF, 1 p.M pepstatin). Protein was eluted with 30 ml of elution buffer (50 
mM HEPES.KOH (pH 7.4), 300 mM NaCl, 250 mM imidazole, 5% (v/v) glycerol, 5 
mM 3-mercaptoethanol, 1 mM PMSF, 1 p.M pepstatin) collected in 30 x I ml 
fractions. Peak fractions, determined by Bradford assay (section 2.23) were pooled, 
diluted four-fold in buffer 88 (20 mM HEPES.KOH (pH 6.8), 150 mM KOAc, 250 
mM sorbitol, 5 mM Mg(OAc),) and loaded onto a 10 ml Q-sepharose column. The 
column was washed with 25 ml of buffer 88 and 30 ml of buffer 88 containing 0.2 M 
KOAc. The protein was eluted from the sepharose with a 30 ml linear gradient of 
buffer 88 from 0.2 M KOAc to 2 M KOAc. 30 x 1 ml fractions were collected. The 
peak elution fractions were pooled and dialysed against 4 1 of dialysis buffer (50 mM 
Tris.HCI (pH 7.4), 50 mM NaCI, 0.8 mM DTT, 2 mM Mg(OAc),, 5% (v/v) glycerol) 
overnight at 4°C. The protein concentration of the dialysate was determined and 200 
p.1 aliquots frozen in liquid nitrogen and stored at —80°C. 
2.14 Purification of bacterially expressed SR-GST 
M15pREP4 cells transformed with pJE97 were grown, induced and harvested as in 
section 2.1 la, except that kanamycin was added to maintain pREP4. All growth of 
cells, except initial overnight culture, was at 24°C and induction was for 6 hr. The 
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cells were resuspended in 80 ml lysis buffer (50 mM Tris.HCI (pH 7.5), 1 M NaCl, 
0.2% (v/v) tritonX- 100, 1 LM leupeptin and pepstatin, 1 mM PMSF) and sonicated 4 
x 15 s with 2 min on ice between bursts. Insoluble material was pelleted by 
centrifugation at 15000 rpm for 40 min in a Beckman JA25.5 rotor. The lysate was 
diluted 3-fold in equilibration buffer (50 mM Tris.HCI (pH 7.5), 150 mM NaCI) and 
loaded onto a 2 ml column of pre-swelled glutathione agarose, equilibrated in 
equilibration buffer. The column was washed with 50 ml of wash buffer (50 mM 
Tris.HCI (pH 7.5), 0.25 M NaCl) and eluted with 10 x 4 ml of wash buffer 
containing 10 mM reduced glutathione. Peak fractions were pooled and dialysed 
against 11 of dialysis buffer (0.15 M KOAc, 20 m 1-IEPES.KOH (pH 7.5), 15% 
(v/v) glycerol) at 4°C for 8 hr with 2 changes of buffer. 
2.15 Electrophoretic separation and detection of proteins 
Electrophoretic separation of proteins was performed using SDS polyacrylamide gels 
following the method of Laemmli (1970), or with Prosieve 50 acrylamide mix 
(Flowgen), using the solutions detailed below. 
Separating gel buffer 	375 mM Tris.HCI pH 8.8, 0.1% SDS 
Stacking gel buffer 	125 mM Tris.HCI pH 6.8, 0.1% SDS 
Acrylamide stock solution 	30% (w/v) acrylamide, 0.8% (w/v) N,N' methylene 
bisacrylamide 
Electrophoresis buffer 	0.125 M Tris, 0.2 M glycine, 0.1% (w/v) SDS (gives 
pH 8.3 without adjustment) 
Prosieve electrophoresis buffer 
	
0.1 M Tris, 0.1 M tricine, 0.1% (w/v) SDS 
(gives pH 8.3 without adjustment) 
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SDS sample buffer 	50 mM Tris.HCI pH 6.5 (or pH 11 when protein 
samples had been precipitated with TCA), 5% (w/v) SIDS, 10% (v/v) glycerol, 10 
mM DTT, 50 tg/ml bromophenol blue 
Routinely, separating gels of 15% (w/v) and 18% (wlv) (10% (w/v) if using Prosieve 
50 acrylamide mix) with a 5% (wlv) stacking gel were used for the separation of 
proteins. 
2.15a Coomassie Blue staining 
Following electrophoretic separation, protein bands were visualised by staining with 
Coomassie Blue. The gel was covered with a solution of 0.25% (w/v) Coomassie 
Brilliant Blue dissolved in 50% (v/v) methanol, 7% (v/v) acetic acid for 30 mm. The 
stain was then decanted and destaining of the gel achieved by gently agitating in 45% 
(v/v) methanol, 10% (v/v) acetic acid. 
2.15b Silver staining 
Silver staining was carried out as follows using 100 ml of each solution per gel with 
gentle swirling. Gels were soaked sequentially in 10% methanol for 30 mm, 50% 
(v/v) methanol, 12% (v/v) TCA, 2% (w/v) CuCI, for 20 mm, solution A (10 010 (v/v) 
ethanol, 5% (v/v) acetic acid) for 10 mm, 0.01% (w/v) KMnO 4 for 20 mm, solution 
A for 10 mm, 10% (v/v) ethanol for 10 mm, 10 min in water, 10 min with a 0.1% 
(wlv) solution of AgN0 31  water for 20 s and 10% (w/v) KCO for 1 mm. Finally the 
gels were developed with 2% (w/v) KCO 1 and 0.03% (v/v) formaldehyde until 
bands appeared. The developing reaction was stopped by transferring the gel to 
solution A before drying. 
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2.16 Transfer of proteins on to nitrocellulose 
Proteins were transferred from acrylamide gels to Protran nitrocellulose (Schleicher 
and Schuell) by either of the following two methods. 
2.16a Semi-dry blotting 
Proteins were transferred from gels, after electrophoresis, onto nitrocellulose filter by 
a semi-dry blotting procedure using a BIORAD semi-dry blotting apparatus 
according to the manufacturers instructions. 
2.16b Wet blotting 
The gel was placed next to a sheet of nitrocellulose which had been soaked in 
Towbin transfer buffer (50 mM Tris, 380 mM glycine, 0.1% (w/v) SIDS, 20% (v/v) 
methanol) and sandwiched between three sheets of 3MM and two pads of sponge 
also soaked in transfer buffer. The assembly was then placed in a cassette and 
slotted into a tank so that it was completely submerged in Towbin transfer buffer 
with the nitrocellulose closest to the anode. A current of 15 mA was then applied for 
16 hr. 
2.16c Ponceau S staining 
The presence of proteins on nitrocellulose filters was detected by Ponceau S staining. 
The nitrocellulose was immersed in Ponceau S solution diluted from concentrate 
(Sigma) as per manufacturers instructions. The stain was decanted and destaining 
achieved by washing the nitrocellulose repeatedly with distilled water to reveal the 
stained proteins. 
2.17 Immunoblot analysis 
Proteins on nitrocellulose membranes were detected as follows using specific 
(primary) antibodies against the desired protein (table 3). All steps were carried out 
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on a shaking platform/rocker. Membranes were incubated sequentially for 20 min in 
blotto (5% (wlv) non-fat dried milk, 0.5% (v/v) Tween 20 in TBS) to block non-
specific binding of the antibody, for 1 hr with primary antibody in blotto (diluted as 
in table 3), twice for 10 min in blotto to remove unbound antibody, for 1 hr with 
HRP-conjugated anti-rabbit IgG or HRP-conjugated anti-rat lgG (detailed in table 3), 
twice for 10 min with blotto before a final rinse with TBS. The bound antibodies 
were visualised by incubation with equal volumes of chemiluminescent detection 
solution (Solution 1: 2.5 mM 3-aminophthalhydrazide. 0.1 mM Tris.HCI (pH 8.5), 
0.396 mM cumaric acid; Solution 2: 0.0192% (v/v) H2O, 0.1 mM Tris.HCI (pH 8.5)) 
and exposure to film. 
2.18 Production of polyclonal antibodies from rabbits 
2.18a Immunisation and serum collection 
Immunisation of and serum collection from rabbits for production of antibodies 
against SRa and SRI3 was carried out by Diagnostics Scotland. 100 Vg of 
immunogen (in 250 j.tl of PBS buffer) was mixed with an equal volume of Freund's 
Adjuvant and injected subcutaneously. Three booster injections of identical 
anti gen/adjuvant mix were applied at one monthly intervals. 
2.18b Affinity purification of antibodies using purified protein 
Antibodies directed against SRa or SRI3 were purified from polyclonal serum by 
binding and elution from the fusion proteins against which they had been raised, 
immobilised on affigel-10. Removal of antibodies raised against the GST moiety 
was by prior incubation with GST immobilised on affigel- 10. 10 ml of resin was 
prepared containing 3 mg of fusion protein or GST coupled as detailed in Harlow 
and Lane, (1988). The coupled resin was washed twice with 10 ml of 0.1 M 
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Hepes.KOH (pH 7.4) and incubated overnight with 30 ml immune serum (raised 
against the appropriate protein) at 4°C on a roller before being packed into a 20 ml 
Poly Prep (BIORAD) chromatography column. The column was washed with 100 
ml of 0.1 M Hepes.KOH (pH 7.4) and the antibodies eluted with 10 x 1 ml washes of 
0.2 M glycine (pH 2.5). Fractions were collected into tubes containing 75 tl of 1 M 
Tris.HCI (pH 8.0) (yielding a final pH of 7.4). Peak fractions (determined by 
Bradford analysis 2.20) were pooled and dialysed against 2 1 of dialysis buffer (lx 
PBS, 20% (v/v) glycerol, 1 mM PMSF). After dialysis the antibodies were frozen in 
100 tl aliquots and stored at —80°C. 
2.19 Protein purification 
2.19a Preparation of microsomal membranes 
To prepare ER-derived microsomes for use in in vitro translocation assays, to 
provide material for solubilisation and reconstitution of proteoliposomes and for 
purification of SR, the following protocol (adapted from McClellan et al., 1998) was 
followed. The appropriate yeast strain was grown to an OD of 2 (or OD 0.5 for 
galactose induction of SR-PrA) in 2 1 of YPDA medium at 30°C (or 32 1 for 
induction of SR-PrA). The cells were harvested by centrifugation at 5,000 rpm for 5 
min in a Beckman JLA 10,500 rotor and washed with water by resuspension and 
centrifugation as before. The cells were resuspended to 50 OD units/ml in 100 mM 
Tris.HCI (pH 9.4), 10 mM Dli' and incubated at 24°C for 10 min with gentle 
shaking. The cells were then harvested as before and resuspended to 50 OD units/ml 
in lyticase buffer (0.7 M sorbitol, 1% (w/v) yeast extract and 2% (w/v) peptone, 
0.5% (w/v) glucose, 10 mM Tris.HCI (pH 7.4)). 5 pi of cell suspension was 
sampled, diluted into 995 tl of distilled water and the OD 6 measured. 1 ml of 
lyticase (section 2.12) per 1500 OD units of cells was added and the cell suspension 
incubated with gentle swirling (1 hr) at 30°C. A time course to monitor 
sphaeroplasting was carried Out where 5 jd of cells were sampled and diluted into 
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995 tl of distilled water and the OD measured. Sphaeroplasting was considered 
complete when the final OD 6.  was less than 10% of the initial value. 15 ml aliquots 
of the sphaeroplasts were overlayed onto 15 ml of ice cold cushion 1 (0.8 M sucrose, 
1.5% (w/v) Ficoll 400, 20 mM Hepes.KOH (pH 7.4)) in 50 ml polycarbonate tubes, 
and the sphaeroplasts collected by centrifugation at 6,000 rpm for 10 min in a 
Beckman JS 13.1 rotor. The sphaeroplasts were resuspended in 35 ml of ice cold 
lysis buffer (0.1 M sorbitol, 50 mM KOAc, 2 mM EDTA, 20 mM Hepes.KOH (pH 
7.4), 1 mM DTI, 1 mM PMSF) and homogenised with 20 strokes in a motor-driven 
Status R50 homogeniser at setting 16. 15 ml aliquots of homogenate were overlayed 
onto 15 ml of ice cold cushion 2 (1 M sucrose, 50 mM KOAc, 20 mM Hepes.KOH 
(pH 7.4), 1 mM DTI) and unbroken cells pelleted by centrifugation at 6,000 rpm for 
10 min in a Beckman JS 13.1 rotor. The top 20 ml of the supernate of this step was 
transferred into fresh 50 ml polycarbonate tubes and microsomes pelleted by 
centrifugation at 17,000 rpm for 20 mm in a Beckman JA25.5 rotor. The 
microsomes were washed in 20 ml of ice cold buffer 88 (20 mM Hepes.KOH (pH 
6.8), 150 mM KOAc, 250 mM sorbitol, 5 mM Mg(OAc)-,) by resuspension and 
centrifugation as before. The microsomes were finally resuspended in 500 tl of ice 
cold buffer 88. 5 .tl of this suspension was diluted into 995 .tl of 2% SDS and the 
A- 0 measured. A volume of buffer 88 was then added to the microsome solution to 
adjust the 0D2 80 to 40 (corresponding to a protein concentration of approximately 10-
12 mg/ml). The microsomes were frozen by dropping into liquid nitrogen in 60 pJ 
aliquots and stored at —80°C. 
When microsomes were to be used in a translocation assay they were washed to 
remove ribosomes and mRNA from their surface. 60 jtl of EDTA solution (20 mM 
Hepes.KOH (pH 7.5), 250 mM sucrose, 50 mM EDTA (pH 8.0), 1 mM DTT) was 
added per 60 tl of microsomes and the mixture incubated on ice for 15 min before 
pelleting by centrifugation at 13000 rpm for 15 min at 4°C in a microcentrifuge. The 
microsome pellet was then resuspended in 200 jtl of salt solution (20 mM 
Hepes.KOH (pH 7.5), 250 mM sucrose, 500 mM KOAc, 1 mM DT!') and incubated 
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on ice for 1 hr. The microsomes were pelleted by centrifugation as before and 
washed twice in 200 pi of membrane storage buffer (20 mM Hepes.KOH (pH 7.5), 
250 mM sorbitol, 50 mM KOAc, 1 mM DTT) by resuspension and centrifugation. 
After the final wash the microsomes were resuspended in membrane storage buffer 
to the starting volume and frozen by dropping into liquid nitrogen in 60 t1 aliquots 
and stored at —80°C. 
2.19b Ion-exchange chromatography 
Yeast strain ARY2 was grown harvested and microsomes prepared as described in 
section 2.19a. Deviations from this protocol are indicated, where appropriate, in 
Chapter 3. Typically, 8,000 OD 80 units of microsomal membranes were solubilised 
in digitonin buffer (3% (wlv) digitonin, 50 mM KOAc, 20 mM Hepes.KOH, 1 mM 
DTT). Insoluble material was pelleted by centrifugation at 17,000 rpm for 30 min in 
a Beckman JA25.5 rotor. The supernate containing soluhilised membrane proteins 
was incubated overnight at 4°C on a roller with 5 ml of pre-equilibrated ion-
exchange resin (CM, Q, SP or S-sepharose). The resin was packed into a 20 ml Poly 
Prep (BIORAD) chromatography column. The column was washed with 100 ml of 
wash buffer (1% (w/v) digitonin, 50 mM KOAc, 20 mM Hepes.KOH, 1 mM DIT) 
and eluted with 10 x I ml washes of elution buffer (1% (w/v) digitonin, 20 m 
Hepes.KOH, 1 mM DTT) containing 0.1-1 M KOAc. 
2.19c Purification of oligohistidine-tagged proteins 
Yeast strains ARY2 or ARY3 were grown harvested and microsomes prepared as 
described in section 2.19a. Deviations from this protocol are indicated, where 
appropriate, in Chapter 3. Solubilised membrane proteins were prepared as in 2.19b 
except buffer contained 0.8 mM imidazole. The supernate was incubated overnight 
at 4°C on a roller with 0.3 ml of pre-equilibrated Qaigen Ni-NTA agarose. The 
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protein bound agarose was packed into a 20 ml Poly Prep (BIORAD) 
chromatography column. The column was washed with 100 ml of wash buffer (1% 
(w/v) digitonin, 50 mM KOAc, 20 mM Hepes.KOH, 8 mM imidazole, 1 mM PMSF) 
and eluted with 10  1 ml washes of elution buffer (1% (w/v) digitonin, 50 m 
KOAc, 20 mM Hepes.KOH, 50 mM imidazole, 1 mM PMSF). 
2.20 Purification of SR from yeast 
2.20a Over-expression of SR in yeast by induction of the 
galactose promoter 
Typically 321 of culture containing yeast strain JDY225 (harbouring pAR143) was 
grown to OD,( 	in YPD at which point over-expression of SR was induced by the 
addition of galactose to a final concentration of 1% (w/v). Induction proceeded until 
the OD 6( reached 2.0 at which time the cells were harvested and washed as 
described in section 2.19a and stored at —80°C. 
2.20b Purification of SR 
The cells were thawed and microsomes prepared as described in section 2.19a. 
Microsomes were resuspended in 15 ml of solubilisation buffer (100 mM KPO 4 (pH 
7), 20% (v/v) glycerol, 10 mM DTT, 500 mM KOAc) with sufficient tritonX- 100 
layered on top of the suspension to yield a final concentration of 3% (v/v). The 
suspension was then vortexed vigorously for 10 s to solubilise the microsomes. 
Insoluble material was pelleted by centrifugation at 17,000 rpm for 30 min in a 
Beckman JA25.5 rotor. The soluble protein fraction was subjected to centrifugation 
at 60,000 rpm for 90 min to pellet ribosomes and ribosome associated membrane 
proteins. The supernate from this step was incubated overnight at 4°C on a roller 
with 1 ml of pre-equilibrated IgG sepharose. The sepharose was then packed into a 
20 ml Poly Prep chromatography column (1310-RAD) and washed with 100 ml of 
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wash buffer A (500 mM KOAc, 100 mM KPO 4 (pH 7), 20% (v/v) glycerol, 10 mM 
DTT) and 100 ml wash buffer B (100 mM KPO 4 (pH 7),20% (v/v) glycerol, 10 mM 
DTT, 150 mM KOAc). Protein was eluted from the sepharose by incubation with 2 
ml elution buffer (wash buffer B + 50 U TEV protease (Gibco BRL)) for 1 hr at 
24°C. After incubation with TEV protease the protein was collected by washing the 
sepharose with 5 x 1 ml washes of buffer B containing alternately 150 mM KOAc 
and 500 mM KOAc. Peak fractions (determined by Bradford analysis) were pooled 
and bound to 0.3 ml pre-equilibrated Qaigen Ni-NTA agarose overnight on a roller at 
4°C to remove the hexa-histidine tagged TEV protease. Silver or coomassie staining 
indicated that this step effectively removed the TEV protease from the protein 
mixture. 
2.21 Purification of Sec61163p from yeast 
Purification of Sec complex through protein A-tagged Sec63p was essentially as 
described by Beckman etal., (1997). Yeast strain JIDY5I6 (table 1) expressing 
Sec63-PrA was created by homologous integration of a PCR amplified cassette using 
oligos 5SEC63PRA and 3SEC63PRA (table 4) consisting of a TEV cleavage site, 2x 
protein A IgG binding domain and the S. pombe his5 gene from plasmid pJE39 
(table 2, gift of Sean Munro, MRC-LMB, Cambridge). Upon purification digitonin 
in the elution buffer was exchanged for deoxyBigCHAP to facilitate reconstitution as 
described in section 2.24. 
2.22 Concentration of protein 
Centricon columns (Amicon) with a cut-off of 30,000 Da were used for the 
concentration of small volumes of protein following the manufacturer's instructions. 
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2.23 Estimation of protein concentration 
Protein concentration was routinely determined by Bradford assay. 10 tl of the 
sample to be analysed was added to 740 .fl of distilled water and mixed. 250 .tl of 
BIORAD Bradford reagent was then added and mixed. The absorbance of the 
sample was then measured at OD 59 at 24°C. The concentration of protein in the 
sample was estimated by comparing the absorbance of the sample with that of a 
control with a known concentration of protein (routinely a BSA standard curve from 
0.5 pg/ml to 1 mg/ml). 
2.24 Detergent exchange 
Proteins puified and eluted into buffer containing either digitonin or tritonX-100 had 
this detergent exchanged for another to facilitate reconstitution. The first step in 
reconstitution of membrane proteins into liposomes is overnight dialysis into buffer 
containing liposomes without detergent. Digitonin and tritonX-100 do not dialyse 
away from protein fractions and as such must be removed before the dialysis step. 
Peak elution fractions were diluted 10-fold in buffer 1 (50 mM Hepes.KOH (pH 74), 
5 mM DTT, 0.3% (v/v) tritonX-100 or digitonin) and incubated overnight on a roller 
at 4°C with 0.5 ml CM. Q or S-sepharose. The sepharose was packed into a 10 ml 
Poly prep (BIORAD) chromatography column and washed with 2 x 50 ml buffer 2 
(50 mM Hepes.KOH (pH 7.4),15% (v/v) glycerol, 5 mM DTT, 0.5% (w/v) 
deoxyBigCl-IAP) and eluted with 10 x 100 tl buffer 3 (50 mM I-Iepes.KOH (pH 7.4), 
750 mM KOAc, 5 mM DTT, 15% (v/v) glycerol, 0.5% (w/v) deoxyBigCHAP). 
2.25 Immunoprecipitation 
100 ml of each yeast strain was grown, harvested and microsomes isolated as 
described in section 2.19a. Microsomes were solubilised and soluble protein 
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recovered from these as described in section 2.20b except 200 tl solubilisation 
buffer was used. 1 l of polyclonal antibody was added to each 50 M'  of soluble 
protein extract diluted to 500 .tl in solubilisation buffer and incubated at 4°C on a 
roller for 1 hr. 10 tl of a 1:1 slurry of protein A sepharose: solubilisation buffer 
were added and the mixture incubated at 4°C on a roller for 1 hr. The protein bound 
sepharose was pelleted by centrifugation at 10,000 rpm for 1 min in a 
microcentrifuge and the pellet washed 2 x 0.5 ml with solubilisation buffer and 3 x 
0.5 ml with TBS. Both pellet and supernate were reserved for analysis by SDS-
PAGE and Western blotting. 
2.26 Cross-linking 
100 ml of each yeast strain was grown, harvested and microsomes isolated as 
described in section 2.19a. 50 jil of microsomes were used per cross-linking 
reaction. A final concentration of 5.43 mM DSS was added to 50 tl of microsomes 
and incubated at 24°C between 5 and 20 mm. The reaction was quenched by the 
addition of an equal volume of 0.1 M Tris.HC1 (pH 7.5). The protein was then 
precipitated by the addition of an equal volume of 30% (w/v) TCA or the 
microsomes solubilised and protein recovered for immunoprecipitation of cross-
linked complexes (section 2.25). 
2.27 RAMP sedimentation 
1 1 of each yeast strain was grown, harvested and microsomes isolated as described in 
section 2.19a. Microsomes were solubilised and soluble protein recovered from 
these as described in section 2.20b except 1 ml solubilisation buffer was used. 
Ribosome associated membrane proteins (RAMPs) were recovered by centrifugation 
at 60,000 rpm for 90 min at 4°C in a Beckman T170.1 rotor. 
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2.28 Preparation of yeast lysate 
A protease-resistant yeast strain (RSY607) was grown in 10 1 of YPD to an OD of 
3. The cells were harvested by centrifugation at 5,000 rpm for 5 min in a Beckman 
JLAIO.500 rotor at 4°C and washed with DEPC-treated water by resuspension and 
centrifugation as before. The cells were resuspended in 10 ml of ice cold buffer A 
000 mM KOAc, 2 mM Mg(OAc).,, 20 mM Hepes.KOH (pH 7.4)) and the cells 
frozen by pouring a thin stream of the yeast cell suspension from a 25 ml glass 
Pipette into a canister of liquid nitrogen. The frozen cells were transferred to a 
Waring blender where they were lysed by blending in the presence of liquid nitrogen 
for 8-10 min continuously, adding liquid nitrogen when required. The cell powder 
was transferred to a beaker where the liquid nitrogen was allowed to evaporate and 
the powder thawed on ice. 30 ml of buffer A containing 0.5 mM PMSF was then 
added and the cell lysate transferred to 50 ml polycarbonate tubes. Unbroken cells 
and all debris were pelleted by centrifugation at 9,000 rpm for 10 min in a Beckman 
JA25.5 rotor at 4°C. The supernate of this step was collected and transferred to one 
or two T145.5 tubes and subjected to centrifugation at 36,000 rpm for 30 min in a 
Beckman T145.5 rotor at 4°C. The supernate of this step was applied to a 100 ml 
Sephadex G-25 column equilibrated in buffer A containing 14% (v/v) glycerol and 
the buffer A/glycerol buffer reapplied at a flow rate of 1 ml/min. Fractions of 3 ml 
were collected and the absorbance of a 1:200 dilution of each fraction at OD, 60 
measured. Fractions with an OD, of greater than 30 units were pooled, frozen in I 
ml aliquots in liquid nitrogen and stored at —80°C. The Sephadex G-25 column was 
then washed extensively with and stored in buffer A containing 14% (v/v) glycerol 
and 2 mM NaN 3 . 
2.29 Treatment of yeast lysate 
Yeast lysate used to translate exogenously added mRNA must first be treated with 
micrococcal nuclease to remove endogenous mRNA. Each I ml of lysate had 5 tI of 
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micrococcal nuclease (1 mg/ml) and 12.5 pi 40 mM CaCI, added, this was incubated 
at 20°C for 20 mm. 12.5 tl 100 mM EGTA was then added and the sample 
incubated at 20°C for a further 5 min after which time the lysate was frozen at —80°C 
in 100 Al aliquots. 
2.30 Preparation of mRNA 
Capped mRNA was transcribed from XbaT restriction endonuclease cut plasmids 
pDJ 100 and pJD96 (table 2) using the Megascript SP6 transcription kit (Ambion) 
according to the manufacturer's instructions. 
2.31 Preparation of phospholipids 
Azolectin liposomes were prepared by dissolving 5 g azolectin lipid powder in 100 
ml of 10 mM KPO4 (pH 7), 2 mM 3-mercaptoethanol at 24°C with vigorous stirring. 
Once dissolved the liposome suspension was frozen in liquid nitrogen in 1 ml 
aliquots and stored at —80°C. 
2.32 Solubilisation of microsomes and reconstitution into 
proteoliposomes 
Part 1: Solubilisation and removal of detergent 
50 .tl of the appropriate microsomes were added to 360 .tl ice cold solubilisation 
buffer (100 mM KPO 4 (pH 7), 20% (v/v) glycerol, 10 mM DTT, 500 mM KOAc) 
and mixed well. To this, 30 il of sonicated (1 min burst) azolectin liposomes were 
added and the mixture vortexed gently. 60 pi of 10% (w/v) octylglucoside dissolved 
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in distilled water was layered on top and the solution vortexed vigorously for 10 s at 
the highest setting to solubilise the microsomes. Insoluble material was pelleted by 
centrifugation at 60,000 rpm for 30 min at 4°C in a Beckman TLA 120.2 rotor 
alongside the previously sonicated azolectin liposomes to remove multilamellar 
vesicles not disrupted by sonication. The supernate of the sonicated azolectin 
liposomes was removed and stored overnight at 4°C for use in the reconstitution. 
The microsomal supernate containing the proteins to be reconstituted was removed 
and placed in a Spectra/Por dialysis membrane (molecular weight cut-off of 6-8000 
Da) with additional purified proteins such as SR, Sec6lp or Kar2p. If the additional 
proteins were not supplemented with lipid sonicated azolectin liposomes were added 
to the mixture to a final concentration of 3 mg/ml to maintain the protein: lipid ratio. 
This was necessary to maintain the activity of the added proteins. The volume of 
purified material added to the solubilised microsomal proteins was less than one third 
of the total volume for efficient reconstitution. Once all additions were made the 
mixture was dialysed against 0.5 1 of dialysis buffer (150 mM KOAc, 20% (v/v) 
glycerol, 20 mM KPO 4 (pH 7), 2 mM 13-mercaptoethanol) per dialysed sample at 4°C 
for 16-17 hr and no longer. 
Part 2: Reconstitution 
Following dialysis 350 jtl of dialysate was mixed gently with 350 il of sonicated and 
centrifuged azolectin liposomes in a glass test tube, providing the lipid necessary for 
reconstitution of proteins. This mixture was immersed in a dry ice/acetone bath for 
20 s and then allowed to thaw at 24°C for approximately 10 mm. The reconstituted 
proteoliposomes in the mixture were then pelleted by centrifugation at 55,000 rpm 
for 45 min at 4°C in a Beckman TLA 120.2 rotor and the supernate removed. The 
proteoliposomes were resuspended in residual liquid for use in the translocation 
assay. 
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2.33 Translation assay 
In vitro yeast translation reactions were carried out as follows. 1-2 tg of transcript 
mRNA, 9 p.1 of 3 x translation buffer (75 mM creatine phosphate, 2.25 mM ATP, 
300 p.M GTP, 120 p.M amino acids minus methionine (Promega), 360 mM KOAc, 6 
mM Mg(OAc),, 66 m Hepes.KOH, 5.1 mM DT-F), 1 p.1 of creatine phosphokinase, 
20 U of RNasin (Promega), 9 p.l of yeast cell lysate, 1 p.1 of 35S-methionine (specific 
activity 37 TBq/mmol) and 38 p.1 of buffer 88 (see section 2.19a) in a total volume of 
60 p.1 were mixed and incubated at 20°C for 20 mm (or 40 min if translocation was to 
be monitored). The reactions were terminated by addition of an equal volume of 
30% (w/v) TCA and centrifugation at 13000 rpm for 15 min at 4°C in a 
microcentrifuge. Pellets were washed in acetone before being subjected to SDS-
PAGE and phosphoimage analysis. 
2.34 Translocation assay 
When translocation was monitored each reaction was supplemented with 4 p.t of the 
appropriate microsomes or 10 p.1 of the appropriate proteoliposomes reducing the 
amount of buffer 88 appropriately. Upon completion, 20 p.1 of the reaction was 
precipitated by addition of 20 p.1 of 30% (w/v) TCA, 20 p.l was supplemented with 5 
p.1 of 1 mg/ml trypsin (dissolved in PBS pH 3), and 20 p.1 was supplemented with 5 
p.! of 1 mg/ml trypsin and 2 p.1 of 10% (v/v) tritonX-100. Samples supplemented 
with trypsin and/or tntonX-100 were incubated for 20 min on ice before precipitation 
with an equal volume of 30% (w/v) TCA. Samples were pelleted by centrifugation 
at 13,000 rpm at 4°C for 15 min and pelleted protein was washed with acetone before 
being subjected to SDS-PAGE and phosphoimage analysis. 
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2.35 Sec6l-peptide test 
Yeast strains were grown, harvested and microsomes recovered as described in 
sections 2.5 and 2.19a. Translation/translocation assays were carried out as 
described in sections 2.33 and 2.34 except 500 nM, 5 tM, 50 j.tM and 500 ltM 
Sec6 1 -Ntermi nal peptide (sequence SSNRVLDLFKPFESFLPEVIAP, corresponding 
to residues 2-22 of Secôlp) or 500 jtM control peptide were added to the reactions. 
2.36 Two-hybrid blue/white assay 
The blue/white filter lift assay, to determine if proteins were interacting in a two-
hybrid screen, was carried out according to the protocol described in Fromont-Racine 
et al. (1997). 
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Table I 
Bacterial Genotype References 
Strain 
DH5(x supE44 AlacU169(80 Sambrook and Russell, 2001 
/acZAMI5) hsdRl7 recAl 
endAl grvA96 ihi-1 re/Al 
M 1 5pREP4 Not available Qaigen 
Yeast Strain Genotype Reference 
JDY3 trpl, Iys2, his3, ura3, ade2 Parker et al. (1988) 
JDY5I6 As JDY3 but SEC63-TEV- This study 
ZZ: :his5 
JDY72 As JDY3 but srp]01::ADE2, Dr J. Brown, University of 
srp]02::HIS3 Edinburgh, UK 
ARYI As JDY3 but SRP]02-TEV-ZZ, This study 
his5 
ARY2 As JDY3 but SRPJ02-HIS 6 , This study 
URA3 
ARY3 As JDY3 but SRPJ02-HIS 8 , This study 
URA3 
ARY4 As JDY3 but SRP]02-CBD- This study 
TEV-ZZ, his5 
ARY5 As JDY3 but HMG/-TEV-ZZ, This study 
his-5'  
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RSY937 le112-3, 112, ura3-1, Gift of Dr M. Morrow and Dr J. 
sec6l::HIS3, his3-11, 15, Brodsky, Pittsburgh, USA 
pRS3 16-N-terminal 
SEC6](HIS 6) tag 
RSY607 ura3-52, leu2-3, 112, Gift of Dr M. Morrow and Dr J. 
pep4.: URA3 Brodsky, Pittsburgh, USA 
RSY586 MATa, ura3-52, leu2-3, 113, Gift of Dr M. Morrow and Dr J. 
ade2-101, kar2-159 Brodsky, Pittsburgh, USA 
JDY638 Derived from BMA38a: BMA38a was a gift of Prof. J. 
his3A200, leu2 -3,112, ura3-1, Beggs, University of Edinburgh, 
trplAI, ade2-1, canl-100, kan? 
UK 
pGAL-SEC61 JDY638 created by Dr J. Brown, 
University of Edinburgh, UK 
CG 1945 MA Ta, ura3-52, his 3-200, Clonetech, gift of Prof. J. Beggs, 
lys2-801, ase2-101, Irpl-901, University of Edinburgh, UK 
leu2-3, 112, Ga14-542, 
Ga180-538, cyh-2, 
Lys2::GaIJUAS -Ga1JTATA - 
HIS3, URA3: GAL4 
1 7iners(X3)-CyCJTATA -lacZ 
JDY225 GAL4, GAL80, ura3-52, leu2-3, Gift from K. Weis (Berkeley) 
-112, regl-510, gall, pep4-3 
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Table 2 
Bacterial Background Insert Promoter Reference 
plasmids 
pMR2623 pQE9 S. cerevisiae IPTG-inducible Gift from Dr J. 
KAR2 -HIS 6 lacIQ promoter Brodsky, 
Pittsburgh, 
USA 
pUV5-G1S pOP95-15 -1,3-g1ucanase lacUV5 Gift from Dr J. 
Brodsky, 
Pittsburgh, 
USA; Shen et 
al. (1991) 
pJE97 pGEX-3X S. cerevisiae IPTG-inducible Dr J. Brown, 
SRP]OI and lac promoter University of 
SRP102-GST Edinburgh, UK 
(bp 73-735) 
separated by a 
ribosome 
binding site 
pS0488 pGEX-3X S. cerevisiae IPTG-inducible Gift from S. 
SRPI02-GST lac promoter Ogg and P. 
(bp 73-735) Walter, San 
Francisco, 
USA 
pGEXSRPI01 pGEX-3X S. cerevisiae IPTG-inducible Ogg et al., 
SRPJOJ-GST lac promoter 1992; Ng et 
al., 1996 
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pJD96 pJD82 S. cerevisiae N/A Ng et al., 
alpha factor with 1996; Mason 
DPAP-B signal et al., 2000 
sequence 
pDJ 100 pSP65 S. cerevisiae N/A Hansen etal., 
alpha factor 1986 
pJDY96 pRS3 16 S. cerevisitie N/A Dr J. Brown, 
SEC65-HIS 6  University of 
Edinburgh, UK 
pJE39 pBluescript TEV protease N/A A kind gift of 
site, protein A Dr Sean 
"ZZ" motif and Munro, MRC- 
S. poinbe his5 LMB, 
Cambridge, 
UK 
pJE82 pJE39 Calmodulin N/A Dr J. Brown, 
binding domain, University of 
TEV protease Edinburgh, UK 
site, protein A 
"ZZ" motif and 
S. ponbe his5 
Yeast Background Insert Promoter Reference 
Plasmids 
pAR 143 pTR 143 S. cerevisiae GAL 1/10 This study 
SRPJOI and 
SRP] 02- CBD- 
TEV-ZZ 
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pAR2HI pAS-C SRPI02 bp 73- This study 
735 
pAR2H2 pAS-C SEC61 bp 1-97 Chris Morrow, 
University of 
Edinburgh, UK 
pJDYI87 pACT!! SRPJOJ Dr J. Brown, 
University of 
Edinburgh, UK 
pAR2H4 pACTII SRPI02 bp 73- This study 
735 
pAR2H5 pACTII SEC61 bp 1-97 This study 
pAR2H6 pACTIJ SEC61 bp 502- Chris Morrow, 
636 University of 
Edinburgh, UK 
pAR2H7 pACTII SEC61 bp 781- Chris Morrow, 
886 University of 
Edinburgh, UK 
pAR2H8 pACTI! SEC61 bp 1143- Chris Morrow, 
1249 University of 
Edinburgh, UK 





Antibody Animal raised in Useful dilution Reference 
Anti-SRa Rabbit Western— 1:1000 This study 
Anti-SRO Rabbit Western - 1:1000 This study 
Anti-Sec6lp Rabbit Western - 1:2000 Gift of P. Walter, 
San Francisco, USA 
Anti-Sec62p Rabbit Western - 1:2000 Gift of P. Walter, 
San Francisco, USA 








Oligo name Sequence (5'-3') Amplified DNA 
SRBHISTAG5 GCTTTTGAGGGCAGTAT 3' flanking region of 
TAATAAAAGAAAAAflT SRP102, HIS,, of JDY96 




SRBHISTAG3 GCTATGTTAAATGCYFGT 3' terminator of SRP]02 





SRBHISTAG25 GCTTTI'GAGGGCAGTAT 3' flanking region of 
TAATAAAAGAAAAA11I'T SRP102, HIS, of JDY96 
CCCAATGGCGCGAATGG with 2 additional histidine 
ATAGATGAAAAACTGAC codons and the URA3 
TAGTATTGAAGGTCATC gene 
ATCACCACCAC 
5SRPI02 GCTTTTGAGGGCAGTAT 3' flanking region of 
TAATAAAAGAAAAA1TIT SRP102, the TEV 
CCCAATGGCGCGAATGG cleavage site, the protein 
ATAGATGAAAAACTGGG A "ZZ" motif and the S. 
AGCAGGGGCGGGTGCTA pombe HIS5 gene 
GC 
3SRP 102 GCTATGYT'AAATGCTIITGT SRP102 with the TEV 
109 
1TT'TAAACTATCTATCGT cleavage site and the 
TCATCTAGTTATAAATTA protein A "ZZ" motif 
TAATTATATTAGAGGTC 
GACGGTATCGATAAG 
5SRBSPPAI GTTGC1TTTGAGGGCAG 3' flanking region of 
TATTAATAAAAGAAAAA SRP 102, the calmodulin 
T'FT'CCCAATGGCGCGAA binding domain spacer, 
TGGATAGATGAAAAACT the TEV cleavage site, the 
GGCGAGCTCCAGCTCCA protein A "ZZ" motif and 
GCTCCAGCTCCACCGCG the S. pombe HIS-5' gene 
GCCATG 
5SFR60X GCCGAATTCATGCYT'AG SRPJ02 
TAATACACTT 
3SRBOXNEW GAATTCTACCGATCACG SRPI02 with the 
AGTTCGCGTC calmodulin binding 
domain spacer, the TEV 
cleavage site and the 
protein A "ZZ" motif 
2MAOX5 GCGGGATCCTCACCCCT SRPIOI 
CAGTATCCCT 
2MAOX3 GCGGGATCCTTAAGACA SRPJOI 
TTAATGTATT'AAC 
5SEC63PRA GCTAGCGATTATACTGA 3' flanking region of 
TATCGATACGGATACAG SEC63, the TEV cleavage 
AAGCTGAAGATGATGAA site and the protein A 
TCACCAGAAGGAGCAGG "ZZ" motif 
GGCGGGTGCT[TAGCG 
Ifful 
3SEC63PRA AAGATGAAATATATACG 3' terminator of SEC63, 
TCTAAGAGCTAAAATGA the protein A "ZZ" motif 
AAAACTATACTAATCAC and the TEV cleavage site 
TFATATCTAGAGGTCGA 
CGGTATCGATAAG 
5HMGCT CAATYFGGACGCCACTG 3' flanking region of 
ATATAAATCGT11TGAAA HMG-CoA reductase, the 
GATGGGTCCGTCACCTG TEV cleavage site and the 
CATTAAATCCAGCTCCA protein A "ZZ" motif 
CCGCGGCCATGGGAGCA 
GGGGCGGGTGCTAGC 
3HMGCT GTACAAACTATAAAGTA 3' terminator of HMG- 
AATATTTTACGTAACAC CoA reductase, the protein 
ATGGTGCTGTI'GTGCTTC A "ZZ" motif and the 




5SRB2H GTGCAAGAATTCAAGGC bp 73-735 of SRP102 
ATCCTCCAAGACAGGG 
3SRB2H GTGCGGCAA]ITCTTACA bp 73-735 of SRPJ02 
GTTTTTCATCTATCCA 
5NTERM61 GAGGCCCCGGGGATGTC bp 1-97 of SEC61 
CTCCAACCGTGTITCTAG 
3NTERM6 1-2 CGGGGATCCTTAT[TCTG bp 1-97 of SEC61 
GYI'GTATGGAACCTT 
5L00P2 GAGGCCCCGGGGGACGA bp 502-636 of SEC61 
AYITGCTATCTAAG 
3L00P2-2 CGGGGATCCTTATTCGA bp 502-636 of SEC61 
ACTCCYTACCACGACC 
5L00P3 GAGGCCCCGGGGCAAGG bp 781-886 of SEC6I 
CTTCCGTTACGAATITG 
3L00P3-2 CGGGGATCCTTACAACA bp 781-886 of SEC61 
TGA11TGGGGTG'TlTGGA 
5L00P4 GAGGCCCCGGGGGAAAT bp 1143-1249 of SEC61 
CTCCGGCACTI'CC 
3L00P4-2 CGGGGATCCTTACTTCTIT bp 1143-1249 of SEC61 
CAA'FITCTCTGTAAAT 
5SBHI GAGGCCCCGGGGATGTC bp 1-102 of SBHJ 
AAGCCCAACTCCT 




Purification of the SRP-receptor from yeast 
Introduction 
A main aim of my project was to purify the components necessary for, and to 
reconstitute, SRP-dependent targeting and co-translational translocation in vitro. 
This reconstituted system would then be used to look in more detail at interactions 
and processes that occur at the ER membrane during targeting. Previously, the 
translocon has been purified by several means (Panzner et al., 1995 Beckmann et 
al., 1997; Morrow and Brodsky, 2001) and shown to be active in either post-
translational translocation and/or ribosome binding. However, the yeast SRP 
receptor had not been purified and this was considered the major obstacle to 
generation of a co-translational translocation system with yeast components. Here I 
describe a purification procedure for yeast SR, and other experiments that were 
carried out during its development. 
Strategies 
First conditions were established under which the intact SR complex could be 
efficiently solubilised from yeast ER membranes. Second, SR was tagged to 
facilitate purification. Two types of tag were used, poly-histidine and the IgG 
binding domain of protein A (the "ZZ" tag). Both have successfully been used to 
purify membrane proteins from yeast e.g. the translocon component Sec6lp (Morrow 
and Brodsky, 2001) and Golgi resident mannosyltransferases (Rayner and Munro, 
1998). Protein A has been used in the purification and visualisation of many proteins 
(Puig el al., 2001) and binds with high affinity to IgG allowing in many cases a "one 
step" purification. Protein A cross-reacts with many secondary antibodies, anti-
rabbit in particular, which results in visualisation of tagged proteins in Western 
blotting without incubation with primary antibody. The ZZ-tag used in this study 
contained, in addition, a tobacco etch virus protease (TEV protease) site facilitating 
cleavage of protein A from tagged proteins and thus isolation of native SR. Initially 
these tags were incorporated into the genomic SRO locus allowing purification of SR 
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expressed at wild type levels. However, this was found to be insufficient and finally 
a protein A-tagged SR was over-expressed from a galactose-inducible plasmid 
construct. Last, as detergents used for solubilisation and purification steps are 
incompatible with reconstitution of protein into proteoliposomes the ability of SR to 
bind ion exchange resins was investigated. Purified SR bound to such resins 
allowing detergent exchange to be carried out. In addition, ion exchange 
chromatography while on its own unlikely to lead to a rapid purification of SR, may 
be useful for refining the purifications carried out herein. 
3.1 Genome based methods 
3.1.1 Solubilisation of SR 
The first stage in extraction of SR from the ER and purification from other 
membrane proteins was determining which detergent would be the most effective at 
solubilising SR from the ER membrane whilst maintaining the complex intact. 
Detergents tested were octyl-G-glucoside, deoxyBigCHAP, BigCHAP, digitonin and 
tntonX-100. 1-3% (vlv) of detergent in solubilisation buffer were tested. Octyl-G-
glucoside, deoxyBigCHAP and BigCHAP were less effective than digitonin at 
solubilising SR from ER membranes while triton X-100 was the most effective. 
Figure 3.1 shows a comparison between tritonX-100 and digitonin at 3% (v/v). 
While some SRt3 can be seen in the pellet fraction of the digitonin extraction (3. IB) 
virtually all the protein is solubilised by tritonX-100 extraction (3.IA). 
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Figure 3.1 Comparison of extraction of 
microsomes with digitonin and tritonX-100 
Strain JDY3 was used to prepare microsomes as described in section 
2.19a. 12 OD-, 80 units of microsomes were solubilised with 3% 
TritonX-100 (A.) or 3% digitonin (B.)in buffer 88 (section 2.19a) 
and afterwards insoluble material was pelleted by centrifugation at 
13,000 rpm for 15 mins at 4°C in a microcentrifuge. Equal amounts 
of the supernate and pellet of each were loaded. An antibody 
specific for SRI3 was used to detect soluble and insoluble SR. In 
both cases S is the supernate and P is the pellet of insoluble 
material. 
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3.1.2 Histidine tagging 
A. Hexahistidine tagging 
The first tagging strategy adopted was histidine tagging. The tag (HIS,) was 
amplified from plasmid pJDY96 using oligos SRBHISTAG5 and SRBHISTAG3 
(table 4) that contained 66 bases of homology to the 3' end of the SRO ORF and 3' 
flanking DNA respectively. The amplified region also contained a URA3 metabolic 
marker (Figure 3.2). Purified PCR product was transformed into strain JDY3 (table 
1). Cells expressing Ura3p were identified by their ability to grow on media that did 
not contain uracil. 
Colonies could be isolated which grew on —ura media due to non-homologous 
integration of the URI43 gene or integration into the ura3 locus. Thus, URA3+ 
colonies were also screened by Western blotting for a molecular weight increase in 
SRO indicating the presence of the tag. Unfortunately, antibodies against the 
histidine tag (Qaigen) failed to recognise the protein. 
Only one colony was recovered from many ura+ colonies that expressed 
hexahistidine-SRI3 indicating that the integration was not efficient. I also attempted 
to histidine tag SRa by the same method, but this was unsuccessful. Elements in the 
genome downstream of SRct or the function of the subunit itself may have prevented 
the genomic insertion of a tag. 
Purification of SR via the HIS,-tag at the C-terminus of SRO is shown in Figure 3.3 
(described in section 2.19c). As can be seen (compare lanes 1 and 3), SR bound to 
the Ni-NTA agarose but a proportion of SR is visible in the unbound fraction. In this 
case most of the SRa protein washed away from the agarose immobilised SRO 
indicating that the salt concentration or pH of the wash buffer were inappropriate. 
The SRO protein still present on the agarose eluted in fractions 1-3 (lanes 7-9). 
Although the composition of the wash buffers were varied for pH, salt and imidazole 
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Figure 3.2 Schematic of tagged SRP constructs 
Constructs were made by genomic insertion of a tag and a marker gene at 
the C-terminus of the SR3 subunit. The tag DNAs were PCR amplified 
from plasmids (table 2). PCR amplification and integration was carried out 
as described in sections 2.6 and 2.8 using oligonucleotides described in 
table 4. Selection of integrants was by their ability to grow on media 
lacking uracil, in the case of the he xa/octa-histi dine tags or histidine, in the 
case of the ZZ-tags. Integrants isolated by the activity of the requisite 
metabolic marker had the presence of the correct protein tag confirmed by 
SDS-PAGE and Western blotting. (A) hexa-histidine construct containing 
the S. cerevisiae URA3 gene, (B) octa-histidine construct containing the S. 
cerevisiae URA3 gene, (C) ZZ-tag with an N-terminal TEV protease site 
containing the S. poinbe his5l gene and (D) ZZ-tag with an N-terminal TEV 
protease site with a calmodulin binding domain (CBD) as a spacer between 
the SRP gene and the TEV protease site at its N-terminus with the S. pombe 
his5 gene as metabolic marker. 
Also shown, in orange, is the transmembrane domain of SR beta at the N 
terminus of the protein. 
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I TMDJ 	 SR13 	 HIS 	URA3 
 
I TMD J 	 SRI3 	 HIS 8 1 	URA3 
TEV protease site 
IITMDI 	 SRI3 	 I 	ZZ 	I S.pombe his5 
TEV protease site 
ITMDI 	 SR3 	 I CBD I 	22 	I S.pombe his51 
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Figure 3.3 Purification of SR via a hexa-histidine tag 
240 0D280 units of microsomes recovered from ARY2 were solubilised in 
digitonin buffer and insoluble material pelleted (section 2.19c). Ribosome 
associated membrane proteins were pelleted from the membrane extract 
(section 2.27) and the post-ribosomal supernate bound to NI-NTA agarose 
overnight at 4°C on a roller. The sepharose was washed and eluted as 
described in section 2.19c. 1/200th  (lanes 1-6) and 115 1 (lanes 7-11) of 
samples loaded were analysed by SDS-PAGE, Western blotting and silver 
staining. Antibodies specific for SRct and SRI3 were used to detect SR. The 
Western blot is shown in panel A while the silver stain is shown in panel B. 
The lanes in panels A and B are loaded with identical samples. 
Lane 
1 Load fraction (post-ribosomal supernate) 
2 Ribosomal pellet 
3 Unbound fraction 
4 Wash 1 
5 Wash2 
6 Wash  
7 Elution 1 
8 Elution 2 
9 Elution 3 
10 Elution  
11 Elution 5 
121 
1 	2 	3 	4 	5 	6 	7 	8 	9 	10 	11 
S Ru —1 __- 	 - - 
66 kDa - 
45 kDa H 
S R 	- 	 .- 	 - - - - 
29kDa-1 - 
B. 
116 kDa - 
93 kDa - 
66 kDa - 
45 kDa - 
29 kDa- 
1 	2 	3 	4 	5 	6 	7 	8 	9 	10 	11 
Irr 	 II 
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concentration, in every case either SR would elute in the wash step or the subunits 
would dissociate into individual components rendering this technique useless for 
purification of intact receptor. It was concluded that as SR washing off the agarose 
before the elution step was a consistent problem, a tag of six histidine residues was 
not sufficient and that increasing the number of residues may prove beneficial. 
Indeed, it had been suggested that when purifying proteins from yeast an octa-
histidine tag could be more effective than a hexa-histidine tag (Alan Boyd, 
unpublished observations). 
B. Octahistidine tagging 
The method used previously to HIS 6-tag SRI3 was used to generate the HIS,-tag 
however, two additional histidines were encoded by the oligonucleotide 
SRBHISTAG25 (table 4) used to generate the PCR product. Figure 3.2 outlines the 
structure of the octa-histidine tag. The PCR product was purified and transformed 
into a haploid yeast strain, as before, and putative positive transformants were 
selected for their ability to grow on -ura media. Positive transformants were detected 
by a molecular weight shift of SR3-HIS 8 compared with SR-FHS 6 and SRO wild 
type. 
Once a positive SR-HIS, tagged strain was isolated, purification of SR proceeded as 
before. As hoped, the octa-histidine tag conferred greater affinity for the NI-NTA 
resin, and SR remained bound during the washing steps (Figure 3.4A). However, as 
can be seen in Figure 3.413 the elution fractions contained many contaminating 
proteins. Ion-exchange chromatography was then used as a second purification step. 
In this experiment the eluate from the Ni-NTA agarose was incubated with DEAE-
sepharose in an attempt to remove contaminants. Unfortunately, SR bound 
inefficiently to the DEAE resin under these conditions (50 mM KOAc) and no 
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Figure 3.4 Purification of octa-hisitidine tagged SR 
by affinity and ion-exchange chromatography 
240 0D180 units of microsomes recovered from ARY3 were solubilised in 
digitonin buffer and insoluble material pelleted (section 2.19c). Ribosome 
associated membrane proteins were pelleted from the membrane extract 
(section 2.27) and the post-ribosomal supernate bound to NI-NTA agarose 
overnight at 4°C on a roller. The sepharose was washed and eluted as 
described in section 2.19c. The eluate from the NI-NTA agarose was bound 
to DEAE sepharose overnight at 4°C on a roller. The sepharose was washed 
once in wash buffer (50 mM NaPO4 (pH 8), 100 mM NaCl, 1%(v/v) 
tritonX-100). Protein was eluted in 2 x 1 ml elution buffer 1(50 mM 
NaPO4  (pH 8), 150 mM NaCl, 1%(v/v) tritonX-l00), 2 x 1 ml elution buffer 
2 (50 mM NaPO 4 (pH 8),175 mM NaCl, 1%(v/v) tritonX-100) and 2 x 1 ml 
elution buffer 3 (50 mM NaPO 4 (pH 8), 200 mM NaCl, 1%(v/v) tritonX-
100). 1/20011  (lanes 1-6) and liSt!'!  (lanes 7-11) of samples loaded were 
analysed by SDS-PAGE, Western blotting and silver staining. Antibodies 
specific for SR( and SRO were used to detect SR. The Western blot is 
shown in panel A while the silver stain is shown in panel B. The lanes in 
each are loaded with identical samples. 
Lane 
1 Load fraction (post-ribosomal supernate) 
2 Unbound fraction 
3 Wash 1 
4 Wash  
5 Elution from NI-NTA agarose, 
load fraction of DEAE sepharose 
6 Unbound fraction 
7 Wash 1 
8 Elution 1 
9 Elution lb 
10 Elution 2 
11 Elution 2b 
12 Elution  
13 Elution 3b 
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significant purification from contaminating proteins was achieved. Also apparent is 
a degree of dissociation of SR( from SRO during the purification. 
As no significant improvement in purification was achieved despite attempts using 
several ion exchange resins I concluded that histidine tagging of SRO was not an 
efficient means of purifying SR and decided to purify SR using a protein A-tag. 
3.1.3 Protein A-tagging 
A. Protein A-tagging SRE1 
Oligonucleotides were designed to amplify the protein A ZZ-tag with flanking 
regions of homology to SRO for integration and a S.pombe his5 metabolic marker, 
which complements a his3 mutation in S. cerevisiae, for selection from plasmid 
vector (pJE39) as described in section 2.6 and shown in Figure 3.2. 
Expression of protein A-tagged SRO was confirmed by Western blotting with anti- 
protein A antibodies (Sigma) which revealed a protein of the expected 45 kDa size. 
Purification of protein A-tagged SRO was carried out as described (section 2.20b). 
After elution the fractions were analysed by SDS-PAGE and Western blotting. 
Purification of the protein A-tagged SR was complicated by the fact that the TEV 
protease was unable to cleave the protein A tag off SRO successfully. Figure 3.5 
shows a typical purification of SR via the protein A-tag. The protein A-tag conferred 
efficient binding of SR to IgG sepharose with very little SR remaining in the 
unbound fraction. Very little protein washed off the resin and all of the protein is 
still bound to the resin after incubation with TEN protease. Repeated attempts using 
buffers at different salt composition and concentration with different protein A-
tagged strains were all unsuccessful. As the result was the same with several 
different strains this problem is unlikely to be due to a PCR induced mutation in the 
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Figure 3.5 TEV protease is insufficient to cleave 
PrA-tag from SR 
240 0D1 5() units of microsomes recovered from strain ARYI were 
dissolved in solubilisation buffer and isoluble material pelleted as 
described in section 2.20b except 0.5 ml solubilisation buffer was 
used. Ribosome associated membrane proteins were pelleted from the 
membrane extract (section 2.27) and the post-ribosomal supernate 
bound to 200 tl IgG seph arose overnight at 4°C on a roller. The 
sepharose was washed and eluted as described in section 2.20b except 
10 units of TEV protease were added to 1 ml elution buffer and 
afterwards the sepharose was washed with 5x  ml aliquots of wash 
buffer. 112001  of all samples, including a sample of the IgG-
sepharose were analysed by SDS-PAGE and Western blotting. 
Antibodies specific for SRct and protein A were used to detect SR. 
Lane 
1 Load fraction (post-ribosomal supernate) 
2 Unbound fraction 
3 Wash 1 
4 Wash  
5 Elution 1 
6 Elution 2 
7 Elution 3 
8 Elution  
9 Elution 5 
10 Elution 6 









cleavage site sequence. Instead it suggests that the tag may fold into a conformation 
at the C-terminus of SRO making the TEV site inaccessible to the protease. 
It seemed reasonable that introducing some distance between the C-terminus of SR1E 
and the N-terminus of the protein A-tag would increase the space between SR1 and 
the protein A domain allowing the TEV protease access to the cleavage site. 
B. Protein A-tagging SRO with spacer 
Having decided that a solution to cleavage by TEV protease was to add a spacer to 
the SRO-PrA construct, the decision now was which form of spacer should be used. 
Other purifications had been published using the "TAP-tagging" system (Tandem 
Affinity Purification) in which a calmodulin binding domain is inserted between the 
C-terminus of the tagged protein and the TEV protease site at the N-terminus of the 
protein A-tag (Puig, et al., 2001). A construct was thus made in which the sequence 
of the human calmodulin binding domain was inserted before the N-terminus of the 
protein A sequence in pJE39 (pJE82, J. Brown). Again, wild type yeast cells were 
transformed with a PCR product derived from the plasmid (using oligos 
5SRBSPPAI and 3SRP 102 (table 4)) and selected for their ability to grow on -his 
media. Transformants were screened by Western blotting for the presence of the 
fusion protein. Once positive transformants were selected purification of SR was as 
before. However, in this case the addition of TEV protease now eluted SR intact 
from the IgG sepharose. Figure 3.6 shows clearly that upon addition of TEV 
protease both subunits of SR are co-eluted from the resin with protein A remaining 
attached to the sepharose at the end of the experiment. In this experiment some SR3- 
ZZ remained uncleaved and bound to the resin. 
This purification was scaled-up in an attempt to purify sufficient protein to attempt 
reconstitution experiments. Figure 3.7 shows a typical purification of SR via the 
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Figure 3.6 TEV protease cleavage of CBD-PrA-tag 
from SR 
120 OD,, ( , units of microsomes recovered from ARY4 were dissolved in 
0.5 ml solubilisation buffer and insoluble material pelleted (section 2.20b). 
Ribosome associated membrane proteins were pelleted (section 2.27) and 
the post-ribosomal supernate bound to 200 ltl IgG sepharose overnight at 
4°C on a roller. The sepharose was washed twice in wash buffer (1% (v/v) 
triton X-100, 0.4 M KOAc, 14% (v/v) glycerol, 20 mM Hepes.KOH (pH 
7.4), 2 mM DTT, 1 mM PMSF). Sepharose was incubated in ImI wash 
buffer containing 10 units of TEV protease and incubated at room 
tempterature for 1 hour on a roller. After which the elute was collected, 
the sepharose washed 3 x I ml with wash buffer and 3 x 1 ml TBS and the 
IgG sepharose pellet collected for analysis. 11200th  of all samples were 
analysed by SDS-PAGE and Western blotting. Antibodies specific to 
SRu and SRO were used to detect SR (table 3). 
Lane 
L Load fraction 
U Unbound fraction 
E Eluate 
P IgG sepharose pellet 
130 








Figure 3.7 Purification of SR from yeast via Protein 
A-tag 
7,680 OD, 80 units of microsomes prepared from strain ARY4 were 
solubilised in solubilisation buffer and insoluble material pelleted (section 
2.20b). Ribosome associated membrane proteins were pelleted (section 
2.27) and the post-ribosomal supernate bound to IgG sepharose overnight 
at 4°C on a roller (section 2.20b). The sepharose was washed twice in 
wash buffer (1% (v/v) triton X-100, 0.4 M KOAc, 14% (v/v) glycerol, 20 
mM Hepes.KOH (pH 7.4), 2 mM DTT, 1 mM PMSF) and incubated at 
room temperature for 1 hour with imI of wash buffer containing 50 units 
of TEV protease. The eluate was collected and 1/200th  (lanes 1-4), 1110th 
(lane 5), 115th  (lane 6) and 1/2 (lane 7) of the samples were analysed by 
SDS-PAGE, Western blotting (A) and coomassie staining (B). Antibodies 
specific for SRa and SRO were used to detect SR. 
Lane 
1 Load fraction (post-ribosomal supernate) 
2 Unbound fraction 
3 Wash  
4 Wash  
5 Elution 1 
6 Elution 2 
7 Elution 3 
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protein A-tag. Bands of 69 kDa and 30 kDa were expected size for SRa and SR 
respectively. Contaminating bands of 50 kDa and 25 kDa were of the size expected 
for IgG and TEV protease. IgG can be removed from the elution fractions by 
incubation with protein A-sepharose and TEV protease can be removed by 
incubation with Ni-NTA agarose since it is provided in hexa-histidine tagged 
recombinant form (GIBCO-BRL). Although bands on the coomassie stained gel can 
be putatively identified as corresponding to SR subunits, the bands are extremely 
faint. The SR proteins are clearly not major constituents of the elution fraction as 
these samples comprised one fifth of the total elution from 200 g of yeast cells, the 
product of a 32 1 fermenter of yeast cell culture. Thus, either these proteins are not in 
abundance in the cell, or cell lysis, membrane solubilisation or SR recovery were 
inefficient. Despite sphaeroplasting cells before dounce homogenisation to lyse them 
(section 2.19a), a significant proportion of cells remain unbroken. This is also true 
for cells lysed using a Waring blender in the presence of liquid nitrogen (section 
2.28). Membrane solubilisation is less likely to be a source of lost SR as membrane 
dispersion was monitored by sedimenting insoluble membranes and analysing for the 
presence of SR by SDS-PAGE and Western blotting. It is also unlikely to be due to 
insufficient SR recovery after membrane solubilisation as little SR3-PrA was ever 
seen in the unbound fraction. However, although no data is published on the 
concentration of SR in ER membranes it does not appear to be as well expressed as 
SRP (data not shown), which is consistent with SR having a regulatory function in 
protein targeting where stoichiometric amounts of SR to SRP would not be required. 
3.1.4 Ion-exchange chromatography 
Previous work on mammalian SR described its ability to bind and elute specifically 
from an ion-exchange resin, for the purpose of exchanging detergent present in the 
column buffer. This detergent exchange was a necessary step before reconstitution 
of the subunits could go ahead. To examine the pattern of proteins eluting with or 
without yeast SR from several different ion-exchange resins I attempted to identify a 
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particular resin that would allow binding and elution of SR with a minimum of other 
proteins. The four resins chosen were CM, DEAE, Q and SP sepharoses for their 
strong or weak anion or cation exchange properties. 
Solubilised ER membrane fractions were bound to each ion-exchange resin and the 
pattern of proteins eluting from this examined by SDS-PAGE and silver staining 
(section 2.15). In each case almost all of the proteins present after binding eluted in 
the same fraction as the SR subunits. This was despite many variations of salt 
concentration and pH in binding, wash and elution buffers. It was clear that ion-
exchange chromatography would not be efficient as a second stage in the purification 
of SR if the first stage eluate was heavily contaminated with other proteins. 
However, binding of SR to these resins identified the conditions under which SR 
could bind and elute for the future step of detergent exchange. 
As described, if the eluate containing SR was heavily contaminated ion-exchange 
could not be used to further purify the complex. Therefore, it was thought that 
removal of as many contaminating proteins as possible before binding would be 
beneficial. After solubilisation of ER-derived microsomal membranes many of the 
proteins present are ribosomal or ribosome-associated. Ultracentrifugation can 
remove ribosomal proteins and ribosome-associated membrane proteins (RAMPs). 
As a result, this ultracentrifugation step was included in the strategy for purification 
of SR. Figure 3.8 shows a typical ion-exchange mediated purification of SR. The 
Western blot (A) shows that SR bound to the resin, a little protein was in the 
unbound fraction, and bound SR eluted in fractions 1 to 4. The silver stain (B) 
highlights proteins co-eluting with SR. As in this case a previous purification step 
had not been attempted there are many contaminating proteins with SR in the eluate. 
However, the ribosomal pellet fraction (lane 2) illustrates that many proteins are 
removed by the ultracentrifugation step that would otherwise be free to bind to the 
ion-exchange resin. Also, in this experiment it is clear that SR does bind to and elute 
from CM-sepharose as a complex and as such this could be used for the detergent 
exchange step. 
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Figure 3.8 Isolation of SR by ion-exchange 
chromatography using CM sepharose 
240 OD, M(; units of microsomes recovered from ARY2 were solubilised 
in digitonin buffer and insoluble material pelleted (see section 2.19b). 
Ribosome associated membrane proteins were pelleted from the 
membrane extract (section 2.27) and the post-ribosomal supernate bound 
to CM sepharose overnight at 4°C on a roller in buffer containing 50 
mM KOAc. The sepharose was washed with buffer containing 50 mM 
KOAc and eluted in buffer containing between 0.1 and 1 M KOAc as 
described in section 2.19b. 1/200th (lanes 1-6) and 115th  (lanes 7-11) of 
samples loaded were analysed by SDS-PAGE, Western blotting and 
silver staining. Antibodies specific for SRct and SRO were used to 
detect SR. The Western blot is shown in panel A while the silver stain is 
shown in panel B. The lanes in each are loaded with identical samples. 
Lane 
1 Load fraction (post-ribosomal supernate) 
2 Ribosomal pellet 
3 Unbound fraction 
4 Wash 1 
5 Wash  
6 Wash  
7 Elution 1 
8 Elution 2 
9 Elution 3 
10 Elution  
11 Elution  
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3.1.5 Discussion (Part 1) 
I have shown that polyhistidine tags are insufficient to purify intact SRP receptor free 
from contaminants. I have also shown that protein A-tagging allows the purification 
of SR free of almost all contaminants, and that this tag, with the addition of a spacer, 
can be cleaved from SR allowing purification of native intact complex. Last, I have 
determined which of the four ion-exchange resins tested bind SR with sufficient 
affinity that they may be used to exchange detergent before reconstitution. However, 
it was clear from these experiments that SR expressed from its endogenous 
promoters and isolated from yeast was not in significant quantity to allow 
reconstitution or testing its activity. As a result over-expression and purification of 
SR from yeast was carried out. 
Part 2: Over-expression of SR-protein A 
3.2.1 Over-expression of SR-Protein A 
The decision was made to over-express both SRa and SRO in yeast under control of 
the GALl/JO promoter with the aim of obtaining large amounts of the complex 
containing SRO-PrA. GALl/JO divergent promoters have been shown to induce up 
to 1000-fold over-expression of proteins compared to expression from their 
endogenous promoters (West et al., 1987). SRO is required for SRa to fold correctly 
in vivo (Young and Andrews, 1996) and co-expression of both subunits is necessary 
for solubility in E.coli (Fulga etal., 2001). As a result, I decided to express both 
SRPJOJ (SR() and SRPJ02 (SRO) from the same plasmid and thus the GALl/JO 
divergent promoters were chosen. SRO-CBD-PrA and SRa were amplified from 
genomic DNA of ARY1 used previously to purify SR (section 3.1.3-13). The 
products were cloned into pTRI43 (Roberts et al., 1994) as described (section 2.6 
and Figure 3.9) under control of the divergent GALl/JO promoters yielding plasmid 
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Figure 3.9 Plasmid map of pAR143 and diagnostic 
digests 
Plasmid map of pAR 143 (not to scale). 
Restriction endonuclease cleavage of three possible clones of SRa and SR- 
Approximately 2 jig of each plasmid was digested with the restriction 
endonucleases Ba,n 1-IT and EcoRI according to the manufacturers instructions. 
The samples were electrophoresed through a 1% (w/v) agarose gel as described 
in section 2.6. 
Lanes for (B) 
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pAR 143. Sequencing confirmed that the coding sequences for SRI3-CBD-PrA and 
SRa in pAR 143 contained no mutations from the wildtype SRPJOI, SRP102 and 
CBD-PrA (Appendix 1). pAR 143 was then transformed into several yeast strains to 
characterise expression. These were a wildtype strain (SDY3), a strain that lacked 
SR (JDY72) and a regl-501 strain (JDY225) which is deficient in glucose 
repression, thereby allowing expression from the GALl/JO promoter in glucose 
containing media. This was considered desirable as it would by-pass the need for a 
change of media during large-scale culture. In addition, it would allow maximum 
growth rates in glucose rather than slower growth on sucrose or raffinose, the most 
commonly used non-repressing carbon sources. Initial tests of induction (data not 
shown) indicated that the JDY225 gave, as expected, the most rapid response to the 
inducing carbon source galactose, and did not require shift to a non-repressing sugar 
before addition of galactose. Thus, this strain was chosen for further experiments. 
For reasons that are not clear all strains tested expressed the SRI3-CBD-PrA fusion at 
all times, whereas SRct was only expressed under inducing conditions (Figure 3.10a). 
Optimisation of expression was carried out by inducing expression at several cell 
densities, for different times and with increasing concentrations of galactose. Figure 
3. lOa shows that induction of SRa and 3 was optimum when started at OD 0.2. 
Figure 3. lOd shows that induction of SRa was increased by the addition of 
increasing galactose concentration up to 1% (wlv), at which point it was saturated. 
Thus, 1% (w/v) galactose was used in all subsequent experiments. Induction time 
courses revealed that induction of SRct is rapid and saturated by 1 hour (Figure 
3. lOe). One advantage of allowing induction to proceed beyond saturation at one 
hour is that the cells will multiply, increasing the final mass of cells harvested and, 
thus, the concentration of protein purified. This is especially relevant as maximum 
induction was achieved when the cells were induced when at a very low cell density 
(OD6w 0.2). Typically, cells were induced with galactose for 8-12 hours. 
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Figure 3.10 Characterisation of plasmid over-expression of SR 
(A). (B) and (C) Determination of optimum optical density of yeast cells for maximum over-expression of 
SR. 10 ml cultures of strain JDY225(pAR 143) were grown in glucose containing selective media to OD 
0.2, 0.5 or 1.0 at which time protein over-expression was induced by the addition of galactose to a final 
concentration of 1% (w/v). Protein over-expression was induced for 6 hours after which time the cells were 
harvested, washed, lysed (section 2.19a) and proteins analysed by SDS-PAGE and Western blotting 
(section 2.15). Antibodies specific to SRa and SRO were used to detect SR (table 3). In all cases a pre- 
induction sample was taken at the zero time point. (A) induction of cells at OD 0.2. (B) induction of 
cells at OD 0.5. (C) induction of cells at ODl.0. 
Determination of optimum galactose concentration for maximum over-expression of protein. 10 ml 
cultures of strain JDY225(pAR 143) were grown in glucose containing selective media to OD600  0.2 at 
which time protein over-expression was induced by the addition of galactose to final concentrations of 
0. 1, 0.2, 0.3. 0.4, 0.5, 0.6.0.7, 0.8, 0.9, 1.0 and 2.0% (w/v). Protein expression was allowed to proceed and 
proteins analysed as in (A). 
Determination of optimum length of induction. A 100 ml culture of strain JDY225(pAR143) was 
grown and protein over-expression induced as in (A) and the cells sampled every hour after induction. A 
pre-induction sample was taken at the zero time point. Proteins were analysed as in (A). 
Lanes for (A), (B) and (C) 
1 Uninduced JDY225(pAR 143) 
2 Induced JDY225(pAR 143) 
Lanes for (D) 
1 Uninduced JDY225(pAR 143) 
2 0.1% (w/v) galactose induction 
3 0.2% (w/v) galactose induction 
4 0.3% (w/v) galactose induction 
5 0.4% (wlv) galactose induction 
6 0.5% (w/v) galactose induction 
7 0.6% (w/v) galactose induction 
8 0.7% (w/v) galactose induction 
9 0.8% (w/v) galactose induction 
10 0.9% (w/v) galactose induction 
11 1.0% (w/v) galactose induction 
12 2.0% (w/v) galactose induction 
Lanes for (E) 
I Uninduced JDY225(pAR143) 
2 1 hour after induction 
3 2 hours after induction 
4 3 hours after induction 
5 4 hours after induction 
6 5 hours after induction 
7 6 hours after induction 
8 7 hours after induction 
9 8 hours after induction 
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In order to characterise expression of SR from pAR 143 further two additional 
experiments were carried out. The first judged the fold over-expression of SRcx and 
13 that was obtained compared to wild type expression. The second determined 
whether over-expression of SR was detrimental. To assess the amount of SR over-
expressed from pAR 143 microsomes were prepared from strain ARY4 (table 1) 
which expresses SR13-CBD-PrA and non-tagged SRa from their normal 
chromosomal promoters, and from strain JDY225(pAR 143). Dilutions of each were 
analysed by SDS-PAGE and Western blotting. The concentration of microsomes 
analysed in 0D 180 units per ml are indicated on figure legend 3.11. The asterix in 
lanes 2 and 7 of panel B indicates bands of protein corresponding to SR13-CBD-PrA 
of approximately equal intensity, indicating that SR13-CBD-PrA expressed from 
pAR 143, was approximately 8-fold over-expressed compared with wild type. 
Comparing over-expression of SRI3-CBD-PrA with wild type expression of SRf3- 
CBD-PrA eliminated any artificial increase in signal intensity generated by protein A 
itself. The arrows in Figure 3.11 indicate two bands of protein corresponding to 
SRa. The band in lane 2 was that of over-expressed SRa and appears approximately 
4-fold darker than the band in lane 9 (SR(x expressed at wild type levels). As 64-fold 
more protein was analysed in lane 9 than in lane 2 it can be conservatively estimated 
that SRa was 250-fold over-expressed from pAR 143 compared with wild type. 
Despite SRa and 13 not being present in equal amounts SRa appears to be stably 
associated with the microsomal membrane. Previous work indicated a membrane-
binding site within SRa, also found to be necessary for binding to SR13 (Young and 
Andrews, 1996). In the absence of sufficient SR13 this binding site would be free to 
associate with microsomes. This was seen previously when in the absence of SRI3 a 
little SRa was found associated with the ER membrane (Ogg et al., 1998). As 
deletion mutants of SRO no longer have functional SRP-dependent targeting 
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Figure 3.11 Estimation of fold over-expression 
480 and 240 OD-, 80 units of microsomes were recovered from strain ARY4 (wild 
type expression) and JDY225(pAR 143) (over-expressed) respectively as 
described in section 2.19a. Increasing volumes of microsomes from both strains 
were analysed by SDS-PAGE and Western blotting. Antibodies specific for SRcx 
(A) and SRI3 (B) were used to detect SR. Microsomes isolated from strain 
JDY225(pAR 143), panels A and B, lanes 1-5. Microsomes isolated from strain 
ARY4, panels A and B, lanes 6-10. 
Lanes for (A) 
	
Lanes for (B) 
1 0.04 OD, 80 units 
	
1 0.04 0D 280 units 
2 0.2 0D280 units 	 2 0.2 OD 280 units 
3 0.4 OD280 units 	 3 0.4 OD 280 units 
4 0.8 OD, 80 units 	 4 0.8 OD280 units 
5 2.0 OD, 80 units 	 5 2.0 0D 280 units 
6 0.64 OD,80 units 
	
6 0.32 0D280 units 
7 3.2 OD280 units 	 7 1.6 0D 280 units 
8 6.4 0D280 units 	 8 3.2 0D 180 units 
9 12.8 0D780 units 
	
9 6.4 0D 280 units 
10 32 OD,80 units 	 10 16 0D280 units 
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pathways it can be assumed that any excess SRa attached to the membrane is 
inactive. 
To assess whether overproduction of SR was detrimental, growth rates of strain 
JDY3(pAR 143) were monitored in media containing one of three combinations of 
carbon sources: glucose; sucrose and raffinose or sucrose, raffinose and galactose. 
Only in the presence of galactose would over-expression of SRa be permitted, with 
SRO over-expressed at all times (Figure 3.10). Figure 3.12 shows no significant 
difference in growth rate between cells with slightly over-expressed SRO (square and 
rhombus data sets) and those with over-expressed SR (round data set). It was 
concluded that over-expression of SR was not detrimental to the cell. 
3.2.2 Large-scale purification of SR 
Having characterised over-expression from pARI43 large-scale (32 1) cultures of 
JDY225(pAR 143) were grown, induced and SR purified from the cells (section 
2.20). Figure 3.13 shows a typical purification of SR using this method. From the 
Western blot (A) it was estimated that approximately half SR in the load bound to the 
IgG sepharose with endogenous wild type SRO also present that does not bind IgG as 
it is expressed without the "ZZ-tag" and all the SR eluted in eluates 1 and 2. Also in 
eluates 1 and 2 are 2 bands of lower molecular weight than SRO-CBD. These can be 
attributed to degradation, one of these species appears to co-migrate with 
endogenous SRO (compare panel A, lanes 1 and 5) and is presumably generated by 
degradative cleavage of the calmodulin binding domain creating "wild-type" SRO. 
The slightly lower molecular weight band in lane 6 must be due to further 
degradation of the "wild-type" species. Silver staining (B) revealed several 
additional proteins in the elution fractions. The major contaminants in the 
purification are putatively identified as IgG and TEV protease from their predicted 
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Figure 3.12 Growth rates of yeast containing pAR143 
3 x 100 ml cultures of yeast strain JDY3 (table 1) containing pAR 143 were 
grown in rich growth medium containing glucose (square data set), sucrose 
and raffinose (rhombus data set) and sucrose, raffinose and galactose (round 
data set). Each culture was sampled at 2 hourly intervals and the OD 6.  of 


















Figure 3.13 Purification of over-expressed 
SR 
SR was over-expressed and purified from strain JDY225(pARI43) as 
described in section 2.20. 1/100011  (lanes 1-4) and 11501h  (lanes 5 and 6) of 
each sample were TCA precipitated and analysed by SDS-PAGE, Western 
blotting (A) and silver staining (B). Antibodies specific for SRa and SR3 
were used to identify SR. Only the first 2 of the 5 elutions are shown as 
eluates 3-5 did not contain any SR. 
Lanes for (A) and (B) 
1 Load (solubilised membrane fraction minus RAMP proteins) 
2 Unbound 
3 Wash A 
4 Wash B 
5 Elution 1 
6 Elution 2 
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molecular weight. Other, less abundant contaminating proteins are present but in 
much smaller amounts than either subunit of SR. Almost 100 jig of protein was 
isolated, as estimated by Bradford protein assay, and available for reconstitution. 
3.2.3 Discussion (Part 2) 
In this Chapter protocols for purification of SR from large-scale culture of yeast 
strain ARY4 were developed and the conclusion made that over-expression was 
necessary. I detailed how SR was over-expressed. I described the purification of 
sufficient quantity of SR to allow reconstitution experiments to be undertaken. 
These experiments (Chapter 4) revealed that the purified material retained activity. 
To continue this work in the future my first concern would be to over-express each 
subunit of SR at the same level, thereby potentially allowing purification of greater 
amounts of SR and, perhaps, a reduction in the scale of cultures necessary to provide 
sufficient material for reconstitution experiments. Second, it should be possible to 
remove the two major contaminating proteins from the purified material (IgG and 
TEV protease) by incubation of the eluates with protein A sepharose and Ni-NTA 
agarose. Preliminary attempts to remove these contaminants failed due to protein 
degradation (data not shown); however, this should be easily rectified. Despite the 
necessity for further steps in this purification, it can be concluded that a protocol for 
the purification of active SR from yeast has been developed to the point at which this 
material can be tested in vitro. 
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Chapter 4 
In vitro reconstitution of SRP-dependent 
translocation 
4.1 Introduction 
The development of strategies for the purification of yeast SR provided a crucial tool 
for the reconstitution of SRP-dependent targeting and translocation. A long-term 
goal of this work was reconstitution of this entire pathway. Thus, in addition to SR, 
other components necessary for SRP-dependent targeting also had to be purified. To 
this end, published protocols for the purification of the translocon and Kar2p 
(Beckmann et al., 1997; McClellan et al., 1998) were used and/or adapted. The 
Sec6lp complex is necessary for all modes of translocation across the ER. Kar2p is 
known to be essential for post-translational translocation, but as discussed 
(introduction) has also been suggested to be necessary for co-translational 
translocation. In this chapter the preparation of components necessary for in vitro 
trans lation/translocation are described along with activity tests of the purified factors. 
Unfortunately, due to time constraints, the final experiments, testing translocation 
with only purified proteins, were not carried out. 
4.2 Preparation and titration of essential components 
In vitro translation/translocation reactions require a number of components. These 
are translation extract (YTE), capped mRNA (whether SRP-dependent or - 
independent) and microsomes (yRM) from appropriate yeast strains. Established 
protocols were used for the preparation of YTE and yRM, and mRNAs were 
prepared using commercial transcription kits (section 2.30). 
Endogenous mRNA in YTE competes with exogenously added mRNA for 
translationally active ribosomes, and thus must be removed. YTE is therefore treated 
with micrococcal nuclease before use (section 2.29). As this nuclease requires 
calcium ions for activity, addition of the chelating agent EGTA effectively inhibits 
the enzyme and prevents degradation of subsequently added synthetic mRNA. The 
activity of the treated YTE was tested with mRNAs encoding either SRP-dependent 
or —independent proteins and compared with a previously prepared extract (a gift of 
Reconstitution of purified proteins 	 154 
Jeff Brodsky, University of Pittsburgh) for comparison (data not shown). To ensure 
that the reactions were efficient each batch of rnRNA was titrated against the YTE 
(data not shown). 
Figure 4.1 shows titration of purified microsomes into translation reactions. mRNAs 
used in every translation reaction encoded a dipeptidylaminopeptidase-B-pro-alpha 
factor fusion (D(xF) which is SRP-dependent (Ng et al., 1996), and pre-pro-alpha 
factor (pp(xF), which is SRP-independent (Hansen and Walter, 1988). Panel A 
shows the titration of microsomes isolated from a wild type yeast strain. These 
support translocation of both DEICUF  and ppaF substrates, observed by the signal 
sequence cleavage of ppctF and the appearance of glycosylated forms of both 
proteins. In panel B titrated into a translation reaction are microsomes derived from 
the SR-deficient strain JDY72 (table 1). Hence, translocation of DHCUF  is not seen 
as this protein requires SR (lanes 2-5, panel B; Ng et al., 1996). However, the post-
translational pathway is still active in these microsomes and ppaF is translocated 
(lanes 7-10, panel B). Often a low level of translocation of D14aF  into SR-deficient 
microsomes was observed. This was presumably due to "leakage" through the post-
translational translocation pathway as substrate fidelity within targeting pathways is 
often not absolute. A phenomenon observed here and seen with many different 
microsome preparations (compare panel A, lanes 1 and 4 and panel B, lanes 1 and 5) 
was inhibition of protein synthesis upon addition of a high concentration of 
microsomes. For that reason it was important to titrate each microsome preparation 
to determine the amount that gave maximal translocation while not impairing 
translation. 
4.3 Purification of active bacterially over-expressed SR 
While I was optimising the conditions for purification of over-expressed SR from 
yeast, a plasmid was generated in the laboratory from which SR could be 
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Figure 4.1 Titration of translocationally active microsomes 
480 Oft 80 units of microsomes were prepared from yeast strains JDY3 (wild type) 
and JDY72 (srpl01:.ADE2, srp102::HIS3) (section 2. 19a). The translocation 
activity of the prepared microsomes was assessed in an in vitro 
trans lati on/tran sl ocati on assay (sections 2.33 and 2.34). Microsomes prepared from 
strains JDY3 (A) and JDY72 (B) were tested. 
(A) Lanes 
1 0 microsomes, DHCaF  mRNA 
2 0.16 0D250 units, DHCaF  mRNA 
3 0.32 0D280 units, DHCaF  mRNA 
4 0.48 OD, 80 units, DHCUF  mRNA 
5 0 microsomes, ppaF mRNA 
6 0.16 OD-, 80 units, ppaF mRNA 
7 0.32 Oft80 units , ppaF mRNA 
8 0.48 OD280 units, ppaF mRNA 
(B) Lanes 
1 0 microsomes, DHCctF  mRNA 
2 0.16 OD280 units, DHCaF  mRNA 
3 0.32 Oft80  units,  DHCaF  mRNA 
4 0.48 0D280 units, DHCaF  mRNA 
5 0.64 0D280 units, DHCaF  mRNA 
6 0 microsomes, ppcxF mRNA 
7 0.16 OD280 units, ppaF mRNA 
8 0.32 OD, 80 units, ppaF mRNA 
9 0.48 OD 280 units, ppaF mRNA 
10 0.64 OD, 80 units, ppctF mRNA 
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over-expressed in bacteria as a soluble complex lacking the transmembrane domain 
of, and with GST fused to, the N-terminus of SR (Jeremy Brown). The plasmid 
was created initially for purification of SR for crystallisation trials. If addition of this 
purified SR to microsomes recovered from a SR deficient yeast strain restored 
translocation activity it would provide an important additional tool for analysis of 
SRP-dependent targeting in vitro. Figure 4.2 shows the purification of the SR-GST 
from E. co/i. (section 2.14). 
The purified SR-GST protein was tested in vitro to determine if it was active and 
would stimulate translocation of an SRP-dependent substrate. Figure 4.3 shows that 
addition of purified SR-GST to translation reactions containing microsomes lacking 
endogenous SR resulted in increased translocation of the SRP-dependent substrate 
D 11 aF (compare lane 3 with 5 and 7) while the translocation of ppaF was unaffected 
(compare lane 4 with 6 and 8). Addition of 2 j.tg of SR-GST increased the 
translocation of DfICaF  over two-fold (compare lanes 3 and 5) while addition of 4 jig 
resulted in a three-fold increase (compare lanes 3 and 7). Thus, despite lack of a 
transmembrane domain in SRI3-GST the protein, together with SRa, is able to 
stimulate the translocation of an SRP-dependent substrate. There is a precedent for 
the activity of SR-ATMI3 in yeast (Ogg et al., 1995) as a yeast strain containing this 
allele grew well and had no observable defects in translocation. In addition, while 
this work was in progress a similar construct of mammalian SR was also shown to be 
active in vitro (Fulga et al., 2001). 
It was of interest to determine if SR(ATM)-GST associated with components of the 
microsomal membrane or only interacted with the membranes during the SRP-
dependent targeting cycle. To test this, purified SR-GST alone, SR-deficient 
microsomes alone and purified SR-GST mixed with SR-deficient microsomes were 
incubated on ice for 30 mm, after which they were subjected to centrifugation at 
13,000 rpm for 15 min to pellet microsomes and any insoluble material. Figure 4.4 
shows that in the absence of microsomes SR(TM)-GST remains entirely in solution 
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Figure 4.2 Purification of SR-GST 
SRa and SRt3(ATM)-GST were over-expressed in strain M15pREP4(pJE97) 
and purified according to the protocol described (section 2.14). 1/2000th 
(lanes 1-5) and 1/50th  (lanes 6-8) of samples were analysed by SDS-PAGE 
and Coomassie staining. 
Lanes 
1 Pre-induction 
2 Induced cells 
3 Load 
4 Flow through 
5 Wash 
6 Elution 1 











Figure 4.3 Activity test of purified SR-GST 
SR was bacterially over-expressed and purified (section 2.14, Figure 4.2). 
Zero (lanes 1-4), 2 lig (lanes 5 and 6) and 4 tg (lanes 7 and 8) of the proteins 
were added to in vitro transl at] on/trans location reactions (section 2.33 and 
2.34) containing 0 0D 280 units (lanes 1 and 2) or 0.32 OD, 80 units (lanes 3-8) 
of microsomes recovered from yeast strain JDY72 (table 1) (section 2.19a). 
1/3 rd  of each reaction were analysed by SDS-PAGE and phosphoimaging. 
Lanes 
1, 3, 5 and 7 DcxF  mRNA 
2, 4, 6 and 8 ppaF mRNA 
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Figure 4.4 Association of SR-GST with microsomal 
membranes 
2 tg SR(ATM)-GST alone (lanes 1 and 2), 0.32 OD, 80 units of 
microsomes recovered from JDY72 (SR deficient) alone (lanes 3 and 4) 
and 2 jag SR(ATM)-GST mixed with 0.32 OD, 80 units SR deficient 
microsomes (lanes 5 and 6) were incubated on ice for 30 mm. 
Microsomes were pelleted by centrifugation at 13,000 rpm for 15 min at 
4°C in a microcentrifuge. All of the supernate and pellet were analysed 
by SDS-PAGE and Western blotting. Antibodies specific for SRa and 
SRP were used to detect SR. 
Lanes 
1, 3 and 5 Supernate 
2,4 and 6 Pellet 
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and does not pellet upon centrifugation. However, in the presence of microsomes 
SR(ATM)-GST is found in equal quantity in the supernatant as in the pellet 
confirming that the proteins associated with microsomal membranes. 
4.4 Reconstitution of translocation using purified yeast ER 
membrane proteins 
4.4.1 Titration of lipid for protein reconstitution 
Previously post-translational translocation has been reconstituted with purified yeast 
proteins (Panzner et at., 1995). Co-translational translocation has been reconstituted 
with purified mammalian proteins (Görlich and Rapoport, 1994). However, co-
translational translocation with yeast components had not been accomplished. 
Therefore, demonstrating co-translational translocation with proteoliposomes 
prepared with total yeast microsomal membrane proteins was imperative before 
embarking on assays using purified SR or other membrane proteins. Thus, yeast ER-
derived microsomes were solubilised and proteins reconstituted into proteoliposomes 
using a protocol previously used to demonstrate activity of proteins involved in post-
translational translocation (Brodsky et at., 1995). 
As noted earlier (section 4.2) high concentrations of microsomes inhibit translation 
reactions. Initial assays of translocation in the presence of proteoliposomes showed 
severely reduced translocation. This effect was substantially more pronounced with 
proteoliposomes than microsomes and was also seen when liposomes were added to 
in vitro translation reactions, indicating that the presence of lipids was the 
detrimental factor (data not shown). 
Proteoliposomes are generated by mixing purified and/or solubilised proteins with 
azolectin (the source of lipid for the proteoliposomes) and carrying out a freeze-thaw 
cycle (section 2.32). Given that translation is inhibited by proteoliposomes it was 
considered that the volume of lipid added before the freeze-thaw step and thus the 
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lipid: protein ratio, as well as the volume of proteoliposomes added to the 
transi ationitranslocation reactions might be crucial. Therefore, titration experiments 
were carried out to determine a) the volume of proteoliposomes that could be added 
to the reaction without substantially decreasing the translation rate and b) whether 
the lipid: protein ratio in the reconstitutions could be reduced. Figure 4.5 shows the 
comparative levels of translation obtained in a reaction with decreasing lipid: protein 
ratios used to reconstitute protein and with increasing volumes of proteoliposomes 
added to the translation/translocation reaction. It is apparent that decreasing the 
lipid: protein ratio of the proteoliposomes added to the reaction results in a 
corresponding increase in translation (Figure 4.5, panel A, compare lanes 3, 6 and 9 
with 12). In addition, decreasing the volume of proteoliposomes added to the 
reaction leads to a corresponding increase in translation (panels A and B, compare 
lanes 4, 7, 10 and 13 with lanes 2,5,8 and 11). The effect is more pronounced when 
translating the co-.translationally dependent substrate D 1 aF than the post- 
translationally dependent substrate ppcxF. However, when one third of the reaction 
volume consists of proteoliposomes (as described in McClellan et al., 1998) 
translation of both substrates diminishes almost entirely (Figure 4.5, panels A and B, 
lanes 4, 7, 10 and 13). As this is the case for both SRP-dependent and —independent 
substrates, this suggests a universal inhibition of ribosome function in the presence of 
high concentrations of lipid and not a specific substrate-related defect. 
Decreasing the lipid: protein ratio when reconstituting proteins would be expected to 
lead to a decrease in incorporation of protein into proteoliposomes and thus, a 
corresponding decrease in translocation. However, the higher the concentration of 
proteoliposomes in a translation reaction the lower the level of translation that is 
observed. Therefore, a balance is necessary between observable translocation and 
necessary translation. From the titration experiments detailed here it was concluded 
that using a lipid: protein ratio of 1: 1 and adding one-sixth the total reaction volume 
of proteoliposomes was a suitable compromise (section 2.33 and 2.34). 
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Figure 4.5 Titration of lipid 
4 OD,80  units of microsomes each, recovered from strain JDY3 (wild type) were 
solubilised and the protein fraction reconstituted into proteoliposomes (section 
2.32). Four different ratios of lipid:protein were analysed: 2:1 (panels A and B, 
lanes 2-4), 1.6:1 (panels A and B, lanes 5-7), 1.3:1 (panels A and B, lanes 8-10) 
and 1:1 (panels A and B, lanes 11-13). 5, 10 and 20 tl of the proteoliposomes 
generated were added to translation reactions containing DHCaF (A) and ppaF 
(B) mRNA and their effect on its translation monitored by SDS-PAGE and 
phosphoimaging. 
Lanes for (A) and (B) 
1 no proteoliposomes 
5, 8 and 11 5 l proteoliposomes 
6, 9 and 12 10 j.tl proteoliposomes 
4, 7, 10 and 13 20 j.il proteoliposomes 
	
1 	2 	3 	4 	5 6 	7 	8 	9 10 11 12 13 
ProteoIiposomes(tI) 	0 	5 10 20 	5 1 10 20 	5 10 20 5 	10 	20 
Lipid:protein ratio 	a 2:1 	1.6:1 	1.3:1 	1:1 
DHCaF 
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1 2 	3 	4 	5 6 	7 	8 	9 10 	11 12 13 
- 	 -1 _______ 	 ppaF 
Proteoliposomes(j.iI) 	0 	5 1 10 1 20 	5 I 101 20 	5 1 10 1 20 5 1 10 1 20 
Lipid -.protein ratio 	o 2:1 	1.6:1 	1.3:1 	1:1 
4.4.2 Reconstitution of Kar2p 
The ER lumenal Hsp70 homologue Kar2p is essential for post-translational 
translocation (Lyman et al., 1995; Panzner et al., 1995; Matlack etal., 1997). As 
discussed (introduction) this protein binds the translocon component Sec63p and is 
thought to provide a driving force for translocation (Matlack et al., 1999). Recent 
evidence suggests that it is also essential for co-translational translocation both in 
vitro and in vivo (Brodsky et al., 1993; Young et al., 2001). To test the requirement 
for Kar2p in co-translational translocation Kar2p was purified and tested for its post-
translational translocation promoting activity before incorporation into 
proteoliposomes to test its ability to stimulate co-translational translocation. Kar2p 
was purified from bacterial cells expressing pMR2623 (McClellan et al., 1998) (see 
section 2.13). Such a purification is shown in Figure 4.6 (panels A, B and Q. To 
test the activity of this purified protein without endogenous Kar2p activity 
microsomes were isolated from a yeast stain defective in Kar2p (RSY586; kar2-159). 
Although generation of a deletion mutant of Kar2p is not possible (Kar2p is essential 
in yeast) certain temperature sensitive mutations allow the isolation of microsomes 
with insufficient Kar2p activity to stimulate translocation, of which kar2-159 is one 
(Vogel et al., 1990; Brodsky et al., 1995). 
Purified Kar2p was included in a reconstitution of proteins from solubilised RSY586 
microsomes at 30 ltg per reaction (as in the published protocol (McClellan et al., 
1998)). Figure 4.6d shows translocation of ppcF only in the presence of added 
Kar2p. In addition to showing that the purified Kar2p was active in vitro, this 
experiment also demonstrates that identification of translocated species is different 
when using proteoliposomes than when using native microsomes. Protein 
translocated into microsomes are typically recognised as species lacking signal 
sequences and/or through N-glycosylation. When using proteoliposomes these 
species do not appear, indicating that the solubilisation and reconstitution process 
removes and/or inactivates the enzymes from the ER lumen responsible for signal 
sequence cleavage (SPase) and glycosylation (OSTase). Therefore, proteins 
translocated into proteoliposomes were detected by incubating the 
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Figure 4.6 Purification of Kar2p 
Kar2p was over-expressed and purified from strain DH5a(pMR2623) (table 2) as 
described in section 2.13. (A) Induction, (B) Ni-NTA affinity chromatography, (C) 
Jon-exchange chromatography on Q- sepharose. 1120011  of all fractions in (A), (B) 
and (C) were analysed by SDS-PAGE and Coomassie staining. 
Lanes for (A) 
	
Lanes for (B) 
1 Uninduced cells 	 1 Load (clarified cell extract) 
2 Induced cells 	 2 Wash 1 
3 Wash 2 
4 Wash 3 
5-14Elutions 1-10 
Lanes for (C) 
1 Load (Ni-NTA agarose eluate) 
2 Unbound 
3 Wash 1 
4 Wash 2 
5-15 Elutions 1-11 
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Figure 4.6(D) Reconstitution of Kar2p 
Proteoliposomes were reconstituted with or without 30 .tg of Kar2p and proteins 
solubilised from 4 OD 280 units of microsomes recovered from strain RSY586 (table 
1) as described in section 2.32. No proteolipsomes (panel D, lanes 1-3), 10 .tl of 
proteolipsomes without additional Kar2p (panel D, lanes 4-6) and 10 jil of 
proteolipsomes with additional Kar2p (panel D, lanes 7-9) were included in 
trans lation/translocation reactions (sections 2.33 and 2.34) containing ppcF mRNA. 
Translocation of the in vitro radiolabelled protein was monitored by the addition of 
trypsin and/or tritonX-100 to the reactions, after which 1/3111  of each was analysed 
by SIDS-PAGE and phosphoimaging. 
Lanes 
1,4 and 7 No additions 
2, 5 and 8 5 jtg trypsin 
3, 6 and 9 5 tg trypsin, 1% (v/v) tritonX-100 
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TritonX-1 00 (% (v/v)) 
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translation/translocation reaction with trypsin, to degrade non-translocated and thus 
non-protected protein. Addition of trypsin and tritonX-100 (to disrupt the 
proteoliposomes) results in degradation of all protein. Thus, in Figure 4.6d 
comparison of lanes 2, 5 and 8 reveals that only lane 8 contains ppctF that is 
protected from the addition of trypsin to the reaction. The ppctF was translocated 
into the lumen of the proteoliposomes only in the presence of microsomal proteins 
and purified Kar2p. This confirms that the Kar2p purified was active in promotion 
of the translocation of an SRP-independent substrate. 
4.5 Reconstitution of co-translational translocation 
4.5.1 Reconstitution of purified yeast Kar2p and SR 
Having determined that the purified Kar2p was active in promoting post-translational 
translocation the next step was to attempt to reconstitute co-translational 
translocation. In order to restore Kar2p activity to microsomes isolated from strain 
RSY586 30 tg of purified protein must be incorporated. However, when adding 
purified Kar2p to wild type microsomes to ensure adequate Kar2p activity is retained 
only 15 ig of protein need be reconstituted (McClellan et al., 1998). Microsomes 
isolated from wild type and SR deficient yeast strains (section 2.19a) were 
solubilised and reconstituted in the presence of purified Kar2p into proteoliposomes 
that were assayed for their ability to translocate D11aF  and ppaF. Figure 4.7, panel 
A shows translocation of D11aF and ppctF into proteoliposomes reconstituted from 
proteins resident in wild type microsomes. Both SRP-dependent and —independent 
substrates are translocated. Figure 4.7, panel B shows the translocation of DHCUF 
and ppaF into proteoliposomes. Even in the presence of Kar2p proteoliposomes 
reconstituted from the proteins resident in SRL\ microsomes cannot support SRP-
dependent translocation (panel B, lane 2). However, as seen previously 
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Figure 4.7 Reconstitution of microsomal membrane 
proteins 
Membrane proteins solubilised from microsomes recovered from strains JDY3 
(wild type) and JDY72 (srp]01.:ADE2, srp102::HIS3) (table 1) were 
reconstituted into proteolipsomes in the presence of 15 tg purified Kar2p. 10 
jil proteoliposomes reconstituted with wild type proteins (A) and 10 tl 
proteoliposomes reconstituted with SR-deficient proteins (B) were included in 
translati on/trans location reactions containing D H( aF (panels A and B, lanes 1-
3) or ppctF (panels A and B, lanes 4-6) mRNA. Translocation was monitored 
by addition of trypsin and/or tritonX-100 and analysis by SDS-PAGE and 
phosphoimaging. 
Lanes for (A) and (B) 
1 and 4 No additions 
2 and 5 5 jtg trypsin 







loom 	 ~ DHCaF  
- ppaF 
Trypsin (jtg) 	0 5 5 	0 	5 5 
TritonX-100 (% (v/v)) 	0 0 	1 	0 	0 
% translocation 	 6.9 	26.9 
176 
with intact SRA microsomes (Figure 4. 1, panel B) they do support the translocation 
of SRP-independent substrates (lane 5). In this experiment it is clear that the 
efficiency of translocation of DHCaF is poor relative to the translocation of ppaF 
(compare panel A, lanes 2 and 5). This is typical of in vitro reconstituted co-
translational translocation but despite the low efficiency of the reaction it is 
reproducible. One method of increasing the efficiency of the reaction may be to 
increase the concentration of SRP in the translation extract by supplementing with 
purified SRP. This experiment showed that it is possible to reconstitute microsomal 
membrane proteins and retain the activity of those proteins required for co-
translational translocation. 
Having established conditions under which co-translational translocation could be 
reconstituted using solubilised ER membrane proteins, the next step was to assay the 
activity of purified yeast SR. The purification of SR and concentration of protein 
added in vitro are detailed in Chapter 3 and Section 2.20. Proteins solubilised from 
microsomes without endogenous SR (SRA) were used in the reconstitution along 
with SR, Kar2p or both. Translocation of both DHCaF  and ppaF was assayed and, as 
before, detected by the presence of protease-protected material (Figure 4.8). PpaF 
was translocated in all of the reactions except when Kar2p was omitted from the 
reconstitution or when SR was added. As Kar2p is absolutely required for 
translocation of SRP-independent substrates this result was not surprising. However, 
SR inhibited the translocation of ppctF. This was surprising, and perhaps the 
presence of a high concentration of SR resulted in generation of translocation sites 
specific for SRP-dependent translocation thereby limiting the capacity of the 
membranes for SRP-independent translocation. In contrast, translocation of D FIC cZF 
was stimulated by addition of purified SR and Kar2p. The purified receptor is thus 
active in promoting SRP-dependent translocation and translocation is dependent also 
on the presence of active Kar2p. The basal level of translocation in lane 2 (6.9%) is 
enhanced substantially by the addition of SR and Kar2p (lane 20, 14.5%). Therefore, 
SR over-expressed and purified from yeast by the protocol described yields active 
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Figure 4.8 Reconstitution of purified SR 
SR was over-expressed and purified from strain JDY225(pAR 143) (table 1) as 
described in section 2.20 (Figure 3.13). Membrane proteins solubilised from 
microsomes recovered from strain JDY72 (table 1) were reconstituted into 
proteoliposomes with approximately 9.5 tg purified protein containing SR in the 
absence or presence of 15 p.g purified Kar2p (section 2.32). 10 .tl of 
proteoliposomes without any additional purified proteins (lanes 1-6), 10 .tl of 
proteoliposomes containing only 15 ig Kar2p (lanes 7-12) and 10 p.1 of 
proteolipsomes containing only SR (lanes 13-18) or SR and Kar2p (lanes 19-24) 
were included in trans lation/translocation reactions containing DHCF  (lanes 1-3, 
7-9, 13-15 and 19-21) or ppaF (lanes 4-6, 10-12, 16-18 and 22-24) mRNA. 
Translocation was monitored be addition of trypsin and/or tritonX-100 to each 
reaction. 1/3rd  of each reaction was analysed by SDS-PAGE and phosphoimaging. 
Lanes 
1, 4, 7, 10, 13, 16, 19 and 22 No additions 
2,5,8, 11, 14, 17,20 and 23 5 p.g trypsin 
3, 6, 9, 12, 15, 18, 21 and 24 5 p.g trypsin, 1% (v/v) tritonX-100 
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protein that can restore the SRP-dependent targeting activity to microsomes derived 
from an SRA yeast strain only in the presence of active Kar2p. It should be noted 
that the preparation of SR used contained a number of contaminants. Of these, the 
major contaminants are IgG and TEV protease that would not be expected to 
stimulate membrane targeting or translocation. The other contaminants have yet to 
be identified. While it is possible that these are responsible for the protein targeting 
activity that is seen upon addition of the purified protein to the assay this is 
considered unlikely, particularly as the only factor missing from the membranes used 
in the reconstitution was SR itself. 
In an attempt to titrate the amount of added SR necessary for translocation of D HCaF 
the experiment was repeated from purification through to reconstitution. 
Unfortunately, this preparation failed to yield sufficient material for this analysis and 
time constraints prevented further experiments from being carried out. 
4.5.2 Reconstitution of the Sec complex 
The second protein complex purified for inclusion into the in vitro assay was the Sec 
complex. Beckmann et al. (1997) described a purification procedure for the Sec6l 
complex that was used to generate a cryo-EM structure of the Sec61-ribosome 
complex. This purification was modified to yield the entire Sec complex. The 
purification utilises Sec63p modified to include a cleavable Protein A-tag at its C-
terminus similar to that generated for SRO (section 2.6). A yeast strain expressing 
Sec63-PrA was generated and used to purify the Sec complex (described in section 
2.21) which is shown in Figure 4.9. The Western blot reveals that binding of this 
complex to IgG sepharose was efficient (lane 2) and that the majority of the complex 
eluted from the resin following treatment with TEV protease (lanes 6-9). Western 
blotting identified Sec63p, Sec6lp and Sec7lp. As solubilisation of the Sec complex 
requires digitonin and elution of the complex is into buffer containing digitonin an 
additional detergent exchange step had to be undertaken before reconstitution could 
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Figure 4.9 Purification of intact Sec complex 
Sec complex was purified from strain JDY5I6 as described in section 2.21. 1/200' of 
each fraction from the purification were analysed by SDS-PAGE and Western blotting 
(A) and 1/100th  of each fraction from the detergent exchange step were analysed by 
SDS-PAGE and silver staining (B). Antibodies specific for Sec6l, Sec63 and Sec7lp 
were used to identify intact Sec complex. 
Lanes for (A) 
1 Load (post-ribosomal supernate) 
2 Unbound 
3 Wash 1 
4 Wash 2 
5-10 Elutions 1-6 
Lanes for (B) 
1 Load (elutions 2-5 of the purification) 
2 Unbound 
3 Wash 1 
4 Wash 2 
5-12 Elutions 1-8 
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be carried out (section 2.24 and Figure 4.9). Silver stain analysis of the fractions 
collected during the detergent exchange of digitonin for deoxyBigCHAP revealed 
very little protein in the unbound or wash fractions, the complex eluting in fractions 
3-7 (lanes 6-10). Approximately 6.tg of Sec complex was recovered for 
reconstitution into proteoliposomes. 
To assay the purified Sec complex it was necessary to isolate microsomes from a 
yeast strain deficient in Sec6lp. Sec6lp is essential in yeast therefore a construct 
was created in which SEC61 was constitutively expressed only in the presence of 
galactose. When the cells were grown in glucose Sec6lp was depleted to 
undetectable levels within 6-8 hours (Jeremy Brown). Microsomes were isolated 
from this strain (JDY638, table 1) after 6-8 hours of glucose depletion of endogenous 
Sec6lp. Solubilised proteins from these microsomes were used in the reconstitution 
of purified Sec complex into proteoliposomes in the presence or absence of purified 
Kar2p. Figure 4. 10, lane 2 shows very little translocation of ppaF in the absence of 
purified Sec complex or Kar2p. Upon addition of purified Sec complex no increase 
in translocation of ppcF can be detected (lane 5). However, in the presence of 
purified Sec complex and Kar2p an increase in translocation of ppaF can be seen 
(lane 8). This increase may have been due to the addition of Kar2p to the reaction 
and not to the presence of active purified Sec complex. Western blot analysis of all 
the proteoliposomes used in the experiment showed Sec6Ip was only present in 
fractions where purified Sec complex was added (Figure 4.10b). The data suggest 
that Sec complex, purified from yeast and reconstituted into proteoliposomes, was 
active. 
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Figure 4.10 Activity test of purified Sec complex 
Sec complex, purified from strain JDY5I6 (Figure 4.9), was subjected to a detergent 
exchange step (section 2.24) and included in a reconstitution of membrane proteins 
from microsomes recovered from strain JDY638(pGAL-SEC61) (Sec6lp-deficient; 
Table I) (section 2.32). Proteoliposomes without added purified proteins (panel A, 
lanes 1-3), proteolipsomes with added purified Sec complex (panel A, lanes 4-6) and 
proteoliposomes with added Kar2p and added Sec complex (panel A, lanes 7-9) were 
included in translation/translocation reactions containing ppF mRNA. Translocation 
was monitored by addition of trypsin and/or tritonX-100 to the reactions and 1/3"' of 
each reaction was analysed by SDS-PAGE and phosphoimaging. 
Lanes for (A) 
4 and 7 No additions 
5 and 8 5 jig trypsin 
6 and 9 5 tg trypsin, 1% (v/v) tritonX-100 
Proteolipsomes added to translation/translocation reactions were subjected to 
centrifugation at 55,000 rpm for 45 min at 4°C in a Beckman TLA 120.2 rotor. The 
supemate and pellet of this centrifugation step were TCA precipitated and analysed by 
SDS-PAGE and Western blotting. Antibodies specific for Sec6lp were used to 
identify the Sec complex. 
Lanes for (B) 
1 Supernate of proteoliposomes included in panel A, lanes 1-3 
2 Pellet of proteoliposomes included in panel A, lanes 1-3 
3 Supernate of proteoliposomes included in panel A, lanes 4-6 
4 Pellet of proteoliposomes included in panel A, lanes 4-6 
5 Supernate of proteoliposomes included in panel A, lanes 7-9 
6 Pellet of proteoliposomes included in panel A, lanes 7-9 
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ppaF— 	 - 
Trypsin (jig) 	0 	5 	5 	0 	5 	5 	0 	5 	5 
TritonX-100 (% (v/v)) 	0 	0 	1 	0 	0 	1 	0 	0 	1 
Kar2p(jig) 	 0 	 0 	 15 
Sec complex (jig) 	0 	 3 	 3 







In this Chapter 1 have described the preparation of all of the materials necessary to 
reconstitute SRP-dependent targeting and the optimisation of each step in the 
translation/translocation reaction. I describe the purification of active yeast SR 
(Chapter 3), Kar2p, the Sec complex and bacterially over-expressed SR-ATMf3 and 
their reconstitution. Finally, I have shown the reconstitution of SRP-dependent 
targeting using yeast components and demonstrated that Kar2p is necessary to 
stimulate SRP-dependent translocation in this in vitro system. 
I have shown that SR-ATMI3 associates with microsomal membranes and retains 
activity despite the absence of a transmembrane domain on SRO (Figure 4.4). 
Interestingly, approximately 25% of SR-ATMP associates with the ER membrane in 
vivo (Ogg et al., 1995). This in vitro experiment extends this finding and suggests 
that SR-ATMP associates with an ER membrane component thus providing a binding 
site for SR. The finding that SRO interacts with Sec6lp in a two-hybrid assay 
supports this possibility (section 5.3). Alternatively, and like the E. co/i SRa 
homologue FtsY, SR may have an affinity for the lipid components of the membrane 
(de Leeuw ci al., 2000). Thus, SR-GST provides a tool to investigate interactions of 
SR-ATM3 and how SR-ATMP is tethered to the membrane during protein targeting 
and translocation in vitro. 
It was observed that the presence of SR inhibited post-translational translocation 
(Figure 4.8). The observed interaction between SRO and Sec6Ip (Chapter 5) 
suggests that SR may compete with Sec62p for available translocons. In this 
scenario a translation/translocation reaction with excess SR would titrate out 
available translocons thereby favouring SRP-dependent over SRP-independent 
translocation. 
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The purified Sec complex was shown to be active. However, as this experiment was 
carried out only once it must be repeated. Although SRP-dependent translocation 
was reconstituted, fulfilling one of the aims of this study, the assay was not 
established using only purified components. A necessary step before completion of 
this aim will be to establish firmly the activity of purified Sec complex. While it was 
established that purified yeast SR was present in the proteoliposome fraction 
included in the translation/translocation assays it was not demonstrated conclusively 
whether SR was associated with or was incorporated into proteoliposomes. In order 
to establish this proteoliposomes composed of lipid and purified SR must be either 
sedimented upon high salt and urea treatment or subjected to flotation gradient 
analysis under the same conditions. In the presence of high salt and urea protein 
associated with the proteoliposomes will not be found in the same fraction with 
them, however, protein incorporated into the liposome will. 
Once it has been established that active Sec complex can be reproducibly purified 
reconstitution of SRP-dependent targeting using only purified components can be 
attempted. Sec6lp can be purified and reconstituted separately from the Sec62/63p 
complex. This will allow three questions to be addressed: what is the minimum 
translocation apparatus necessary to support co-translocational translocation in vitro, 
what role has SRO in the pathway and is Sec63p absolutely required? 
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Chapter 5 
SR1 interacts with Sec6lp 
5.1 Introduction 
The sequence of events that must occur to transfer RNC from SRP to the translocon 
is incompletely understood. As SR and the translocon provide the contact points for 
the SRP-ribosome complex on the membrane it is perhaps likely that they do 
interact, either providing a joint "landing site" or in a regulated "gating" function to 
promote transfer of nascent chains from SRP to the translocon. With this hypothesis 
as a starting point the experiments described in this chapter were carried out in 
attempts to determine if such an interaction does indeed occur. The results obtained 
strongly support an interaction between SRO and Sec6lp. 
5.2 Co-isolation of Sec6l p and SR-PrA 
While optimising conditions to purify native SR complex (see Chapter 3), 1 observed 
that a small proportion of Sec6lp co-isolated with SR. The co-isolation of Sec6lp 
only occurred when microsomal membranes used to recover SR were solubilised 
with digitonin. Figure 5.1 shows Western blots of fractions from an isolation of SR-
PrA (Chapter 3 section 3.1.3) (A) and a control experiment using non-tagged strain 
JDY3 (B). The nitrocellulose was cut using molecular weight markers as a guide and 
incubated with antibodies raised against protein A, Sec6lp and Sec62p (table 3). 
The association of Sec6lp with SRO-PrA in the pellet fraction can be clearly seen 
(panel A, compare pellet lanes). Sec62p was also detected, at a very low level, in the 
pellet fraction. Subsequent attempts to detect Sec62p co-isolating with SR failed 
(data not shown). Neither Sec6lp nor Sec62p was detected in the pellet of the 
control experiment (figure 5.1b). 
The interaction between SR-PrA and Sec6lp could have been due to an interaction 
between Sec6lp and the protein A-tag at the C-terminus of SRO. To test this 
hypothesis 3-hydroxy-3-methylglutaryl coenzyme A reductase (1IMG-CoA 
reductase), an integral ER membrane protein involved in lipid, fatty-acid and sterol 
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Figure 5.1 Co-isolation of Sec6l and Sec62p with SR-
PrA 
240 0D0 units of microsomes recovered from strains ARY1 (A) and JDY3 (B) 
(section 2.19a) were solubilised in solubilisation buffer which contained 1% 
(v/v) digitonin and 150 rnlvl KOAc (section 2.20b). Insoluble material was 
pelleted by centrifugation at 17,000 rpm for 20 min at 4°C in a Beckman JA25.5 
rotor. The soluble fractions were bound to 200 ltl IgG sepharose for 1 hr at 4°C 
and the supernates and pellets recovered. Both pellet fractions were washed 3 x 
1 ml solubilisation buffer and 2 x 1 ml TBS. 1/4 (lanes T and S, both panels) 
and 1/2 (lanes P, both panels) of the fractions were analysed by SDS-PAGE and 
Western blotting. Antibodies specific for protein A, Sec6lp and Sec62p were 
used to identify SRO, Sec6lp and Sec62p. 
Lanes for (A) 
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metabolism, was genomically protein A-tagged, the fusion protein being expressed 
from the endogenous HMG-CoA reductase promoter (section 2.6 and 2.8). 
Microsomal membranes were isolated and solubilised from this strain and HMG-
CoA reductase-PrA isolated as described for SR-PrA (section 2.20). Under these 
conditions Sec6lp could not be co-isolated with HMG-CoA reductase-PrA (data not 
shown). Therefore, the co-isolation of Sec6lp with SR was not the result of non-
specific interactions between Sec6lp and IgG Sepharose or the protein A-tag itself, 
but due to an interaction direct or indirect between Sec6lp and SRa and/or SRO. 
The interaction between SR and Sec6lp was sensitive to salt concentration. When 
the co-isolation experiment was carried out in buffer containing 500 mM KOAc 
(Figure 5.2) as opposed to 150 m KOAc (Figure 5.1) the interaction was lost and 
Sec6lp was no longer detected in the pellet fraction (Figure 5.2b, lane P). This 
suggested that the interaction between SR and Sec6Ip was relatively weak. 
However, the interaction between SR and Sec6lp may have a regulatory role or only 
be a transient contact. In this case, a relatively weak interaction may be all that is 
required and might be expected. Co-isolation of Sec62p with SR suggested the 
possibility that both the SRP-dependent and —independent translocation apparatus 
form complexes in the ER membrane. 
SRO is an ER integral membrane protein with no previously characterised function. 
Therefore, it seemed plausible that SRO was the Sec6lp interacting component. 
Deletion of either SRa or SRO results in a complete loss of SRP-dependent targeting. 
Therefore, removing one subunit of SR to study the effects on translocation 
complexes was not possible. To study the interaction in more detail two-hybrid 
analysis was employed (Section 5.3). 
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Figure 5.2 The SR-Sec6lp interaction is not seen at 
high salt concentration 
240 OD ,,() units of microsomes recovered from strain ARY! were solubilised 
in solubilisation buffer containing 500 mM KOAc (sections 2.19a and 2.20b). 
Insoluble material was pelleted by centrifugation at 17,000 rpm for 20 min at 
4°C in a Beckman JA25.5 rotor. The soluble fraction was bound to 200 p.1 
IgG sepharose for 1 hr at 4°C and the supernate and pellet recovered. The 
pellet fraction was washed 3 x 1 ml solubilisation buffer and 2 x 1 ml TBS. 
1/4 (lanes T and S, both panels) and 1/2 (lanes P, both panels) of the fractions 
were analysed by SDS-PAGE and Western blotting. Antibodies specific for 
SRa, SRO and Secólp were used to identify SR and Sec6lp. 
Lanes for (A) 	 Lanes for (B) 
T Total 	 T Total 
S Supernate 	 S Supernate 
P Pellet 	 P Pellet 
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5.3 Dissection of Sec6l p-SR3 interaction 
Two-hybrid analysis allows the identification of protein-protein interactions through 
the reconstitution of the activity of a transcriptional activator. The method (Fields 
and Song, 1989; Chien etal., 1991) is based on the properties of the yeast GAL4 
protein, which Consists of separable domains responsible for DNA-binding and 
transcriptional activation. Once separated these domains cannot interact. Plasmids 
encoding two hybrid proteins, one (the bait fusion) consisting of the GAL4 DNA-
binding domain fused to protein X and the other (the prey fusion) consisting of the 
GAL4 activation domain fused to protein Y, are constructed and introduced into 
yeast. Interaction between proteins X and Y leads to the transcriptional activation of 
a reporter gene containing a binding site for GAL4. 
Initially, all but the transmembrane domain of SRI3 was cloned into a two-hybrid bait 
vector (pAS-C) while the cytosolic domains of a variety of ER integral and 
peripheral membrane proteins were cloned into two-hybrid prey vectors (pACT II) 
illustrated in Figure 5.3. Strain CG1945 (table 1) was used to assay the plasmid 
constructs and contained iacZ and HIS3 reporter genes. A feature of cloned prey 
fusion proteins is a HA-tag (Figure 5.3). Western blotting and incubation with anti-
haemagglutanin (HA) antibodies revealed that all but 1 of the prey fusions were 
expressed (Figure 5.4, lanes 1-7). 
All combinations of bait and prey vectors were transformed into strain CG1945 for 
analysis (section 2.8). The cells were grown on solid media lacking leucine, 
tryptophan and histidine (selecting for activation of the HIS3 reporter) and media 
lacking all three but containing varying concentrations of 3-aminotriazole (3-AT). 3-
AT is an inhibitor of the product of the HIS3 gene and thus monitors the level of 
transcriptional activity of the HIS3 reporter. Weak transcriptional activation of the 
HJS3 reporter results in growth of strains with non-interacting bait and prey fusions. 
Low levels of 3-AT suppress growth of these "false positives" (Bartel and Fields 
(ed.), 1997). Figure 5.5 shows a typical result of this experiment. In panel A the 
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Figure 5.3 Schematic of two-hybrid bait and prey 
constructs 
Schematic of constructs used in two-hybrid analysis. All bait fusions (A.) have 
the GAL4 DNA binding domain (GAL4DBD) (pink) at the N-terminus of the test 
protein (yellow). All prey constructs (B.) have haemagglutanin (HA) (green) at 
the C-terminus of the test protein (yellow) and the N-terminus of the GAL4 
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Figure 5.4 Expression and visualisation of two-hybrid 
prey fusion proteins 
Combinations of bait and prey two-hybrid fusions were expressed in strain 
CG1945 (table 1) and visualised by SDS-PAGE and Western blotting. 
Antibodies specific for haemagglutanin were used to identify expressed prey 
fusions. Bait fusions were not identified. 
Lanes 
1 Sec6l-N terminus prey (pAR2H5) 
2 Loop 6 Sec6lp prey (pAR2H6) 
3 Loop 8 Sec6lp prey (pAR2H7) 
4 Cytosolic domain of Sbhlp prey (pAR2H9) 
5 Empty vector 
6 SRcx prey (pJDY187) 







Figure 5.5 Growth of cells on selective media 
Combinations of two-hybrid bait and prey fusions were expressed in strain 
CG1945. Growth of each strain described on -HLW media containing 50 m 3-
AT was monitored and tabulated (A) and plate growth of 3 strains on -HLW 
media containing 100 or 150 mM 3-AT recorded (B). 
Key to table 
N/A = growth of strains with these combinations of bait and prey fusions not 
determined 
+ = minimal growth 
++ = good growth 
thick growth 
- no growth 
Panel 4 (key for (B)) 
1 pAR2HI + pJDYI87 (SRI3 bait + SRa prey fusions) 
2 pAS-C + pAR2H5 (empty bait vector + Secôl-Nterm peptide prey fusion) 
3 pAR2HI + pAR2H5 (SRP bait + Sec6l-Nterm peptide prey fusions) 
Media 
1 -leu, -trp, -his (-HLW) 
2 -HLW, 100 mM 3-AT 
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growth of strains containing combinations of bait and prey plasmids is recorded in a 
table. Growth of each strain was on media lacking leucine, tryptophan and histidine 
(-HLW media) and containing 50 mM 3-AT. In panel B growth of 3 strains 
(containing SRO bait and SRu prey fusions, empty bait vector and N-terminus of 
Sec6lp prey fusion and SRO bait and N-terminus of Sec6lp prey fusions) on —HLW 
media alone or containing 100 mM 3-AT and 150 mM 3-AT is shown. Cells 
expressing the SRf3-GAL4BD bait fusion and the SRa prey fusion grew on media 
containing up to 200 mM 3-AT concentrations (data not shown) indicating a strong 
interaction between these two proteins. Cells expressing the SRO bait fusion and the 
Sec6l-Nterm prey fusion grew on media containing up to 150 mM 3-AT (Figure 5.5, 
panel B). Cells expressing the reciprocal combination of Sec6l-Nterm bait fusion 
and SRO prey fusion grew on media containing up to 50 mM 3-AT (Figure 5.5, panel 
A). Hence, the interaction between SRO and the Sec61-N terminal domain is weaker 
than that between SRO and SRa. Only strains expressing the SRI3-bait fusion with 
either the Sec6l-Nterm peptide or SRa grew on media containing 3-AT. Growth of 
the strain containing the empty bait vector and the Sec6l-Nterm peptide prey fusion 
on —HLW media must be due to auto-activation. 
Figure 5.6 shows the results of a blue/white test for activation of the lacZ reporter 
carried out on the SRO-GAL4BD bait fusion and the Sec6lp/Sbhlp cytosolic loop 
prey fusions. In the presence of both the SRI3-GAL4BD fusion and either the SRa or 
Sec61-Nterm prey fusion proteins -galactosidase was expressed resulting in these 
patches being bright blue on incubation in Z-buffer (section 2.36). All other patches 
remained white indicating that the lacZ gene was not activated. Combining the 
results of growth on 3-AT and the 3-galactosidase assay only three combinations of 
bait and prey fusions showed significant interaction. These are those containing the 
Sec6lp N-terminal cytosolic domain (bait or prey fusion) and SRO (prey or bait 
fusion), and the SRa prey fusion with the SRO bait fusion (positive 
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Figure 5.6 Blue/white test of two-hybrid assay positives 
Two-hybrid blue white assay was carried out as described in section 2.36. 
Combinations of bait and prey fusions expressed in CG 1945 were tested. Colour 
photo of test filter (A.), black and white photo of test filter (B.) and key to 
fusions expressed in each patch of cells (C.) are shown. 
Fusions tested 
1 pAR2I-1 I + pACTIL (SRP bait fusion and empty prey vector) 
2 pAR2I-1l + pAR2H5 (SRI3 bait fusion and Sec6l-Nterm peptide prey fusion) 
3 pAR2H 1 + pJDY 187 (SRI3 bait fusion and SR(t prey fusion) 
4 pAR2I-1l + pAR2H6 (SRP bait fusion and Sec6 1-loop 6 prey fusion) 
5 pAR2H1 + pAR2H7 (SRI3 bait fusion and Sec6 1-loop 8 prey fusion) 
6 pAR2HI + pAR2H9 (SRP bait fusion and Sbhl-cytosolic domain prey fusion) 
7 pAS-C + pAR2H5 (empty bait vector and Sec6 1 -Nterm peptide prey fusion) 
8 pAS-C ± pJDY 187 (empty bait vector and SR(x prey fusion) 
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control). Therefore, out of all the prey fusion proteins tested only SRa and the 
Sec6l-N terminal domain interact with SRO. 
With the caveat that two-hybrid analysis can yield false positive results these data 
indicate that the N-terminal cytosolic domain of Sec6lp interacts with the cytosolic 
domain of SRO. This interaction may be transient in vivo but is maintained long 
enough in a two-hybrid assay to support growth on high concentrations of 3-AT and 
express 13-galactosidase. One model of the functional significance of this interaction 
may be that the cytosolic domains of the two proteins interact in a regulatory 
capacity, allowing the transfer of RNC to the translocon only when a vacant site is 
available. It has been suggested that Sec6lp may act as a GEF for SRO (Fulga et al., 
2001) while ribosomal proteins acts as a GAP (Bacher et al., 1999). Perhaps the N-
terminal domain of Sec6lp recruits SRP-SR-RNC complexes through the interaction 
with SRO, the ribosome acting as a GAP for SRO while Sec6lp acts as a GEF once 
transfer of the RNC is complete or to stimulate the transfer itself. 
54 Cross-linking and immunoprecipitation of microsomal 
membrane proteins 
The data in sections 5.2 and 5.3 support a weak and/or transient interaction between 
SR and Sec6lp. To attempt to demonstrate this interaction or the proximity of SR 
and Sec6lp directly cross-linking and immunoprecipitation were carried out. The 
non-cleavable cross-linker disuccinimidyl suberate (DSS) was added to microsomal 
membranes for varying lengths of time (section 2.26). The membranes were then 
solubilised and proteins immunoprecipitated from the soluble fraction (section 2.25). 
Figure 5.7 shows a Western blot of a typical cross-linking reaction and 
immunoprecipitation of protein with anti-SRI3 antibodies. The load, supernate and 
pellet fractions from the immunoprecipitation were analysed by SDS-PAGE 
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Figure 5.7 Cross-linking and immunoprecipitation of SR 
Cross-linking of and immunoprecipitation from 240 OD, 80 units of microsomes 
recovered from strain JDY3 were carried out as described in section 2.25 and 
2.26. Microsomes with cross-linker (lanes 4-6, 10-12 and 16-18) and 
microsomes without (lanes 1-3, 7-9 and 13-15) were solubilised and 
immunoprecipitated with anti-SRO. 1/8 of the total fraction (lanes 1,4,7, 10, 13 
and 16), 1/4 of the supernate fractions (lanes 2,5,8, 11, 14 and 17) and 1/4 of the 
pellet fractions (lanes 3, 6, 9, 12, 15 and 18) were analysed by SDS-PAGE and 
Western blotting. Antibodies specific for SRO (lanes 1-6), Sec6lp (lanes 7-12) 
and SRa (lanes 13-18) were used to identify cross-linked complexes containing 
SR and Sec6lp. 
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separately three times so that the nitrocellulose could be incubated with three 
different primary antibodies at once. Ponceau S staining of the nitrocellulose prior to 
antibody incubation revealed that addition of cross-linker resulted in a shift of low 
molecular weight proteins to larger, presumably cross-linked complexes. This was 
also seen on the immunoblots as monomeric SRoc and P were all reduced in 
abundance. However, it is not clear where these cross-linked protein complexes 
migrate to on the protein gel. Also, comparing lanes 3 and 6 It is evident that upon 
addition of cross-linker there is no longer any immunoprecipitation of free SRO. It 
appears that after addition of cross-linker the anti-SRO antibodies lose their ability to 
recognise SRO. The antibodies also do not immunoprecipitate any complexes 
containing SRO as none are seen with any of the antibodies tested. This may be due 
to the epitopes recognised by the antibodies being modified by cross-linker and/or 
cross-linked to other proteins. To circumvent this problem the cross-linking reaction 
was repeated with microsomal membranes isolated from a strain expressing SR- 
PrA. The presence of the protein A-tag allowed purification of cross-linked protein 
complexes using IgG Sepharose. The problem with this technique involved the 
reactivity of protein A to secondary antibodies and enhanced chemiluminescence 
(ECL). The presence of the protein A-tag allowed the identification of complexes of 
cross-linked protein that migrated to higher molecular weight positions on the protein 
gel. However, it was impossible to determine which proteins were in the complexes 
as the protein A-tag cross-reacted strongly with anti-rabbit secondary antibodies. 
The conclusions drawn from these experiments were that upon cross-linking of 
microsomal membrane proteins anti-SRI3 antibodies no longer recognise free or 
SR3-containing protein complexes, and that protein A-tags render cross-linking 
patterns uninterpretable. 
Cross-linking of microsomal membranes and immunoprecipitation of complexes 
containing SRO may still be a useful technique to isolate proteins that interact 
transiently with SRO. Other approaches could involve the use of a hexa-histidine 
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(HIS 6) or glutathione-S-transferase (GST) tag on SRO. These would allow 
I mmunoprecipitation of cross-linked complexes containing SRO while eliminating 
the problem of cross-reactivity encountered with the protein A-tag. Another 
approach might be to raise another antibody against SRO in the hope that these 
antibodies might not be so affected by the presence of cross-linker in the samples. 
5.5 Discussion and future work 
An association between SRO and Sec6lp was demonstrated using a pull down assay 
(section 5.2) and has been dissected by two-hybrid analysis (section 5.3). The 
interaction was shown to involve the N-terminal cytosolic domain of Sec6lp and the 
cytosolic domain of SRO. However, cross-linking and immunoprecipitation of 
complexes containing SRO and other proteins was unsuccessful (section 5.4). The 
next step should be to try and demonstrate the interaction using other biochemical 
methods. One possibility would be to immobilise an N-terminal peptide of Sec6lp 
on a chromatography column and to examine any interaction between the Sec6lp N-
terminal domain and recombinant SRO. This could enable several important 
questions to be studied regarding the interaction. Does the interaction require GTP? 
Can the complex be trapped or dissociated by non-hydrolysable analogues of GTP or 
GDP respectively? Does the interaction require the presence of other factors such as 
ribosomal proteins, ribosomes or RNCs? 
A related experiment was attempted using a 10- and 100-fold molar excess of N-
terminal peptide of Sec6lp, over endogenous Sec6lp, added to a 
translation/translocation assay (section 2.33/2.34). This was carried out to determine 
if the peptide would exhibit any inhibitory effects through its interaction with SRO. 
Translocation of SRP-dependent and —independent substrates was monitored (Figure 
5.8). No inhibition was observed for either SRP-dependent or —independent 
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Figure 5.8 Inhibition of protein translocation by Sec6lp-
Nterminal peptide 
The effects of the N-terminal peptide of Sec6lp (sequence 
SSNRVLDLFKPFESFLPEVIAP, corresponding to residues 2-22 of Sec61p) on 
translocation of in vitro radiolabefled DcF  (lanes 1,3,5,7,9, 11 and 13) and 
ppaF (lanes 2, 4, 6, 8, 10 and 14) were tested as described in section 2.35. 
Translocation was monitored by SDS-PAGE and phosphoimage analysis. 
Lanes 
1 0 microsomes, 0 peptide 
2 0 microsomes, 0 peptide 
3 microsomes, 0 peptide 
4 microsomes, 0 peptide 
5 microsomes, 5 tM peptide 
6 microsomes, 5 tM peptide 
7 microsomes, 500 nM peptide 
8 microsomes, 500 nM peptide 
9 microsomes, 50 .tM peptide 
10 microsomes, 50 tM peptide 
11 microsomes, 500 pM peptide 
12 microsomes, 500 p.M peptide 
13 microsomes, 500 p.M control peptide 
14 microsomes, 500 p.M control peptide 
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substrates indicating that the N-terminal domain of Sec6lp alone in solution is 
insufficient to affect protein targeting. However, once immobilised it may be 
possible to determine the conditions required for its interaction with SRO. 
Another possibility would be to carry out a synthetic lethal screen with Sec6lANterm 
and/or SRI3ATM and other cold sensitive alleles of SEC61. Synthetic lethal screens 
can allow the identification of proteins that interact within the same pathway in the 
cell and may lead to the identification of other domains within Sec6lp important for 
the interaction with SRO. A synthetically negative interaction has been identified 
between Sec61Nterm and SRATM (B. Wilkinson and C. Stirling, personal 
communication) supporting the existence of a physiologically important interaction 
between SRO and Sec6lp. In addition, recent work utilising the split ubiquitin assay 
(coupled to growth on —URA media) provided evidence of close physical proximity 
between SRO and both Sec6lp and Sshlp (Wittke etal., 2002). As Sshlp is 
proposed to comprise the major subunit of an entirely SRP-dependent translocon 
(Wilkinson et al., 2001) the observed proximity to SRO strengthens the argument for 
Sshlp in this role. The observed interaction between SRO and Sec6lp in the split 
ubiquitin assay provides further evidence that this interaction has a significant role in 
SRP-dependent targeting in vivo. 
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Discussion and future work 
The broad aims of this study were to identify the functions of SRO and to identify 
and study interactions of SRO that take place during SRP-dependent targeting. A 
major goal was the purification of proteins necessary for and reconstitution of SRP -
dependent co-translational translocation. Previous work with mammalian proteins 
established the requirement for Sec6lp and SR in SRP-dependent co-translational 
translocation (Gorlich and Rapaport, 1993). In addition, there is genetic evidence in 
yeast for a requirement for Kar2p and Sec63p in co-translational translocation 
(Young et al., 2001). However, the role of SRO in co-translational translocation has 
not been established save as a membrane anchor for SRa with a GTPase domain 
essential for its function (Ogg et at., 1998). Post-translational translocation was 
reconstituted using purified yeast components establishing the requirement for the 
Sec62/63p complex in SRP-independent targeting (Panzner et at., 1995). Therefore, 
reconstitution of protein translation and translocation is an established method used 
to elucidate involvement of a protein in targeting. 
Protocols for the over-expression and large-scale purification of SR were developed 
and described. Conditions under which SR can be bound and eluted from a variety 
of ion-exchange resins for further purification and buffer exchange are also detailed. 
Finally, the purification of sufficient quantity of SR to allow reconstitution 
experiments to be undertaken was described (Chapter 3). 
The preparation of all of the materials necessary to reconstitute SRP-dependent 
targeting and the optimisation of each step in the translationitranslocation reaction 
are summarised. I describe the purification of active yeast SR (Chapter 3), Kar2p, 
the Sec complex and bacterially over-expressed SR-ATM3 and their reconstitution. I 
have discussed previously the belief that over-expressing each subunit of SR at the 
same level would facilitate purification of larger quantities of protein for 
reconstitution and thus should be the next logical step. Also, reconstitution of a 
mock purified fraction from a strain with non-tagged SR should be carried out to be 
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convinced that purified SR, and not an unknown contaminant, is stimulating SRP-
dependent translocation in the in vitro assay. Finally, I have shown the reconstitution 
of SRP-dependent targeting using yeast components and demonstrated that Kar2p is 
necessary to stimulate SRP-dependent translocation in this in vitro system. 
An interaction between SRO and Sec6lp was demonstrated and dissected using two- 
hybrid analysis (sections 5.2 and 5.3). This interaction is localised to the N-terminal 
cytosolic domain of Sec6lp and the cytosolic domain of SRO. An interaction was 
also identified between SR and Sec62p. It could be speculated that the components 
involved in each translocation pathway form a specific complex (of Sec6lp, 
Sec62/63p and SR) in the membrane until contacted by either a post-translational 
dependent signal sequence or a translating ribosome. The complexes would then 
dissociate allowing co- or post-translational translocation to proceed. While this may 
be the case, I was unable to co-isolate Sec62p with SR again suggesting that this 
result was somehow artifactual. Despite many attempts, cross-linking and/or 
immunoprecipitation of complexes containing SRO and other proteins failed to 
provide further evidence of the interaction with Secólp. Cross-linking may be a 
useful tool in the future, as new antibodies against SRO have been generated. 
Previously, upon cross-linking the antibodies could no longer recognise SRO or 
complexes containing SRO. As this was likely due to the antibodies new antibodies 
may now be able to recognise SRO epitopes even after addition of cross-linker. 
The work that I have carried out in this study can be related to the model for SRP-
dependent targeting that I proposed in the introduction. The model was based on all 
of the relevant data in the field and my own discovery of an interaction between SRO  
and Sec61p. In this model, (Figure 1.5) binding of SRO to a ribosomal protein 
stabilises the empty conformation of the GTPase domain of SRO. The stable empty 
conformation leads to dissociation or significant structural rearrangement of SR( and 
SRO but stable binding between GTP-bound SRa and GTP-bound Srp54p ensures 
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the RNC-SRP-SR complex remains intact on the membrane. At the point in the 
targeting cycle when SRO is bound not only by the ribosomal protein but also by 
Secôlp this stimulates GTP binding and hydrolysis by SRO allowing dissociation of 
the RNC-SRP-SR complex and docking of the RNC on the translocon. SRcx and 
Srp54p reciprocally stimulate each other's GTPase activities, SRa and Srp54p 
dissociate and SRa and SRO re-associate or regain their usual conformation on the 
ER membrane. This mechanism of protein targeting ensures that transfer of the RNC 
to the translocon can only take place when each are in close proximity to one 
another. Presumably, binding of SRO to Sec6lp would be inhibited should the 
translocon be occupied by another translating ribosome or engaged in translocation 
of a post-translational substrate. This model can also be applied to the sequence of 
events leading up to translocation through an Sshlp translocon. The recently 
demonstrated proximity of SRO to Ssh I  strongly suggests that binding of SRO to 
Sshlp or Sec6lp is interchangeable (Wittke et al., 2002). In the case of targeting to 
the Sshlp translocon, binding of SR to Sshlp and the ribosome would stimulate 
GTP binding and hydrolysis and allow transfer of the RNC to the translocon. 
Dissociation of SRa and SRO during protein targeting has not been observed: indeed 
the subunits have previously only been purified as a stable complex. It can be 
assumed that if the proteins do dissociate during each cycle of targeting then it is 
only transient and you should not see it as they are still held within the targeting 
complex. Presumably, as dissociation has not been observed the empty state of the 
GTP binding domain of SRO, stabilised by the ribosome, must be transient. Should 
cell lysis occur when this empty state is stable dissociation of SRO and the ribosome 
would lead to GTP binding by SRO and re-association of the subunits of SR. 
Despite an enormous amount of analysis of the targeting and translocation pathways, 
there are still many questions to be answered. SRP is conserved throughout all three 
kingdoms of life but differences still exist in the composition of the proteins involved 
Discussion and future work 	 215 
in and the mechanisms of SRP-dependent co-translational translocation. It will be 
very interesting to learn fully which aspects of the pathway are specific to a 
particular organism and which are general to all. 
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Appendix 2 Production of affinity purified polyclonal 
antibodies 
During this study polyclonal antibodies were raised against SRa and SRO in order 
that these proteins might be immunoprecipitated and/or visualised by 
immunoblotting. 
Plasmids containing fusions of the genes encoding SRcx (pGEXSRPIOI) and SRO 
(pS0488) with glutathione-S-transferase (GST) were kind gifts of Prof. P. Walter 
(U.C. San Francisco) (table 2). The fusion proteins were over-expressed in bacteria, 
purified on glutathione agarose (section 2.l lc) and used to immunise rabbits. 
The polyclonal antibodies were affinity purified as described (section 2.18b) using 
GST-fusions of SRa and SRO, identical to those originally used for rabbit 
inoculation. Affinity purified antibodies were tested by using them to probe Western 
blots of proteins from wild type and SRL\ microsomes. The affinity purified antibody 
raised against SRc recognises a protein of the correct molecular weight in samples of 
microsomes prepared from yeast cells. This is also the case for the affinity purified 
antibody raised against SRO. This recognition is absent when samples of 
microsomes that do not contain SRcx or SRO are used. Both antibodies were titrated 
for optimum dilution for Western blotting and were found to be 1:1000 for both 
antibodies. These results are shown in Figure A2. 1. 
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Figure A2.1 Titration of affinity purified antibodies 
0.8 0D 180 units of microsomes recovered from strain JDY3 (wild-type) and 
5DY72 (SR deficient) (table 1) were analysed by SDS-PAGE and Western blotting 
(JDY3, panel A, lanes 1, 3, 5, 7, 9, 11,13 and 15; JDY72, panel A, lanes 2, 4, 6, 8, 
10, 12,14 and 16). Fractions collected from the affinity purification of these 
antibodies were also analysed (materials and methods, lanes 5-10) Dilutions of 
antibodies specific for SR( (panel B, lanes 1-5) and SRO (panel A, lanes 1-16; 
panel B, lanes 6-10) were used to identify SR. 
Lanes for (A) 
	
Lanes for (B) 
1 and 2 Pre-immune serum 
	
1 1:10,000 anti-SRct 
3 and 4 Production bleed 
	
2 1:5000anti-SRct 
5 and 6 Flow through of GST column 
	
3 1:2000 anti-SRa 
7 and 8 Flow through 2 of GST column 	4 1:1000 anti-SRa 
9 and 10 Wash 	 5 1:500 anti-SRcx 
11 and 12 Dialysate 1:5000 	 6 1:10,000 anti-SRO 
13 and 14 Dialysate 1:1000 	 7 1:5000 anti-SR3 
15 and 16 Dialysate 1:500 	 8 1:2000 anti-SR 
9 1:1000anti-SR 
10 1:500 anti-SR3 
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